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Abstract 
 
A biofilm is a complex community of cells enveloped in a self-produced polymeric 
matrix. Entry into a biofilm is exquisitely controlled at the level of transcription and in 
Bacillus subtilis it requires the concerted efforts of several major transcription factors 
including the repressor SinR and the activator DegU.  I initially identified that these 
transcriptional regulators control biofilm formation via parallel pathways. Through 
investigating the regulation of biofilm formation by SinR and DegU, I discovered that 
biofilm formation is also regulated at the post-translational level. This was achieved by 
identifying three key proteins which are needed for biofilm formation. These proteins 
are PtkA, a bacterial tyrosine kinase; TkmA, the cognate modulator of PtkA; and PtpZ, 
a bacterial tyrosine phosphatase.  By introducing amino acid point mutations within the 
catalytic domains of PtkA and PtpZ it was identified that the kinase and phosphatase 
activities, respectively, are essential for function. In addition, PtkA contains a conserved 
C-terminal tyrosine cluster that is the site of autophosphorylation. Investigation of the 
role of the C-terminal tyrosine cluster tentatively suggests that this domain acts to block 
access to the active site of PtkA, thus affecting the ability of PtkA to phosphorylate its 
targets. Deletion of the gene coding for TkmA demonstrated that this modulator was 
also required for biofilm formation. It was also demonstrated that TkmA may interact 
with other protein partners, at least in the absence of PtkA, raising the question of how 
signal specificity is maintained.  Finally, a systematic mutagenesis approach was used 
with the aim of identifying the target(s) of PtkA and PtpZ during biofilm formation but, 
despite extensive efforts, it remained elusive. The findings presented in this thesis 
highlight the complexity of biofilm formation by B. subtilis by revealing an additional 
level of regulation in the form of protein tyrosine phosphorylation. 
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Chapter 1 - Introduction 
 1
1 Introduction 
1.1 Multicellular behaviour displayed by bacteria 
Bacteria are capable of living in a wide range of different environments which can be 
changeable, and at times, unfavourable.  Bacteria may encounter environmental stresses 
which include, but are not limited to, high salinity, DNA damage by exposure to UV, 
desiccation, and nutrient limitation.  Displaying multicellular behaviour is one method 
that bacteria use to cope with these stresses (Shapiro 1998).  Multicellularity is defined 
here as a type of behaviour that requires cooperation from a population of cells in order 
for a task to be accomplished. By utilising the multicellular potential within the 
population, the cells can achieve tasks which they would otherwise not be able to 
accomplish as individuals. Cooperation of the population depends on being able to 
correctly activate the appropriate behaviour, at the right time. Therefore communication 
between bacteria within the population is paramount. 
Examples of multicellular behaviour displayed by bacteria include swarming motility,  
the secretion of exoproteases for acquiring nutrients, and quorum sensing which is a 
mechanism for detecting population size that is often coupled to triggering behaviours 
which rely on high cell density for success (Shapiro 1998). In addition to these 
examples, many different species of bacteria can form biofilms. The multicellular 
behaviour of biofilm formation will be discussed in more detail in section 1.1.1. 
 
1.1.1 Biofilm formation 
In their natural habitats, bacteria will exist predominantly as part of a biofilm 
(Costerton, Lewandowski et al. 1995).  A biofilm is described here as a dense 
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population of cells that forms either attached to a surface or at an air-liquid interface 
that is surrounded by a self produced exopolymeric matrix.  When forming at the air-
liquid interface, biofilms are referred to as pellicles. However, biofilms are far more 
than a dense population of homogenous cells. Within a biofilm of genetically identical 
bacteria, groups of cells can differentiate into specialised sub-populations whose roles 
include producing enzymes, extracellular proteins or polysaccharides which the 
population as a whole will utilise (Lopez, Vlamakis et al. 2010).    Through division of 
labour, the population can achieve multiple ‘multicellular’ tasks simultaneously, thus 
increasing the chance of survival for the population in a changeable environment.  
Biofilm formation is therefore a very useful survival strategy for bacteria. 
There are many practical reasons for studying biofilm formation.  The study of biofilms 
can provide a simplified model for the investigation of how cell function is controlled in 
a multicellular structure. Also, biofilms have long been associated with chronic 
infections (Hoiby, Bjarnsholt et al. 2010). A contributing factor to the association of 
biofilms and chronic infection is the fact that bacteria living within a biofilm are far 
more resistant to antibiotics than their planktonic counter-parts, which can make the 
treatment of chronic infections more challenging (Hoiby, Bjarnsholt et al. 2010).  
Conversely, biofilms can act as a biocontrol agent, colonising the rhizosphere and 
preventing fungal and bacterial infections of commercially important crops such as 
potato (Morikawa 2006).    For these, and many other, reasons biofilms are an attractive 
bacterial lifestyle to study. 
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1.1.2 Bacillus subtilis  
 
Bacillus subtilis is a Gram-positive bacterium commonly found in soil that has been 
extensively studied under laboratory conditions for many decades.  Due to the extensive 
laboratory use of B. subtilis and the subsequent vast knowledge of its physiological, 
biochemical and genetic pathways, B. subtilis is considered to be a model organism for 
Gram-positive bacteria in the way that Escherichia coli is for Gram-negative bacteria.  
The growing use of B. subtilis as a tool for investigating many different processes, and 
its industrial relevance, prompted the sequencing of the complete genome in 1990.  The 
genome sequence of the B. subtilis isolate 168 was subsequently completed in 1997 and 
the chromosome was found to contain approximately 4,100 genes (Kunst, Ogasawara et 
al. 1997). The 168 strain is a domesticated isolate of B. subtilis (Burkholder and Giles 
1947).  In this case, the term domesticated is used to describe an isolate which has lost 
certain characteristics that its progenitor strain possesses such as the ability to form 
robust biofilms or to swarm, but has improved traits such as its ease of genetic 
manipulation. The progenitor strain of 168 is the undomesticated B. subtilis isolate, 
NCIB3610, which is strongly believed to be a descendant of the original Marburg strain 
of B. subtilis that was first isolated from soil in Marburg, Germany (Zeigler, Pragai et 
al. 2008). The 168 isolate was constructed by exposing the Marburg strain to UV and X-
ray mutagenesis (Burkholder and Giles 1947).  The resulting 168 strain was auxotrophic 
for tryptophan and was subsequently found to grow well on a defined medium under 
laboratory conditions (Burkholder and Giles 1947). It was later identified that the 168 
isolate could be readily transformed with DNA from other domesticated B. subtilis 
strains (Spizizen 1958). 
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The extensive use of B. subtilis under laboratory conditions can be attributed to several 
factors. In addition to its ease of genetic manipulation, B. subtilis is a spore forming 
bacterium (Sonenshein 2000) that provides a simplified system to increase our 
understanding of complex processes such as cell division and development. 
Furthermore, B. subtilis is a ‘safe’ organism that shares significant similarity with 
pathogenic bacteria including Bacillus cereus, which causes food poisoning 
(Drobniewski 1993); Bacillus anthracis, which forms spores capable of causing fatal 
pulmonary and gastrointestinal infections (Spencer 2003); and Listeria monocytogenes 
which can spoil dairy produce and cause listeriosis (Farber and Peterkin 1991).  
As well as its basic scientific interest, B. subtilis is also used extensively in industrial 
settings.  For example, the enzyme subtilisin is one of several industrially important 
secreted enzymes produced by B. subtilis (Morikawa 2006) and was an important 
predecessor to the enzymes found in modern biological washing powders (Gupta, Beg 
et al. 2002). Production of the fermented soybean foodstuff, natto, is produced by B. 
subtilis natto isolates (Nishito, Osana et al. 2010) and B. subtilis is also used 
agriculturally as a biocontrol agent (Emmert and Handelsman 1999).  For these reasons 
it is of interest to understand the formation of biofilm formation by B. subtilis. 
 
1.2 Biofilm formation by B. subtilis 
1.2.1 Structural components of the B. subtilis biofilm matrix 
 
An important component of the biofilm is the self-secreted complex exopolymeric 
matrix which supports cells living within the biofilm (Sutherland 2001; Flemming and 
Wingender 2010).  Despite the significant genetic variation between different species of 
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biofilm-forming bacteria, bacterial biofilm matrices possess common attributes. The 
matrix is largely composed of water, polysaccharides, cellular proteins and some 
bacteria also use extracellular nucleic acids to support the formation of the biofilm 
matrix (Flemming and Wingender 2010).   
It has been previously demonstrated that a polysaccharide component and a protein 
component of the biofilm matrix of B. subtilis are essential for biofilm formation 
(Branda, Gonzalez-Pastor et al. 2001; Kearns, Chu et al. 2005; Chu, Kearns et al. 2006). 
In the sections below I will introduce these components in more detail and I will also 
introduce other genes which encode proteins of unknown function which are also 
essential for biofilm formation by B. subtilis. 
 
1.2.1.1 EPS is essential for biofilm formation by B. subtilis 
 
The extracellular polysaccharide component (EPS) is synthesised by the proteins 
encoded by the 15 gene epsA-O operon (formally known as yveK-yvfF operon) (Kearns, 
Chu et al. 2005) (Figure 1-1).   
 
 
Figure 1-1: Schematic representation of the epsA-O operon 
Organisation of the epsA-O operon on the chromosome is depicted to scale; genes flanking the epsA-O 
operon are depicted in grey; the location of the regulatory RNA element (EAR-element) (Irnov and 
Winkler 2010) is indicated by an arrow between epsB and epsC.  The numbers represent the location on 
the chromosome with respect to the origin of replication. 
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Deletion or disruption of this operon results in a severe loss of colony complexity, 
which clearly demonstrates the important role of the polysaccharide component during 
the formation of robust biofilms (Branda, Gonzalez-Pastor et al. 2004; Kearns, Chu et 
al. 2005) (Figure 1-2).   
 
 
Figure 1-2: Colony morphology of eps, tasA, yuaB and yvcA mutants 
Strains NCIB3610, ΔepsA-O, ΔtasA, ΔyuaB and ΔyvcA were grown on MSgg media for 40h at 37˚C. 
Scale bar represents 5 mm.   
 
 
The biochemical composition of the polysaccharide synthesised by the EpsA-O 
machinery is currently unknown.  Furthermore, the function of all of the proteins 
encoded by the epsA-O operon is not yet known.  However it is known that most 
members of the epsA-O operon are essential for the correct synthesis of the EPS as 
successive deletion of the first 14 genes (epsA-N) results in the formation of fragile 
pellicles (Nagorska, Ostrowski et al. 2010). One protein for which more information is 
known is EpsE.  EpsE is a dual-functional protein which acts to regulate matrix 
production and motility (Guttenplan, Blair et al. 2010).  EpsE interacts with the B. 
subtilis flagella motor, known as FliG, and acts to uncouple the motor from the flagella, 
thus inhibiting motility (Blair, Turner et al. 2008; Guttenplan, Blair et al. 2010).  In 
addition to its role during motility, EpsE is also a putative family II glycosyltransferase 
(Blair, Turner et al. 2008). 
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Consistent with biofilm formation being a highly regulated process, the transcription of 
the epsA-O operon is tightly controlled (see section 1.2.2) and full transcription of the 
epsA-O genes requires the presence of an EAR-element (eps-associated RNA) (Figure 
1-1), which allows progression of RNA polymerase (Irnov and Winkler 2010). The 
environmental signal to which the EAR-element responds is currently unknown. 
 
1.2.1.2  The TasA protein is essential for biofilm formation by B. subtilis 
 
In addition to the EPS found in the biofilm matrix, B. subtilis requires the production of 
a protein called TasA to form robust biofilms (Branda, Chu et al. 2006; Chu, Kearns et 
al. 2006) (Figure 1-2).  TasA is encoded by the third gene in the yqxM-sipW-tasA 
operon (Stover and Driks 1999) (Figure 1-3).   
 
 
Figure 1-3: Schematic representation of the yqxM-sipW-tasA operon 
Organisation of the yqxM-sipW-tasA operon on the chromosome is depicted to scale; genes flanking the 
yqxM-sipW-tasA operon are depicted in grey. The numbers represent the location on the chromosome 
with respect to the origin of replication. 
 
 
TasA was first identified due to its antibacterial properties and its role as a component 
of the mature spore coat (Stover and Driks 1999).  It was subsequently shown that TasA 
formed a significant component of the biofilm matrix and that mutant strains for tasA do 
not form robust biofilms (Branda, Chu et al. 2006; Chu, Kearns et al. 2006) (Figure 
Chapter 1 - Introduction 
 8
1-2).  Recently, it has been demonstrated that TasA forms amyloid fibres which 
presumably give structural support to the matrix architecture (Romero, Aguilar et al. 
2010).  Also encoded within the yqxM-sipW-tasA operon is the protein YqxM, which is 
required for biofilm formation (Branda, Chu et al. 2006; Chu, Kearns et al. 2006).  The 
presence of TasA in the matrix relies on expression of YqxM (Branda, Chu et al. 2006) 
and it was subsequently identified that YqxM acts by anchoring the TasA fibres to the 
cell (Kolodkin-Gal, Romero et al. 2010).  
YqxM is translationally coupled to the second gene product, called SipW, which is 
essential for biofilm formation (Hamon, Stanley et al. 2004; Chu, Kearns et al. 2006).  
SipW is a signal peptidase (Tjalsma, Bolhuis et al. 1998) and is responsible for 
processing TasA by removing the 27 amino acid signal sequence from the N-terminal of 
TasA prior to export out of the cell (Stover and Driks 1999).   
 
1.2.1.3 Additional components that are required for biofilm formation 
 
In addition to the well-characterised EPS and TasA components of the biofilm matrix, 
additional proteins and a polysaccharide have been identified as important for biofilm 
formation and may assist in providing the biofilm with additional structural support. 
One component is the putative membrane anchored lipopeptide YvcA (Tjalsma, 
Kontinen et al. 1999).  YvcA was identified as being essential for robust biofilm 
formation by Verhamme et al. (Verhamme, Kiley et al. 2007) (Figure 1-2).  Strains 
lacking yvcA displayed a gross loss of colony architecture, yet its exact role during 
biofilm formation remains to be established. YuaB is an additional component required 
for biofilm formation (Kobayashi 2007; Verhamme, Murray et al. 2009) (Figure 1-2).  
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Again, the exact function of YuaB during biofilm formation remains to be established. 
Also required for biofilm formation is YoaW, a predicted secreted protein which 
functions to activate the latter stages of biofilm formation through an undefined method 
in a laboratory isolate of B. subtilis (Hamon, Stanley et al. 2004). The requirement of 
yoaW during biofilm development has been brought into question as other groups have 
shown that mutations in yoaW do not significantly alter colony phenotype in an 
undomesticated isolate of B. subtilis (Chu, Kearns et al. 2008). However, the use of 
different isolates of B. subtilis may explain this discrepancy. Another component which 
is required for biofilm formation is the polysaccharide γ-polyglutamic acid (γ-PGA). 
However, it must be noted that γ-PGA is not required by all isolates of B. subtilis 
(Stanley and Lazazzera 2005), including the undomesticated NCIB3610 strain that was 
used in this study (Branda, Chu et al. 2006). 
 
1.2.2 Transcriptional regulation of biofilm formation by B. subtilis 
 
The formation of a biofilm is a highly regulated process. As such the level of 
transcription and timing of transcriptional activation of the operons required for robust 
biofilm formation must be tightly regulated.  To achieve this, B. subtilis has developed a 
complex regulatory network to control biofilm formation which relies on the activation 
of two major transcriptional regulators, Spo0A and DegU.  In the next sections I will 
discuss the mechanisms by which Spo0A and DegU regulate biofilm formation.  
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1.2.2.1 Spo0A activates biofilm formation 
 
Spo0A is a transcriptional activator of B. subtilis biofilm formation (Branda, Gonzalez-
Pastor et al. 2001; Hamon and Lazazzera 2001). Originally, Spo0A was identified as 
essential for the development of environmentally resistant endospores (Sonenshein 
2000).  Later it was noted by Branda et al. that an undomesticated isolate of B. subtilis 
deleted for spo0A was unable to form spores and that this mutation also resulted in a 
loss of biofilm formation in comparison to the wild type strain (Branda, Gonzalez-
Pastor et al. 2001).   In addition, an independent investigation by Hamon et al. using a 
domesticated B. subtilis isolate noted that mutation of spo0A resulted in a dramatic 
reduction in biofilm depth (Hamon and Lazazzera 2001). Since these discoveries, a 
significant effort has been made to identify the mechanism by which Spo0A activates 
biofilm formation.  An important step during the regulation of biofilm formation is the 
phosphorylation of Spo0A. In the following section I will introduce the mechanism by 
which Spo0A becomes phosphorylated. 
 
1.2.2.1.1 Activation of Spo0A requires phosphorylation via a phosphorelay cascade 
 
Spo0A is activated by phosphorylation and this is mediated through a phosphorelay 
cascade which is initiated by the histidine kinases KinA-E and includes the sporulation 
initiation phosphotransferases Spo0B and Spo0F (Sonenshein 2000) (Figure 1-4).  It 
was demonstrated by Hamon et al. that only KinC, KinD and KinE were required for 
activating biofilm formation in a domesticated isolate of B. subtilis (Hamon and 
Lazazzera 2001).  The role of KinE during biofilm formation has since been disputed as 
a mutant strain for kinE did not appear to differ from the wild type undomesticated B. 
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subtilis strain (McLoon, Kolodkin-Gal et al. 2010). However it must be noted that these 
studies were conducted using different B. subtilis isolates and this may account for the 
differences observed.  It is interesting to note that while the initiation of biofilm 
formation and sporulation are linked by a common transcriptional regulator (Spo0A), 
the kinases required to trigger the activation of each developmental process appear to be 
clearly defined (Sonenshein 2000; Hamon and Lazazzera 2001).  
 
 
Figure 1-4: The Spo0A phosphorelay system 
Schematic representation of the phosphorelay system culminating in the phosphorylation and activation 
of the transcriptional regulator Spo0A. The circles containing A, B, C, D and E denote the kinases which 
feed into the phosphorelay system. The grey semi-circle represents the cell membrane. Spo0E is a 
phosphatase which dephosphorylates Spo0A~P. 
 
 
 
Little is known about the environmental signals that trigger the activation of the kinases; 
however it has been shown that KinC phosphorylates Spo0A in response to potassium 
leakage caused by the interaction of the cell with the extracellular lipopeptide surfactin 
(Lopez, Fischbach et al. 2009).  Additionally KinC has been shown to respond to sub-
lethal doses of the biocide ClO2  (Shemesh, Kolter et al. 2010).  Thus, KinC is able to 
sense cell stresses, such as a reduction in membrane potential, and can respond to this 
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by phosphorylating Spo0A and promoting biofilm formation. The role of KinD during 
the phosphorylation of Spo0A has also been investigated.  It has been proposed that 
KinD acts as both a kinase and a phosphatase, maintaining Spo0A~P at a low level until 
a signal is sensed. On detection of the appropriate signal KinD then acts only as a kinase 
and subsequently increases Spo0A~P in the cell to a level sufficient to trigger 
sporulation (Aguilar, Vlamakis et al. 2010).  It is thought that KinD changes from acting 
as a phosphatase to a kinase in response to the presence of extracellular matrix 
components (Aguilar, Vlamakis et al. 2010). In addition to the activity of the 
aforementioned kinases, the level of Spo0A~P is further regulated by the presence of 
Spo0A~P specific phosphatase called Spo0E (Figure 1-4) (Ohlsen, Grimsley et al. 
1994). 
 
1.2.2.1.2 Mid-levels of Spo0A~P activate biofilm formation  
 
Spo0A~P regulates the transcription of approximately 120 genes.  Furthermore, a range 
of thresholds has been determined which group these genes by the intracellular level of 
Spo0A~P required to activate or inhibit their transcription (Molle, Fujita et al. 2003; 
Fujita, Gonzalez-Pastor et al. 2005).  Sporulation is a last resort survival mechanism 
utilised by sporulation competent bacteria during prolonged periods of stress and 
consistent with this the level of intracellular Spo0A~P required to activate sporulation is 
higher than that of biofilm formation.  Having a single transcriptional regulator that is 
able to regulate multiple behaviours provides the cell with the ability to integrate 
divergent processes in response to changing environmental signals. 
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In the following sections I shall discuss the role of Spo0A~P during biofilm formation 
and it should be noted that Spo0A~P activates biofilm formation via an indirect 
mechanism.  The principal role of Spo0A~P is to activate the transcription of operons 
required for biofilm formation that are repressed by the transcriptional regulators AbrB 
and SinR.  In the next sections I will detail the mechanism by which AbrB and SinR 
repress biofilm formation.  The way in which Spo0A~P activates biofilm formation via 
AbrB constitutes a relatively simple genetic pathway (Figure 1-5). However, for SinR it 
is a more complicated system that results in the control of single cell fate within an 
isogenic population of cells (Figure 1-8). 
 
1.2.2.2 AbrB mediated repression of biofilm formation 
 
AbrB was originally identified as a transcriptional repressor of the gene aprE, which 
encodes an alkaline protease (Ferrari, Henner et al. 1988). AbrB was subsequently 
shown to regulate a large number of genes (Hamon, Stanley et al. 2004) and is widely 
regarded as a global ‘transition state’ regulator (Phillips and Strauch 2002). In this role 
AbrB inhibits several multicellular behaviours including sporulation, exoprotease 
production and biofilm formation in actively growing cells (Ferrari, Henner et al. 1988; 
Hamon and Lazazzera 2001; Hamon, Stanley et al. 2004).  In the sections below I will 
discuss the mechanism by which AbrB is controlled and introduce the targets of AbrB 
which are regulated during biofilm formation. 
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1.2.2.2.1 Transcriptional and post-translational regulation of AbrB  
 
The level of AbrB within the cell is controlled at the transcriptional and post-
translational level. Addressing transcriptional control first; the transcription of abrB is 
regulated in two ways.  Firstly, abrB transcription is directly repressed by low levels of 
Spo0A~P (Perego, Spiegelman et al. 1988; Greene and Spiegelman 1996; Fujita, 
Gonzalez-Pastor et al. 2005) (Figure 1-5).  Secondly, AbrB directly represses its own 
transcription (Strauch, Spiegelman et al. 1989).  The post-translational regulation of 
AbrB involves two mechanisms.  Firstly, AbrB is a rapidly degraded protein (O'Reilly 
and Devine 1997).  Secondly, the ability of AbrB to regulate the transcription of its 
target genes is repressed by a small protein called AbbA (Figure 1-5) (Banse, Chastanet 
et al. 2008).  The transcription of abbA is also subject to regulation by low levels of 
Spo0A~P, however in contrast to abrB, abbA is activated by Spo0A~P (Molle, Fujita et 
al. 2003; Fujita, Gonzalez-Pastor et al. 2005; Banse, Chastanet et al. 2008). Thus low 
levels of Spo0A~P inactivates AbrB in two ways: i) by direct transcriptional repression 
and ii) by transcriptional activation of a repressor of AbrB.  The combined effect of 
increasing levels of Spo0A~P on the level of active AbrB in the cell results in the de-
repression of the transcription of operons encoding products needed for biofilm 
formation. 
 
Figure 1-5: Spo0A represses AbrB 
Schematic representation of the regulation of AbrB by Spo0A~P.  Black T-bars indicate repression of 
genes by the transcription regulators. Red T-bars indicate repression by protein-protein interaction.  
Dashed arrows indicate translation. 
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1.2.2.2.2 AbrB represses the transcription of genes required for biofilm formation 
 
AbrB regulates the transcription of a number of genes (Hamon, Stanley et al. 2004), 
including genes which are required for biofilm formation. Genes known to be repressed 
by AbrB which contribute to biofilm formation include the yqxM-sipW-tasA operon, the 
epsA-O operon, the yxaAB operon, yvcA, yuaB and yoaW.  AbrB represses the 
transcription of these genes as detailed below:  
• AbrB directly represses the transcription of the yqxM-sipW-tasA operon which 
encodes the protein component of the biofilm matrix, TasA (Chu, Kearns et al. 
2008).  
• AbrB directly represses the transcription of the epsA-O operon which encodes 
the biosynthetic machinery for the production of EPS (Chu, Kearns et al. 2008) 
(Murray, Strauch et al. 2009).   
• AbrB directly represses the transcription of the yxaAB operon, containing yxaB 
which is predicted to encode a exopolysaccharide synthase (Nagorska, Hinc et 
al. 2008).  The mechanism by which the yxaAB operon activates biofilm 
formation is currently unknown.   
• Deletion of abrB results in an increase in the transcription of a gene called yoaW 
(Hamon, Stanley et al. 2004).  As mentioned in section 1.2.1.3, the requirement 
of YoaW during biofilm formation of undomesticated isolates remains in 
question. It is not yet known whether AbrB regulates the transcription of yoaW 
directly or indirectly.  
• AbrB directly represses the transcription of yvcA, which encodes a putative 
lipopeptide, during exponential growth (Verhamme, Murray et al. 2009). The 
role of yvcA during biofilm formation remains to be established. 
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• Finally, AbrB directly represses the transcription of yuaB during stationary 
phase (Verhamme, Murray et al. 2009).  The role of yuaB during biofilm 
formation remains to be established. 
Taken together, it can be seen that AbrB plays a significant role in the regulation of a 
number of key genes that are important for biofilm formation. 
 
1.2.2.3 Spo0A determines cell fate via a bistable switch involving SinR and SlrR 
 
Within an isogenic population of B. subtilis cells differentiation occurs which leads to 
the formation of specialised subpopulations (Veening, Smits et al. 2008).  An example 
of cell differentiation can be seen in mature biofilms where genetically identical cells 
can exist as motile cells, matrix producers or spores (Vlamakis, Aguilar et al. 2008). 
Additionally a subpopulation of cells secreting exoproteases can also arise (Veening, 
Igoshin et al. 2008).  By differentiating into subpopulations, all of the cells within the 
community can benefit from the communal production of EPS and acquisition of 
nutrients by production of exoproteases without the need for each cell to produce these 
components for themselves. Spo0A~P acts upon a bistable switch comprised of the 
regulators SinR and SlrR, switching cells from one specialised subpopulation to another 
in response to environmental signals.   
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Figure 1-6: Cells differentiate during biofilm formation 
Schematic representation of biofilm formation over time, highlighting the differentiation of cells during 
different phases of biofilm growth.  Green cells indicate motile cell type, yellow cells indicate matrix 
forming cells, and red cells indicate sporulating cells.  Cells coloured green and yellow indicate the 
differentiation from a motile cell to a matrix producing cell. Cells coloured yellow and red indicate the 
differentiation from a matrix producing cell to a sporulating cell. A single cell coloured green and red 
indicates that very rarely do motile cells differentiate into sporulating cells.  Light peach coloured dome 
indicates the presence of the biofilm matrix. Diagram based on results detailed by Vlamakis et al.  
(Vlamakis, Aguilar et al. 2008). 
 
Biofilm formation is subject to spatial and temporal control and an important step in the 
initiation of biofilm formation is the switching from growth in a planktonic state to a 
sessile state (Figure 1-6).  In the planktonic state most of the cells are motile and non-
chained; whereas in the sessile state a proportion of the population switches to become 
chained and produce the biofilm matrix. The switching between these two very distinct 
cell states is governed by a complex regulatory circuit involving SinR, its antagonist 
SinI and a relatively recently identified protein called SlrR.  Spo0A~P is the driving 
force which acts on SinI, SinR and SlrR and initiates the move towards cell chaining 
and matrix production (Figure 1-10). In the following sections I will discuss the roles of 
SinR, SinI and SlrR during biofilm formation and will detail the mechanism by which 
Spo0A~P drives the switch from motile cells to sessile cells as mediated by SinR and 
SlrR. 
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1.2.2.4 SinR represses biofilm formation 
 
SinR is a transcription regulator that was originally identified as an inhibitor of 
sporulation (Gaur, Dubnau et al. 1986).  It was subsequently demonstrated that SinR 
regulates a number of other multicellular behaviours including biofilm formation 
(Kearns, Chu et al. 2005). SinR represses biofilm formation by directly repressing the 
transcription of the epsA-O and yqxM-sipW-tasA operons which are required for matrix 
production (Kearns, Chu et al. 2005; Branda, Chu et al. 2006; Chu, Kearns et al. 2006; 
Kobayashi 2007).  The activity of SinR is indirectly inhibited by low levels of 
Spo0A~P. The mechanism of this repression will be discussed in the following sections.  
 
1.2.2.4.1 SinI acts to derepress the transcription of SinR targets 
SinR is encoded by the gene sinR, which is located within a two gene operon known as 
sinIR (Figure 1-7).  The sinIR operon contains three distinct promoter regions; two 
domains direct transcription of both sinI and sinR, and a separate promoter which 
directs transcription of the downstream sinR gene alone (Gaur, Cabane et al. 1988).  
 
 
 
Figure 1-7: Schematic representation of the sinIR operon 
Organisation of sinIR operon on the chromosome is depicted to scale; genes flanking the sinIR operon are 
depicted in grey. The stalked circle indicates the transcriptional terminator. The numbers represent the 
location on the chromosome with respect to the origin of replication. 
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SinR is subjected to post-translational regulation by the SinR-antagonist SinI (Bai, 
Mandic-Mulec et al. 1993; Sanchez and Olmos 2004). SinI binds to SinR, thus 
inhibiting the DNA binding capability of SinR. SinI therefore indirectly activates 
biofilm formation by de-repressing SinR-repressed genes (Kearns, Chu et al. 2005) 
(Figure 1-8).  Consistent with biofilm formation being activated before sporulation the 
transcription of sinI is directly activated by mid-levels of Spo0A~P (Shafikhani, 
Mandic-Mulec et al. 2002; Molle, Fujita et al. 2003; Fujita, Gonzalez-Pastor et al. 
2005).   
 
 
Figure 1-8: SinR inhibits transcription from the epsA-O and yqxM-sipW-tasA operons 
Genes are depicted by lowercase italics. Proteins are depicted by uppercase letters.  Arrows indicate 
activation of a gene. Dashed arrows indicate production of a protein. Black T-bars indicate transcriptional 
inhibition. Red T-bars indicate inhibition by protein-protein interaction. 
 
 
1.2.2.4.2 SlrR transitions cells from a motile to a matrix producing state 
 
SlrR (previously known as Slr) is a transcription regulator which, in partnership with 
SinR (see section 1.2.2.4.4), represses swarming motility (Kobayashi 2007; Chai, 
Norman et al. 2010) and autolysin production (Chai, Norman et al. 2010).  SlrR also 
activates biofilm formation (Chu, Kearns et al. 2008; Kobayashi 2008; Murray, Strauch 
et al. 2009; Chai, Norman et al. 2010).  Consistent with this, SlrR is seen as a key 
regulator during the transition from a motile state to a matrix producing state.   
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With respect to its role during biofilm formation, Chu et al. demonstrated that SlrR 
activates the transcription of the yqxM-sipW-tasA operon, which is essential for 
producing the protein component of the biofilm matrix, TasA (Chu, Kearns et al. 2008). 
However, the authors noted that deletion of slrR did not affect the transcription of the 
epsA-O operon, which produces the polysaccharide component of the biofilm matrix 
(Chu, Kearns et al. 2008). This is in contrast to the findings of Kobayashi who noted 
that deletion of slrR decreased the transcription of both operons (Kobayashi 2008) and 
Murray et al. who noted that overexpression of slrR increased transcription of both 
operons (Murray, Strauch et al. 2009). However, it must be noted that the study by Chu 
et al. utilised a β-galactosidase assay where the promoter region of eps was fused to the 
gene encoding LacZ.  This technique assesses the level of transcription from the eps 
promoter, taking the population as a whole. As the epsA-O operon is transcribed in a 
small subpopulation of cells and the experiments were conducted under planktonic 
conditions (Chai, Chu et al. 2008) perhaps this technique was unable to detect the 
subtle, yet significant, differences in the transcription of the epsA-O operon between the 
wild type strain and the slrR mutant. Thus in summary, SlrR activates biofilm formation 
by influencing the transcription of both the yqxM-sipW-tasA operon and the epsA-O 
operon which are required for biosynthesis of the biofilm matrix. The mechanism by 
which SlrR activates the transcription from the yqxM-sipW-tasA and epsA-O operons 
will be discussed in detail in section 1.2.2.4.4. SlrR represses key operons that are 
required for swarming and complete separation of daughter cells, however this relies on 
an interaction with SinR.  The mechanism by which SlrR mediates the repression of 
these operons will also be detailed in section 1.2.2.4.4. 
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1.2.2.4.3 Transcriptional regulation of slrR 
 
The gene slrR is located directly downstream, and in the opposite direction, from the 
epsA-O operon (Figure 1-9) and the transcription of slrR is directly repressed by AbrB 
and SinR  (Kearns, Chu et al. 2005; Chu, Kearns et al. 2008; Murray, Strauch et al. 
2009), and activated indirectly by the transcriptional regulator Abh (Murray, Strauch et 
al. 2009). 
 
 
 
 
Figure 1-9: Schematic representation of the slrR gene locus 
The location of the slrR gene on the chromosome is depicted to scale; genes flanking slrR are depicted in 
grey. The stalked circle indicates the transcriptional terminator. The numbers represent the location on the 
chromosome with respect to the origin of replication. 
 
 
Under biofilm activating conditions when Spo0A becomes phosphorylated, the 
transcription of abrB decreases. Additionally, the transcription of sinI increases which 
leads to the production of SinI and subsequent inhibition of the DNA-binding ability of 
SinR (see section 1.2.2.4.1). Therefore, under these conditions the level of SlrR will 
increase, due to de-repression of SinR and AbrB binding to the slrR promoter.  On top 
of this, slrR transcription is regulated by a self-reinforcing positive feedback loop, as 
increased levels of SlrR lead to binding of SlrR to SinR (Chai, Norman et al. 2010) 
(Figure 1-10).   Binding of SlrR to SinR inhibits the ability of SinR to repress the 
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transcription from the slrR promoter region, thus increasing the level of SlrR in the cell 
(Chai, Norman et al. 2010).   
 
 
Figure 1-10: Spo0A~P leads to the switch from motile cells to matrix producing cells. 
Adapted from a figure published by (Chai, Norman et al. 2010). Dashed arrow indicates translation. Solid 
red or blue lines indicate the dominant pathway of repression.  Black T-bars indicate transcriptional 
repression. SlrR·SinR denotes the SinR-SlrR complex. Genes are signified by italics.  
 
 
1.2.2.4.4 Spo0A~P drives the switch from motile cells to matrix producers   
 
During the initiation of biofilm formation B. subtilis cells can exist in two distinct 
states. Firstly, they can exist as motile cells which are repressed for the production of 
matrix operons. In this state, the level of SlrR in the cell is low, due to the repression of 
slrR transcription by SinR (Figure 1-10).  However, as the level of Spo0A~P in the cell 
rises in response to environmental signals, the level of SinI increases.  SinI is then able 
to inhibit SinR from repressing its target genes, including slrR.  The de-repression of 
slrR mediated by SinI causes the level of SlrR in the cell to rise triggering the switch to 
the production of matrix and onset of cell chaining (Figure 1-10).   
Under high levels of SlrR, matrix genes are de-repressed and autolysins are repressed as 
follows.  First, SlrR acts in a similar way to SinI and binds to SinR, thus inhibiting SinR 
Chapter 1 - Introduction 
 23
from repressing the transcription of the epsA-O and yqxM-sipW-tasA operons.  
Secondly, SlrR and SinR form a complex which regulates a distinct subset of genes 
which neither SinR nor SlrR can regulate individually.  The novel group of genes 
repressed by the SinR: SlrR complex includes the lytABC operon and lytF, which code 
for autolysin production (Kobayashi 2008; Chai, Norman et al. 2010). The repression of 
autolysins is a crucial step in the switch from single to chained cells as autolysins act to 
remodel the peptidoglycan at the cell poles after cell division to complete the separation 
of the daughter cells (Smith, Blackman et al. 2000).   
In addition to the lyt genes, the SlrR: SinR complex also represses the transcription of 
hag (Chai, Norman et al. 2010), which encodes for flagellin. The repression of the 
bacterial flagella further reinforces the importance of the SlrR: SinR complex in the 
switch between motile, single cells to sessile matrix producing cells.  Thus upon 
activation of Spo0A~P, a complex regulatory network is put in motion to control single 
cell fate and promote biofilm formation. 
 
1.2.2.5 DegU regulates biofilm formation 
 
Biofilm formation is regulated by DegU, a response regulator belonging to the DegS-
DegU two-component regulatory system (Stanley and Lazazzera 2005; Kobayashi 
2007; Verhamme, Kiley et al. 2007).  DegU, formerly known as SacU, was originally 
identified during a screen for genes required for exoprotease production (Steinmetz, 
Kunst et al. 1976). However since 1976, DegU has been studied extensively and has 
been shown to regulate a number of other multicellular behaviours displayed by B. 
subtilis including swarming and swimming motility (Kobayashi 2007; Verhamme, 
Kiley et al. 2007), and genetic competence (Hamoen, Van Werkhoven et al. 2000).  
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Much like Spo0A~P, DegU is controlled by phosphorylation and is able to integrate the 
control of these multicellular behaviours according to the level of DegU~P in the cell 
(Figure 1-12).  However of particular relevance to this work is the role of DegU during 
the activation and inhibition of biofilm formation at low and high levels of DegU~P, 
respectively.  In the sections below I will discuss how the transcription of DegU is 
controlled and the way in which the level of DegU~P in the cell is regulated. I will also 
discuss some of the key targets of DegU during biofilm formation.  
 
1.2.2.5.1 Transcriptional activation of the degS-degU operon 
 
The concentration of DegU in the cell is controlled at the level of transcription.  The 
gene encoding DegU is located in an operon along with the gene encoding for the 
sensor kinase DegS (Figure 1-11). The promoter region of the degS-degU operon has 
been studied in detail. The degS-degU operon contains three promoters which direct the 
transcription of the operon.  The promoters are located 1) upstream of degS, 2) within 
the coding sequence of degS and 3) in the intergenic region between the coding 
sequences for DegS and DegU (Figure 1-11).  Promoter 1 ensures a basal level of degS-
degU transcription at all times.  Promoter 2 responds to nitrogen-starvation (Yasumura, 
Abe et al. 2008), while promoter 3 is under the control of the phosphorylated form of 
DegU (DegU~P) (Veening, Igoshin et al. 2008).  
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Figure 1-11: Schematic representation of the degS-degU operon 
Organisation of degS-degU operon on the chromosome is depicted to scale; genes flanking the degS-degU 
operon are depicted in grey. The stalked circle indicates the transcriptional terminator. The numbers 
represent the location on the chromosome with respect to the origin of replication. 
 
 
1.2.2.5.2 DegS phosphorylates DegU  
 
DegS, the cognate sensor kinase encoded by the degS-degU operon, responds to 
increased osmolarity (Mukai, Kawata et al. 1990; Tanaka, Kawata et al. 1991). In 
response to osmotic changes, DegS autophosphorylates upon the histidine residue at 
position 189 (Macek, Mijakovic et al. 2007) and transfers a phosphate moiety to DegU. 
In addition to the autophosphorylation of DegS at position 189, DegS can also be 
phosphorylated on a serine residue at position 76, however the effects of this 
modification remain to be established (Macek, Mijakovic et al. 2007).  
DegS is subject to post-translational regulation which affects its ability to phosphorylate 
DegU.   Firstly, a kleisin essential for chromosome partitioning known as ScpA 
interacts with DegS during growth. ScpA, which belongs to the SMC-ScpA-ScpB 
complex acts to inhibit the kinase activity of DegS (Dervyn, Noirot-Gros et al. 2004). 
This inhibition is relieved during stationary phase due to a decrease in the SMC-ScpA-
ScpB complex, which coincides with the requirement of increased levels of DegU~P for 
biofilm formation. An additional factor effecting the level of DegU~P in the cell is the 
fact that, in addition to its role as a kinase, DegS is also a phosphatase and is responsible 
for dephosphorylating DegU~P (Tanaka, Kawata et al. 1991). 
Chapter 1 - Introduction 
 26
1.2.2.5.3 Additional proteins affecting the level of DegU~P in the cell 
 
Three additional proteins significantly affect the level of DegU~P in the cell and these 
are DegQ, DegR and RapG.  Firstly, DegQ acts to increase the transfer of the phosphate 
moiety of DegS to DegU, thus positively influencing the level of DegU~P (Kobayashi 
2007). The transcription of degQ is activated by DegU~P, however very high levels of 
DegU~P lead to transcriptional inhibition (Msadek, Kunst et al. 1990). The B. subtilis 
domesticated strain, JH642, was shown to contain a point mutation within the promoter 
region of degQ which results in a lower level of degQ transcription compared with 
undomesticated strains (Stanley and Lazazzera 2005).   Secondly, the level of DegU~P 
in the cell is affected by the 60 amino acid protein DegR, which acts to stabilise DegU 
in its phosphorylated form by inhibiting the dephosphorylation capability of DegS 
(Msadek, Kunst et al. 1990; Mukai, Kawata-Mukai et al. 1992).  Finally, the ability of 
phosphorylated DegU to bind to its targets is modulated by the response regulator 
aspartyl phosphatase RapG.  RapG binds to DegU and it has been proposed that RapG 
interferes with the DNA-binding capacity of DegU rather than dephosphorylating it 
(Ogura, Shimane et al. 2003).  Thus the binding of RapG to DegU~P lowers the level of 
DegU~P in the cell that is capable of transcriptional regulation. 
 
1.2.2.5.4 Putative DegU recognition sequence 
 
The recognition sequence that DegU binds to is dependent on the phosphorylation state 
of DegU.  In 2004, the first identification of a predicted recognition sequence for DegU 
was discovered (Shimane and Ogura 2004).  In this study, Shimane and Ogura 
suggested that the different phosphorylation states of DegU (DegU and DegU~P) 
Chapter 1 - Introduction 
 27
possessed distinct preferential binding patterns.  It was predicted that unphosphorylated 
DegU would bind to an inverted repeated sequence, such as observed in the promoter 
region of comK, while DegU~P would bind preferentially to a tandem repeated 
sequence, as observed in the aprE promoter region (Shimane and Ogura 2004).  This 
hypothesis was strengthened further in 2007 when Tsukahara et al. demonstrated that 
DegU was able to bind a 3-part tandem repeated sequence located within the promoter 
region of bpr, a bacillopeptidase F activated by DegU~P (Tsukahara and Ogura 2007).  
Tsukahara et al. later conducted footprint analysis in order to confirm that DegU and 
DegU~P preferentially bound inverted and tandem repeated sequences, respectively 
(Tsukahara and Ogura 2008).  It must be noted that while the ability of DegU to bind to 
comK and DegU~P to bind to bpr and aprE has been demonstrated, the ability to predict 
potential targets of DegU/DegU~P based on this predicted recognition sequence is less 
robust. 
 
1.2.2.5.5 Multiple behaviours are controlled according to the level of DegU~P 
 
The DegU regulon includes genes which are required for a range of physiologically 
different activities. DegU coordinates the regulation of these behaviours depending on 
the overall phosphorylation state of DegU in the cell (Figure 1-12). By setting 
thresholds in which different groups of genes are regulated, DegU can integrate the 
regulation of physiologically distinct behaviours. For example, a known target of DegU 
is the promoter region of the fla/che operon, which is involved in the development of 
flagella and chemotactic components (Amati, Bisicchia et al. 2004).  Flagella are 
required for swarming motility (Kearns and Losick 2003) and additionally the 
production of flagella is a requirement for the initial stages pellicle formation 
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(Kobayashi 2007).  Swarming is activated by low levels of DegU~P and inhibited by 
higher levels (Kobayashi 2007; Verhamme, Kiley et al. 2007).   
 
 
 
Figure 1-12: DegU regulates different behaviours depending on its phosphorylation state 
A simplified schematic representation of the effects of increasing levels of DegU~P in the cell and its 
ability to regulate different multicellular behaviours.  Green crosses indicate that the behaviour is 
activated at the level of DegU~P shown.  Red minus symbols indicate that the behaviour is inhibited at 
the level of DegU~P shown. 
 
 
In contrast to swarming, mid-levels of DegU~P activate biofilm formation while very 
high levels of DegU~P inhibit biofilm formation (Kobayashi 2007; Verhamme, Kiley et 
al. 2007).  Indeed, mid-levels of DegU~P have previously been shown to activate the 
transcription of at least two genes required for biofilm formation which are yvcA, which 
encodes a putative lipoprotein (Verhamme, Kiley et al. 2007), and yuaB, which encodes 
a predicted secreted protein known to be involved in latter stages of pellicle formation 
and biofilm formation (Kobayashi 2007; Verhamme, Murray et al. 2009) (see section 
1.2.1.3 ).  High levels of DegU~P activate exoprotease production yet inhibit biofilm 
formation, genetic competence and swarming motility. This is thought to represent an 
escape mechanism for the cells contained within the biofilm (Verhamme, Kiley et al. 
2007). In this thesis, I will introduce additional genes belonging to the DegU regulon 
that I identified as influencing biofilm formation by B. subtilis.  
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1.2.3 Regulation of multicellular behaviours by post-translational modification 
 
In addition to the complex network of transcriptional regulators that govern the 
formation of robust biofilms by B. subtilis, the work conducted during this study has 
identified that post-translational modification by phosphorylation also plays a 
significant role (Kiley and Stanley-Wall 2010).  More specifically, the work shown here 
demonstrates that B. subtilis utilises a bacterial tyrosine kinase and phosphatase pair for 
the modification of a target protein(s) during the formation of a biofilm.  In this section 
I will provide a general overview to bacterial tyrosine phosphorylation and will also 
detail specific proteins encoded within the B. subtilis genome which, as I will 
demonstrate in later sections, contribute to the post-translational regulation of biofilm 
formation. 
 
1.2.3.1 Modification of proteins by phosphorylation in bacteria  
 
It is now accepted that bacterial proteins can be phosphorylated on histidine, aspartic 
acid, tyrosine, threonine and serine residues.  Modulation of protein activity using 
phosphorylation of serine/threonine/tyrosine (Ser/Thr/Tyr) residues was initially 
believed to be confined to eukaryotes (Deutscher and Saier 2005). Prokaryotes were 
thought to be limited to phosphorylation of histidine and aspartic acid residues; a key 
signalling feature of two-component signal transduction systems (Hoch 2000). 
However, this paradigm was revoked in the late 1970’s by the identification of Ser/Thr 
phosphorylation in bacteria (Wang and Koshland 1978; Manai and Cozzone 1979) and 
again when tyrosine phosphorylation was detected in the mid 1990’s (Duclos, 
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Grangeasse et al. 1996). Serine, threonine, and tyrosine phosphorylation has 
subsequently emerged as an important mechanism for mediating the dynamic control of 
diverse cellular processes in bacteria, including polysaccharide biosynthesis (Morona, 
Paton et al. 2000; Vincent, Duclos et al. 2000; Soulat, Grangeasse et al. 2007), DNA 
metabolism (Petranovic, Michelsen et al. 2007), cell division (Wu, Ohta et al. 1999), 
and resistance to antimicrobial compounds (Lacour, Bechet et al. 2008).   
 
1.2.3.2 Protein tyrosine phosphorylation by bacteria 
 
The modification of tyrosine residues by the addition of a phosphate moiety is a 
reversible process that is controlled by specific kinases and phosphatases. 
Phosphorylation can alter the activity, and possibly the localisation, of the target protein 
in the cell (Jers, Pedersen et al. 2010).  Tyrosine phosphorylation of bacterial proteins is 
a very important tool used by bacteria in order to control a wide range of different 
cellular processes.  For example, DivL of Caulobacter crescentus is a tyrosine kinase 
which contributes to the regulation of cellular division  (Wu, Ohta et al. 1999). The 
human pathogen Streptococcus pneumoniae encodes the tyrosine kinase CpsD and 
phosphatase CpsB which are essential for capsule formation and virulence (Bender and 
Yother 2001; Morona, Miller et al. 2004). This is in line with the most common role of 
tyrosine phosphorylation during capsule formation (Grangeasse, Cozzone et al. 2007). 
A novel group of non-eukaryotic-like tyrosine kinases was identified in prokaryotes and 
have since been named as bacterial tyrosine kinases (hereafter referred to as BY-
kinase). BY- kinases are structurally different from their eukaryotic counterparts and 
given the range of cellular processes that are regulated by this group of kinases, BY-
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kinases have been proposed as novel targets for antimicrobial compounds (Lee, Zheng 
et al. 2008; Olivares-Illana, Meyer et al. 2008; Grangeasse, Terreux et al. 2009).  
Therefore, understanding the mechanism(s) and role(s) of modification of tyrosine 
residues by phosphorylation in bacteria is very important. Like eukaryotic tyrosine 
kinases, BY-kinases are nucleotide-dependent but the active site of ATP/GTP binding 
and hydrolysis is not conserved between the eukaryotic and prokaryotic proteins (Lee 
and Jia 2009). Furthermore, BY-kinases possess unique conserved motifs that are 
needed for catalytic activity which are absent from the eukaryotic tyrosine kinases and 
could represent potential targets for small molecule inhibitors (Grangeasse, Terreux et 
al. 2009; Lee and Jia 2009).  Further details regarding the unique features of BY-kinases 
will be presented in section 1.2.3.3. 
 
1.2.3.3 Bacterial tyrosine kinases 
 
1.2.3.3.1 Common features of bacterial tyrosine kinases 
 
BY- kinases represent a novel class of protein tyrosine kinase which differ substantially 
from their eukaryotic counterparts. For example, BY-kinases do not possess the 
characteristic Hanks domains.  Hanks domains are 11 highly conserved sequences 
located within eukaryotic tyrosine kinases that are essential for nucleotide binding and 
kinase activity (Hanks, Quinn et al. 1988; Hovens, Stacker et al. 1992). In contrast BY-
kinases are more closely related to ATPases, yet it must be clarified that ATPases do 
not possess kinase activity (Lee and Jia 2009).  In fact BY-kinases and ATPases share 
such similarity at the protein sequence level (Figure 1-13) that the bacterial ATPase 
MinD belonging to Pyrococcus horikoshii OT3 has been used to solve the crystal 
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structure of the BY-kinase Cap5B2 from Staphylococcus aureus (Olivares-Illana, 
Meyer et al. 2008).   
 
 
 
 
 
Figure 1-13: Protein sequence alignment of confirmed BY-kinases and MinD from Pyrococcus 
horikoshii OT3 
Alignment was conducted using CLUSTAL W (1.83) multiple sequence alignment software.  Protein 
sequences were obtained from the NCBI protein database (http://www.ncbi.nlm.nih.gov/protein/). 
Sequences from the following proteins were assessed: PtkA, belonging to B.subtilis 168; Cap5B, 
belonging to Staphylococcus aureus Mu50; Cps2, belonging to Streptococcus pneumoniae D39; EpsD, 
belonging to Streptococcus thermophilus CNRZ1066; and MinD belonging to Pyrococcus horikoshii 
OT3.  Conserved motifs associated with bacterial tyrosine kinases are highlighted as follows: Walker A 
(red box), Walker A’ (also referred to as the DxD motif) (green box), Walker B (blue box), residues 
comprising the terminal tyrosine cluster (yellow boxes) and proline rich motif (purple box). Asterisks 
indicate complete sequence conservation, colons indicate closely related amino acid residue substitutions, 
and a full stop indicates a semi-conserved amino acid substitution.  
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BY-kinases from Gram-positive and Gram-negative bacteria share several common 
features.  Firstly, an important distinguishing feature of a BY-kinase is the presence of 
three Walker motifs which are necessary for the binding of either ATP or GTP (Lee and 
Jia 2009). These are i) the Walker A motif ([G/A]XXXXGK[S/T]), also known as a P-
loop, which was first identified in ATPases as an essential motif for the binding of the γ-
phosphate of ATP/GTP (Walker, Saraste et al. 1982), ii) the Walker A’ motif 
([ILVFM]XXXDXDXR) which is also referred to as the ‘DxD’ motif due to the 
conservation of the double aspartic acid residues in its sequence (Grangeasse, Terreux et 
al. 2009)   and iii) the Walker B motif ([ILVFM]XXXDXPP) which is necessary for the 
binding of the cationic co-factor Mg2+ and for hydrolysis of ATP/GTP (Walker, Saraste 
et al. 1982). The Walker B motif also possesses two conserved proline residues which 
are important for maintaining the open conformation of the active pocket and thus are 
necessary for allowing substrates to enter and become phosphorylated (Lee and Jia 
2009).   
BY-kinases possess a C-terminal tyrosine rich region known as the terminal tyrosine 
cluster (Figure 1-13).  While the structure of the terminal tyrosine cluster is far less 
conserved between BY-kinases than the Walker motifs (Lee and Jia 2009), the terminal 
tyrosine cluster is nonetheless an important distinguishing feature of a BY-kinase.  
Indeed, the terminal tyrosine cluster is the site of autophosphorylation (Grangeasse, 
Doublet et al. 2002; Mijakovic, Poncet et al. 2003).  However, it must be noted that the 
effect of autophosphorylation of the terminal tyrosine cluster on the activity of the BY-
kinase is not well conserved or well understood.  For example, in the case of Wzc, a 
BY-kinase from Escherichia coli, both autophosphorylation and dephosphorylation of 
the terminal tyrosine cluster is necessary for colanic acid production (Obadia, Lacour et 
al. 2007). Whereas mutation of the terminal tyrosine cluster of CpsD from 
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Streptococcus pneumoniae results in a reduction of capsular biosynthesis (Morona, 
Morona et al. 2003) and can also mildly affect virulence (Morona, Miller et al. 2004). In 
terms of the autophosphorylation reaction, some BY-kinases such as Cap5B2 from 
Staphylococcus aureus do not autophosphorylate their terminal tyrosine cluster residues 
in any particular order, but this is not the case for all BY-kinases (Olivares-Illana, 
Meyer et al. 2008).  The BY-kinase PtkA belonging to B. subtilis preferentially 
phosphorylates the tyrosine at position 228 (Mijakovic, Poncet et al. 2003). The reason 
for the selectivity of the B. subtilis BY-kinase during autophosphorylation is currently 
unknown and an in vivo role for the terminal tyrosine cluster is yet to be shown. 
 
1.2.3.3.2 BY-kinases of Gram-positive and –negative bacteria are different 
 
Significant differences can be observed between bacterial tyrosine kinases of Gram-
positive and Gram-negative bacteria. In Gram-negative bacteria BY-kinases consist of a 
single membrane bound polypeptide where the kinase catalytic activity and modulator 
domains are fused (Mijakovic, Petranovic et al. 2005) (Figure 1-14).  As mentioned 
previously, a key feature of BY-kinases is the ability to autophosphorylate and some 
Gram-negative bacteria display a mechanism of phosphorylation that is specific to 
Gram-negative BY-kinases.  In the case of Escherichia coli K12, it was identified that 
Wzc, a BY-kinase which regulates colanic acid production (Vincent, Duclos et al. 
2000), autophosphorylates in a two-step phosphorylation mechanism (Grangeasse, 
Doublet et al. 2002).  First, intramolecular phosphorylation allows phosphorylation of 
an internal conserved tyrosine residue at position 569, located between the conserved 
Walker A and Walker B motifs.  The phosphorylation of tyrosine-569 subsequently 
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enhances the intermolecular phosphorylation of the terminal tyrosine clusters of 
neighbouring Wzc proteins, thus contributing to colanic acid production (Grangeasse, 
Doublet et al. 2002).  It must be noted however that not all Gram-negative BY-kinases 
which possess this internal tyrosine residue rely on intramolecular phosphorylation in 
order to enhance autophosphorylation (Wugeditsch, Paiment et al. 2001). An additional 
conserved feature of Gram-negative BY-kinases is the highly conserved arginine-lysine 
rich cluster of unknown function located at the N-terminal end of the C-terminal 
cytoplasmic domain (Grangeasse, Terreux et al. 2009). 
 
Figure 1-14: BY- kinases from Gram-positive and Gram-negative bacteria differ in structure. 
Schematic representation of the structural differences of BY-kinases from Gram-positive (A) and Gram-
negative bacteria (B).  Features of BY-kinases are highlighted as follows: NT, N-terminal; CT, C-
terminal; A, Walker A motif; A’, Walker A’ motif; B, Walker B motif; YC, terminal tyrosine cluster; 
grey oval, RK rich cluster; black circle, hydrophobic residue which participates in nucleotide binding; 
orange circle, internal phospho-tyrosine residue which participates in enhancing interphosphorylation of 
BY-kinases.  Figure taken from review by Grangeasse et al. (Grangeasse, Terreux et al. 2009). 
 
 
In contrast to the structure of the Gram-negative BY-kinases, in Gram-positive bacteria 
the BY-kinase is split into two proteins where the genes encoding the modulator and 
kinase domains are co-located on the chromosome and co-transcribed (Grangeasse, 
Cozzone et al. 2007) (Figure 1-14). By separating the kinase domain from the 
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transmembrane bound modulator domain, there is the potential for Gram-positive BY-
kinases to dissociate from their cognate modulators.  It is possible that when dissociated 
from their modulator partners, BY-kinases may possess additional roles in the absence 
of the kinase modulator. Furthermore, the splitting of the kinase and modulator in 
Gram-positive bacteria allows for the potential of spatial regulation.  In contrast, as BY-
kinases from Gram-negative bacteria are anchored to the membrane, they do not possess 
the potential for spatial regulation. 
Gram-positive BY-kinases lack internal phosphorylated tyrosine residues, and 
consequently an alternative mechanism for phosphorylation exists.  In Gram-positive 
bacteria, kinase activity is stimulated by interaction of the C-terminal domain of the 
membrane bound modulator protein with the N-terminal region of the cytoplasmic 
kinase (Mijakovic, Poncet et al. 2003; Grangeasse, Terreux et al. 2009).  More 
specifically, it has been demonstrated that the presence of a hydrophobic residue (such 
as the phenylalanine at position 221 of the modulator CapA from S. aureus) within the 
C-terminal of the modulator protein stimulates the affinity of the BY-kinase for ATP 
(Soulat, Jault et al. 2006; Olivares-Illana, Meyer et al. 2008), thus providing a source of 
phosphate with which target proteins may be modified.   
 
1.2.3.4 Bacterial tyrosine phosphatases 
 
Bacterial tyrosine phosphatases have been identified within a number of different 
families, including the manganese-dependent superfamily and the protein tyrosine 
phosphatase superfamily. Manganese-dependent protein phosphatases have been 
categorised into three major groups which are called the phosphoprotein phosphatases 
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(PPP), the Mg2+ or Mn2+ dependent protein phosphatases (PMP) and the polymerase 
and histidinol phosphatases (PHP) (Shi 2004).  Members of the PPP family were 
originally identified in eukaryotes, but bacterial members have since been identified.  
These phosphatases can be identified according to their signature motif (GDXHG – 
GDXXDRG – GNH[D/E]) (Shi 2004).  Members of this group, such as PrpE from B. 
subtilis, have been found to target tyrosine residues (Iwanicki, Herman-Antosiewicz et 
al. 2002).  Members of the PMP group were also originally identified in eukaryotes.  As 
with the PPP group, the activity of members of the PMP group is dependent on the 
presence of metallo-co-factors.  However, to date members of the PMP group have been 
shown to target phosphorylated threonine and serine residues only, and not tyrosine 
residues (Cozzone, Grangeasse et al. 2004; Shi 2004).  Members of the PHP group have 
only been identified in prokaryotes, and more specifically only in Gram-positive 
bacteria. Furthermore, members of this group have been found only to target 
phosphorylated tyrosine residues (Cozzone, Grangeasse et al. 2004; Shi 2004). 
Phosphatases belonging to the PHP group are defined by their signature motif 
containing 5 conserved histidine residues and 2 aspartic acid residues (Shi 2004; 
Mijakovic, Musumeci et al. 2005).  Deletion of any of the conserved amino acids results 
in a significant loss of phosphatase activity (Mijakovic, Musumeci et al. 2005).  
Members of the PHP group include CapC from S. aureus (Cozzone, Grangeasse et al. 
2004), PtpZ from B. subtilis (Mijakovic, Poncet et al. 2003; Mijakovic, Musumeci et al. 
2005) and CpsB from S. pneumoniae (Morona, Morona et al. 2002). Although members 
of the PHP group appear to exclusively target phosphorylated tyrosine residues, they 
must not be confused with the protein tyrosine phosphatase (PTP) group.  Members of 
the PTP group are characterised by the presence of the CX5R motif, and in addition they 
are not susceptible to the same phosphatase inhibitors that can target members of the 
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PHP group (Mijakovic, Musumeci et al. 2005).  A sub-class of the PTP group has also 
been described. These are known as the low-molecular weight tyrosine phosphatases 
(LMW-PTP).  These phosphatases also possess the characteristic CX5R motif, however 
as the name suggests, these proteins are of a low molecular weight (Shi 2004).  
Members of this family have been shown to regulate the production of polysaccharides, 
for example Wzb from E. coli which regulates colanic acid production (Vincent, Duclos 
et al. 2000). 
 
1.2.3.5 Bacterial tyrosine phosphorylation by B. subtilis 
 
B. subtilis encodes one confirmed and one predicted BY-kinase known as PtkA and 
EpsB, respectively. PtkA is a confirmed and promiscuous BY-kinase (Mijakovic, 
Poncet et al. 2003; Jers, Pedersen et al. 2010). Consistent with the fact that B. subtilis is 
a Gram-positive organism, PtkA must interact with the bacterial tyrosine modulator 
TkmA in order to phosphorylate its specific targets (Mijakovic, Poncet et al. 2003).   B. 
subtilis also possesses three bacterial protein tyrosine phosphatases. First, there is PtpZ 
which, as previously mentioned, belongs to the polymerase and histidinol phosphatase 
(PHP) family and functions to dephosphorylate the targets of PtkA (Mijakovic, Poncet 
et al. 2003; Mijakovic, Musumeci et al. 2005). Second, B. subtilis possesses two 
tyrosine phosphatases belonging to the LMW-PTP family known as YwlE and YfkJ.  It 
should be noted that YwlE and YfkJ modulate a distinct set of targets from PtpZ 
(Mijakovic, Petranovic et al. 2005; Musumeci, Bongiorni et al. 2005).  
It has been previously demonstrated that PtkA (in partnership with TkmA) and PtpZ act 
to modulate the activity of a UDP-glucose dehydrogenase, called Ugd (Mijakovic, 
Chapter 1 - Introduction 
 39
Poncet et al. 2003).  Furthermore, PtkA and PtpZ are also able to regulate the activity of 
TuaD, a homologue of Ugd which is active under phosphate limiting conditions 
(Mijakovic, Poncet et al. 2003) (Figure 1-15).  The regulation of Ugd influences the 
production of teichuronic acid; a component of the cell wall. 
 
 
Figure 1-15: PtkA and PtpZ regulate teichuronic acid biosynthesis 
Schematic representation of the regulation of Ugd activity through phosphorylation.  Cell membrane is 
depicted by a grey bar. UDP-Glc, UDP-glucose; UDP-GlcA, UDP-glucuronate. 
 
 
In addition to PtkA, B. subtilis also encodes a predicted BY-kinase called EpsB (also 
known as PtkB and previously as YveL).  EpsB is encoded by the 15 gene operon epsA-
O that is required for the production of a secreted exopolysaccharide needed for biofilm 
formation (Figure 1-1) (Branda, Gonzalez-Pastor et al. 2001; Mijakovic, Poncet et al. 
2003).  When over-expressed in E. coli, phosphorylated tyrosine could be detected 
within EpsB (Mijakovic, Poncet et al. 2003); however, EpsB was unable to accumulate 
detectable levels of phosphorylation when incubated with radiolabelled ATP 
(Mijakovic, Poncet et al. 2003).  In addition, an in vivo role for EpsB is yet to be 
established. Thus it is unclear whether EpsB is a functional BY-kinase like its 
homologue PtkA. 
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1.3 Project Aims 
 
The overall aim of my project was to understand at the molecular level how DegU 
controls biofilm formation by B. subtilis.  Initial experiments led to the discovery that 
DegU and SinR co-regulate a novel group of genes during biofilm formation. As such, I 
investigated their impact on biofilm formation and surface adhesion.  Through this 
initial study, it was discovered that ptpZ, a DegU and SinR co-regulated gene encoding 
a protein tyrosine phosphatase, was required for the formation of robust biofilms by B. 
subtilis. From this point forward, the aim of my project was to understand the 
involvement of post-translational modifications, in particular protein tyrosine 
phosphorylation, during biofilm formation. 
Chapter 2 – Materials and Methods 
 41
2 Materials and Methods 
 
2.1 Bacterial strains used in this study 
Table 2-1 Bacterial strains used in this study 
 
Strain Relevant Genotype a Source / Construction b 
NCIB3610 Prototroph Bacillus Genetic Stock Center 
JH642 trpC2 pheA1 (Hoch and Anagnostopoulos 1970) 
168 trpC2 (Burkholder and Giles 1947) 
3610 derived strains 
NRS1389 ywfB::pNW33 (cml) SPP1 NRS1377 → NCIB3610 
NRS1499 ΔdegSU (spc) (Kiley and Stanley-Wall 2010) 
NRS1684 ΔsinR (cml) SPP1 BAL2423 →  NCIB3610 
NRS1686 ΔsinR (cml) ΔdegSU (spc) SPP1 BAL2423 →  NRS1499 
NRS1808 yvyE::pBL193 (cml) (Stanley and Lazazzera 2005) 
NRS1826 yueH::pNW300 (cml) SPP1 NRS1815 → NCIB3610 
NRS1827 ptpZ::pNW301 (cml) SPP1 NRS1816 → NCIB3610 
NRS1828 ybfP::pNW302 (cml) SPP1 NRS1817 → NCIB3610 
NRS1829 yomI::pNW303 (cml) SPP1 NRS1818 → NCIB3610 
NRS1830 yvfO::pNW304 (cml) SPP1 NRS1819 → NCIB3610 
NRS1831 ywbC::pNW305 (cml) SPP1 NRS1820 → NCIB3610 
NRS1832 ΔyfmH (cml) SPP1 NRS1821 → NCIB3610 
NRS1833 ΔyulD (cml) SPP1 NRS1822 → NCIB3610 
NRS1842 ΔyvfG (cml) SPP1 NRS1825 → NCIB3610 
NRS1843 Δ degSU (spc) + yvyE::pBL193 (cml) SPP1 NRS1243 → NRS1499 
NRS1844 Δ degSU (spc) + yueH::pNW300 (cml) SPP1 NRS1815 → NRS1499 
NRS1845 Δ degSU (spc) + ptpZ::pNW301 (cml) SPP1 NRS1816 → NRS1499 
NRS1846 Δ degSU (spc) + ybfP::pNW302 (cml) SPP1 NRS1817 → NRS1499 
NRS1847 Δ degSU (spc) + yomI::pNW303 (cml) SPP1 NRS1818 → NRS1499 
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Strain Relevant Genotype a Source / Construction b 
NRS1848 Δ degSU (spc) + yvfO::pNW304 (cml) SPP1 NRS1819 → NRS1499 
NRS1849 ΔdegSU (spc) + ywbC::pNW305 (cml) SPP1 NRS1820 → NRS1499 
NRS1851 Δ degSU (spc) + ΔyulD (cml) SPP1 NRS1822 → NRS1499 
NRS1852 Δ degSU (spc) + ΔyvfG (cml) SPP1 NRS1825 → NRS1499 
NRS1857 Δ degSU (spc) + ΔyfmH (cml) SPP1 NRS1821 → NRS1499 
NRS1859 ΔsinR (kan) (Kiley and Stanley-Wall 2010) 
NRS1860 ΔsinR (kan) ΔdegSU (spc) (Kiley and Stanley-Wall 2010) 
NRS1874 Δ degSU (spc) + yueH::pNW300 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1844 
NRS1875 Δ degSU (spc) + ptpZ::pNW301 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1845 
NRS1876 Δ degSU (spc) + ybfP::pNW302 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1846 
NRS1877 Δ degSU (spc) + yomI::pNW303 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1847 
NRS1878 Δ degSU (spc) + yvfO::pNW304 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1848 
NRS1879 Δ degSU (spc) + ywbC::pNW305 (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1849 
NRS1880 Δ degSU (spc) + ΔyulD (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1851 
NRS1881 Δ degSU (spc) + ΔyvfG (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1852 
NRS1883 Δ degSU (spc) + ΔyfmH (cml) + ΔsinR (kan) SPP1 NRS1858 → NRS1857 
NRS2222 ΔptpZ (Kiley and Stanley-Wall 2010) 
NRS2227  ΔytcA (kan) (Kiley and Stanley-Wall 2010) 
NRS2467 ΔptpZ + amyE::Pspank-hy- ptpZ-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS2468 ΔptpZ + amyE::Pspank-hy- ptpZ (H196A)-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS2471 Δugd (Kiley and Stanley-Wall 2010) 
NRS2544 ΔptkA (Kiley and Stanley-Wall 2010) 
NRS2795 ptkA D83A (Kiley and Stanley-Wall 2010) 
NRS2796 ptkA D81A-D83A (Kiley and Stanley-Wall 2010) 
NRS2799 ptkA Y225A-Y227A-Y228A (Kiley and Stanley-Wall 2010) 
NRS2804 ΔptkA + amyE::Pspank-hy-ptkA-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS2807 ptkA D81A-D83A + amyE::Pspank-hy-ptkA-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS2810 ptkA Y
225A-Y227A-Y228A + amyE::Pspank-hy-ptkA-lacI 
(spc) SPP1 NRS2801→ NRS2799 
NRS2821 Δugd + ΔytcA  (kan) SPP1 NRS2059 → NRS2471 
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NRS3076 sacA::Phag-yfp (kan) SPP1 NRS3070 → NCIB3610 
NRS3201 ahpF::pNW361(cml) SPP1 NRS2858→ NCIB3610 
NRS3205 icd::pNW365 (cml) SPP1 NRS2862→ NCIB3610 
NRS3210 lctE::pNW370 (cml) SPP1 NRS2867→ NCIB3610 
NRS3211 oppA::pNW558 (cml) SPP1 NRS2868→ NCIB3610 
NRS3212 rocA::pNW371 (cml) SPP1 NRS2869→ NCIB3610 
NRS3213 yjoA::pNW372 (cml) SPP1 NRS2870→ NCIB3610 
NRS3214 ynfE::pNW560 (cml) SPP1 NRS3197→ NCIB3610 
NRS3215 yorK::pNW559 (cml) SPP1 NRS3198→ NCIB3610 
NRS3216 yvyG::pNW373 (cml) SPP1 NRS3199→ NCIB3610 
NRS3229 Δugd + tuaD::pNW377 (cml) SPP1 NRS3227→ NRS2471 
NRS3230 ΔytcA (kan) + tuaD::pNW377 (cml) SPP1 NRS3227→ NRS2227 
NRS3231 Δugd + ΔytcA (kan) + tuaD::pNW377 (cml) (Kiley and Stanley-Wall 2010) 
NRS3232 tuaD::pNW377 (cml) (Kiley and Stanley-Wall 2010) 
NRS3241 ΔptkA + sacA::Phag-yfp (kan) SPP1 NRS3070→ NRS2544 
NRS3243 ptkA D81A-D83A + sacA::Phag-yfp (kan) SPP1 NRS3070→ NRS2796 
NRS3244 ptkA Y225A-Y227A-Y228A + sacA::Phag-yfp (kan) SPP1 NRS3070→NRS2799 
NRS3248 ptkA Y
225A-Y227A-Y228A + amyE::Pspank-hy-ptkA -lacI 
(spc) + sacA::Phag-yfp (kan) SPP1 NRS3070→NRS2810 
NRS3528 ΔtkmAΔptkA (Kiley and Stanley-Wall 2010) 
NRS3535 ΔtkmAΔptkA + amyE::Pspank-hy-tkmA -lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS3536 ΔtkmAΔptkA + amyE::Pspank-hy-tkmA ptkA-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS3537 ΔtkmAΔptkA + amyE::Pspank-hy-ptkA -lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS3541 ΔtkmA (Kiley and Stanley-Wall 2010) 
NRS3544 ΔtkmA + amyE::Pspank-hy-tkmA-lacI (spc) (Kiley and Stanley-Wall 2010) 
NRS3557 ptkA Y225E- Y227E- Y228E pNW391 → NCIB3610 
NRS3563 ptkA Y225E- Y227E- Y228A pNW390 → NCIB3610 
NRS3566 ptkA Y225F- Y227F- Y228F pNW393 → NCIB3610 
NRS3570 ΔyvyG pNW399 → NCIB3610 
NRS3571 yvyG Y49A  pNW801 → NCIB3610 
NRS3573 ptkA Y225A- Y227A- Y228E pNW396→ NCIB3610 
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NRS3576 ptkA Y
225F- Y227F- Y228F + amyE::Pspank-hy-ptkA - lacI 
(spc) SPP1 NRS2801 → NRS3566 
NRS3577 ptkA Y
225F- Y227F- Y228F + amyE::Pspank-hy-ptkA 
Y225A- Y227A- Y228A - lacI (spc) SPP1 NRS3221 → NRS3566 
NRS3578 ΔyvyG + amyE::Pspank-hy-yvyG - lacI (spc) SPP1 NRS3256 → NRS3570 
NRS3579 ptkA Y
225F- Y227F- Y228F + amyE::Pspank-hy-ptkA D81A 
– D83A - lacI (spc) SPP1 NRS3220 → NRS3566 
NRS3585 ptkA Y225E- Y227A- Y228A pNW803→ NCIB3610 
JH642 derived strains 
BAL1806 ΔdegSU (spc) (Stanley and Lazazzera 2005) 
NRS1377 ywfB::pNW33 (cml) pNW33 → JH642 
NRS1815 yueH::pNW300 (cml) pNW300 → JH642 
NRS1816 ptpZ::pNW301 (cml) pNW301 → JH642 
NRS1817 ybfP::pNW302 (cml) pNW302 → JH642 
NRS1818 yomI::pNW303 (cml) pNW303 → JH642 
NRS1819 yvfO::pNW304 (cml) pNW304 → JH642 
NRS1820 ywbC::pNW305 (cml) pNW305 → JH642 
NRS1821 ΔyfmH (cml) yfmH (cml) PCR → JH642 c 
NRS1822 ΔyulD (cml) yulD (cml) PCR → JH642 c 
NRS1825 ΔyvfG (cml) yvfG (cml) PCR→ JH642 c 
NRS1858 ΔsinR (kan) ΔsinR  PCR →  JH642c 
NRS2059 ΔytcA (kan) ytcA (kan) PCR→ JH642 c 
NRS2173 amyE::Pspank-hy-ptpZ - lacI (spc) pNW312 → JH642 
NRS2193 amyE::Pspank-hy-ptpZ (H196A) - lacI (spc) pNW316 → JH642 
168 derived strains 
NRS2535 pNW341 pNW341 → 168 
NRS2540 pNW349 pNW349 → 168 
NRS2541 pNW348 pNW348 → 168 
NRS2801 amyE::Pspank-hy- ptkA - lacI (spc) pNW351 → 168 
NRS2858 ahpF::pNW361 (cml) pNW361 → 168 
NRS2862 icd::pNW365 (cml) pNW365 → 168 
NRS2867 lctE::pNW370 (cml) pNW370 → 168 
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NRS2868 oppA::pNW558 (cml) pNW558 → 168 
NRS2869 rocA::pNW371 (cml) pNW371 → 168 
NRS2870 yjoA::pNW372 (cml) pNW372 → 168 
NRS3070 sacA::Phag-yfp (kan) pNW546 → 168 
NRS3197 ynfE::pNW560 (cml) pNW560 → 168 
NRS3198 yorK::pNW559 (cml) pNW559 → 168 
NRS3199 yvyG::pNW373 (cml) pNW373 → 168 
NRS3227 tuaD::pNW377 (cml) pNW377 → 168 
NRS3255 amyE::Pspank-hy- tkmA - lacI (spc) pNW382 → 168 
NRS3256 amyE::Pspank-hy- yvyG - lacI (spc) pNW382 → 168 
NRS3265 amyE::Pspank-hy-tkmA ptkA - lacI (spc) pNW388 → 168 
 
 
a Antibiotic resistance cassettes are indicated as follows: cml, Chloramphenicol resistance; spc, 
Spectinomycin resistance; kan, Kanamycin resistance. 
b Arrow indicates direction of strain construction.  Plasmids (DNA) and SPP1 (phage) were used to 
transform or transduce the recipient strain noted above.   
c Strains containing double-crossover mutations were constructed by transformation with PCR fragment. 
 
 
2.2 Table of Oligonucleotides 
Table 2-2 Oligonucleotides used in this study. 
Primer Target Sequencea Positionb 
RT-PCR analysis of novel DegU/SinR co-regulated genes 
NSW122 yomI CGATGGATCCCTCAACTCCCTCAAGCTC +100 → +117 
NSW123 yomI CGATGGATCCCCTGTCCTAGTTTCTCAGTGG +380 → +400 
NSW126 yvfO CGATGGATCCCAGAGCTTCGGGCAGA +101 → +116 
NSW127 yvfO CGATGGATCCTGAGATTAGCCCAGG +464 → +479 
NSW128 ywbC CGATGGATCCGACCATACAGGCATCATGG +16 → +34 
NSW129 ywbC CGATGGATCCGCTCGATTACACCGTTCG +110 → +127 
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NSW130 ptpZ CGATGGATCCGCGACACCTCATCAT  +115 → +129 
NSW131 ptpZ CGATGGATCCACAGCAAGGACGGGT  +437 → +451 
RT-PCR analysis of tkmA operon 
NSW57 veg CGAAGACGTTGTCCGATATTAAAAG +5 → +29 
NSW58 veg CAACAGTCTCAGTCAAAATATCAGC +193 → +217 
NSW130 ptpZ As above As above 
NSW131 ptpZ As above As above 
NSW163 tkmA GGGAGAATCTACAAGCTTAAAAGAG +3 → +27 
NSW164 tkmA CGTTTTCATCCCTGACTGATATGTT +355 → +379 
NSW165 ugd TCTCTTTCTGAGATTGGACATCATG +52 → +76 
NSW166 ugd CTATAAAAATGATGTCTGCCTGTGC +223 → +247 
tkmA operon analysis 
NSW163 tkmA As above As above 
NSW164 tkmA As above As above 
NSW165 ugd As above As above 
NSW195 ptpZ GGCTAGGACATGATCGCTATTCACTGTCACATT -9 → +24 
NSW220 ugd GCATCCCGGGCACTGTGCTTTTCGTTACCAC +346 → +366 
NSW249 ptpZ CCGGGAGCTCGAATTCTTTCTCTAGAACATAAAGAGCCTCTTGA +615 → +625 
tkmA 5’RACE analysis 
NSW227 tkmA GGGCTCTTAATGATGACA +234 → +251 
NSW228 tkmA GGGTGTAAGTGCGAAGAAA +108 → +126 
NSW367 Poly-C tail GGCCACGCGTCGACTAGTACGGGUGGGUGGGUG N/A 
EMSA analysis of tkmA promoter region 
NSW146 tkmA CGATGAATTCCTAAAAAAGGACATAAAA -500 → -479 
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NSW147 tkmA CGATGGATCCTAACGTTGATAATATC +27 → +42 
NSW163 tkmA As above As above 
NSW164 tkmA As above As above 
NSW61 aprE GGTAAAGCCTATGAATTCTC -620 → - 601 
NSW654 aprE GATCCACAATTTTTTGCT +87 → +104 
NSW50 yqxM TGGCGAATTCATAGACAAATCACACATTGTTTGATCA -312 → - 276 
NSW51 yqxM GCCAGAATTCGGATCCATCTTACCTCCTGTAAAACACTGTAA -26 → +16 
Construction of insertional mutations 
NSW33 ywfB CGAGGCGAATTCACAAGCAGTGAGTACGCA +91 → +108 
NSW34 ywfB GTCTCTGAATTCAAAATCAGGACGAACAGC +325 → +354 
NSW120 ybfP CGATGGATCCCGGCATGTCGGTT +138 → +150 
NSW121 ybfP CGATGGATCCTGTTCGGTATGCTCCTGG +298 → +315 
NSW122 yomI As above As above 
NSW123 yomI As above As above 
NSW124 yueH CGATGGATCCCGCAAACCGGAATGATC +29 → +45 
NSW125 yueH CGATGGATCCCAGGCAGAGTTGATTTAT +140 → +157 
NSW126 yvfO As above As above 
NSW127 yvfO As above As above 
NSW128 ywbC As above As above 
NSW129 ywbC As above As above 
NSW130 ptpZ As above As above 
NSW131 ptpZ As above As above 
NSW132 yvfG GGAGTTTTGCCAAAACAGCCTCCG -505 → -484 
NSW133 yvfG GTTATCCGCTCACAATTCAGACATTTCTTTGGC -9 → +6 
NSW134 yvfG CGTCGTGACTGGGAAACAATCAAAATAAACCTTCC +209 → +226 
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NSW135 yvfG TTTTCTCCAAACGCTGAACGTCTTGA +510 → +535 
NSW136 yfmH CACCATAGAGGCGATGGTTGTCGAATTGG -326 → -298 
NSW137 yfmH GTTATCCGCTCACAATTCCTCATGGTTTTCCC -9 → +5 
NSW138 yfmH CGTCGTGACTGGGAAACGAAAAATGGTAAACACTTAG +61 → +80 
NSW139 yfmH GAAACTAAATCATCCGGATCCCTGGGTTAGATTGA +435 → +454 
NSW140 yulD GCCATCATCTATGCGATAGCCATCAAAGA -356 → -328 
NSW141 yulD GTTATCCGCTCACAATTCGGCTTTTCTTTTCAAACCTT -5 → +15 
NSW142 yulD CGTCGTGACTGGGAAACGGATTGAAAAAC +309 → +320 
NSW143 yulD CGCATGCAGGTTTACGCGGTGC +601 → +622 
NSW148 sinR CAGGCGCTGAAAACCTTGTATCAACC -479 → -454 
NSW149 sinR ATCACCTCAAATGGTTCGCTGCCAATCAATGTCATCACCTTCC -14 → +9 
NSW150 sinR CGAGCGCCTACGAGGAATTTGTATCGGGCGTAGTGCCTGAGCA
GAG 
+331 → +349 
NSW151 sinR GATGCAGCGGCTGCTGAAAAATC +756 → +779 
NSW298 ahpF CGAT CTGCAG ACC AAA AAG TCA TTG ATC AGG +310 → +331 
NSW299 ahpF CGAT GAATTC TTT GTC AGC AAA CTC AGA TGC +598 → +618 
NSW602 ytcA GGCAAAAGGCTGTCCTCCTGC -540 → -520 
NSW603 ytcA ATCACCTCAAATGGTTCGCTCACACAAATTTTCATCACCTGA -7 → +15 
NSW604 ytcA CGAGCGCCTACGAGGAATTTGTATCGGCGTCCATGAAAATACTC
GTCACA 
+1279 → +1301 
NSW605 ytcA GCCGGTGAAAAGCCATATC +1842 → +1860 
NSW904 sdhA GCAT CTGCAG AGA ATT CAT TCA AAT CCA CCC G +690 → +711 
NSW905 sdhA GCAT GGATCC AAG CTT AAT ATC AAG CTC TTT CGG +952 → +975 
NSW906 icd GCAT CTGCAG ATATTTCATCGCGATTAAAGGCC +255 → +277 
NSW907 icd GCAT GGATCC TCG ATC GCA TAA TCA ATG GC +610 → +629 
NSW916 lctE GCAT CTGCAG ATC GTT AGT GAA GTC ATG GC +316 → +355 
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NSW917 lctE GCATGGATCCTTCTCAATGATATGGTAAGCTGC +664 → +686 
NSW918 oppA GCATGTCGACAATGATTCAGTATCAGGCGG +175 → +194 
NSW919 oppA GCATGGATCCCAGTGAAATATGGAGTCGGG +528 → +547 
NSW920 rocA GCATCTGCAGCTGGAAAAAACAAAGACCGG +263 → +283 
NSW921 rocA GCATGGATCCGTAATGATATTGATTGACCTCGC +485 → +506 
NSW922 yjoA GCATCTGCAGCAATCCAATCAAATTGTCAGCC +7 → +28 
NSW923 yjoA GCATGGATCCATGTCAGATCAATTTCTCTGTCC +303 → +325 
NSW924 ynfE GCATGTCGACGAAATACTGAAACAGTATATGGTGC +7 → +31 
NSW925 ynfE GCATGGATCCGTGTTGTCAATCCATAATAAACGG +230 → +253 
NSW926 yorK GCATGTCGACTGCAGATTGTCTTATCAGGC +153 → +172 
NSW927 yorK GCATGGATCCCTGTGCCTCTCTTATTAAGAGC +400 → +420 
NSW928 yvyG GCATCTGCAGGGCAATTATTGAACAATTGAAGCG +12 →  +35 
NSW929 yvyG GCATGGATCCGTATAGTTGTTCCAGCTCTTCC +264 → +285 
NSW930 yxxG GCATCTGCAGGTATAGAACTTGAATTAACACCGAG +23 → +47 
NSW931 yxxG GCATGGATCCCGAACAAGTTGGAGTTCGAC +318 → +337 
NSW934 tuaD CCCTGAATTCCTTCGGGAAG +450 → +469 
NSW935 tuaD CGATGGATCCGATCGTATGCTTTTACATGGGCG +1029 → +1051 
Complementation of mutant strains 
NSW172 ptpZ GGATGTCGACCATCGTGAAAGTTATTTATTT -44 → -24 
NSW173 ptpZ GGATGCATGCGAATCGGCTGTTAAAAAAACC +754 → +775 
NSW258 ptkA GCATGTCGACGAAAACAGCAAAGACCTTACAGGG -56 → +33 
NSW259 ptkA GCATGCATGCGCACGTTATTTATTTTTGCATGAAATTGTCC +693 → +723 
NSW940 yvyG GCATGTCGACAAGCAATAAAAAAGGAGAAAGCCC -34 → -1 
NSW941 yvyG GCATGCATGCAATTCCTTTCTGCTAAGCTTTTGAATC +469 → +505 
NSW948 tkmA GCATGTCGACCTGTCAACACAGTAAATATAGCGC -167 → -134  
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NSW949 tkmA GCATGCATGCGAGCCTCTGTTTTTTCTAAGCG +741 → +772 
Construction of in-frame deletion strains 
NSW218 ptpZ GCATGTCGACATCGATCATGTCCTAGCCCCC -12 → +9 
NSW219 ptpZ GCATGTCGACGGTTTTTTTTAACAGCCGATTCTC +754 → +777 
NSW220 ptpZ GCATCCCGGGCACTGTGCTTTTCGTTACCAC +1305 → +1325 
NSW221 ugd GCATGGATCCGGCAAGCAGCTGAAAGCA -446 → -429 
NSW222 ugd GCATGTCGACGACTGTTATATTCATTGTTTCCCTCCA -12 → +15 
NSW223 ugd GCATGTCGACGGTGCAATTCAATAGATGAAAAAG +1309 → +1332 
NSW225 ptpZ GCATGGATCCGGAGTGGACATTTTGGCGCT -776 → 759 
NSW226 ugd GCATCCCGGGGCGTATCCGCCAATTTTAT +2092 → +2110 
NSW246 ptkA GGGCGATATCGGATCCGCATACTTTTGATTATGATTGTAACCGCG -697 → -659 
NSW247 ptkA GCATAAGCTTCAAAATGTCCACTCCCCGTTTTTT -21 → +13 
NSW248 ptkA CGATAAGCTTCAAAAATAAATAACGTGCATCGTGCCC +696 → +732 
NSW249 ptkA CCGGGAGCTCGAATTCTTTCTCTAGAACATAAAGAGCCTCTTGA +1381 → +1418 
NSW936 yvyG GCATGGATCCATCAGGCAGAAGCGAATTCAG -588 → -558 
NSW937 yvyG GCATTCTAGAAATAATTGCCTTCGCTGACATG +92 → +123 
NSW938 yvyG GCATTCTAGACTGTTTGATTCAAAAGCTTAGCAGAAAG +453 → +490 
NSW939 yvyG GCATGTCGACCAACACAGTTGTATTTAGCTCTGC +1104 → +1137 
NSW944 tkmA GCATGAATTCTTAACTGTTCAGCAGATGCCAG -645 → -614 
NSW945 tkmA GCATAAGCTTTGTAGATTCTCCCATGATACCTCC -9 → +25 
NSW950 tkmA GCATGGATCCTTGCTTTTGCACGTTGCAAG +1340 → +1369  
NSW961 tkmA TCGAAAGCTTTAGTGAAAAAACGGGGAGTGGACATTTTGGCG +701 → +742 
Construction of Point Mutations 
NSW205 ptpZ H196A GTAGCCTCAGATGCCGCTAATGTGAAAACGAGA +571 → +603 
NSW206 ptpZ H196A TCTCGTTTTCACATTAGCGGCATCTGAGGCTAC +603 → +571 
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NSW246 ptkAc As above As above 
NSW249 ptkAc As above As above 
NSW250 ptkA D81A-
D83A 
AAAGTGCTCCTGATTGCTGCTGCTTTGCGAAAACCAACA +226 → +264 
NSW251 ptkA D81A-
D83A 
TGTTGGTTTTCGCAAAGCAGCAGCAATCAGGAGCACTTT +264 → +226 
NSW252 ptkA Y225A- 
Y227A- Y228A 
TCGAAGCACTCTGAAGCCGGAGCTGCCGGAACCAAGGACAAT +658 → +699 
NSW253 ptkA Y225A- 
Y227A- Y228A 
ATTGTCCTTGGTTCCGGCAGCTCCGGCTTCAGAGTGCTTCGA +699 → +658 
NSW942 yvyG Y49A ACAAAAGAGCAAAAAGCAATTCAAGCAATCACG +130 → +162 
NSW943 yvyG Y49A CGTGATTGCTTGAATTGCTTTTTGCTCTTTTGT +162 → +130 
NSW951 ptkA Y225E- 
Y227A- Y228A 
TCGAAGCACTCTGAAGAAGGAGCTGCCGGAACCAAGGACAAT +658 → +699 
NSW952 ptkA Y225E- 
Y227A- Y228A 
ATTGTCCTTGGTTCCGGCAGCTCCTTCTTCAGAGTGCTTCGA +699 → +658 
NSW953 ptkA Y225E- 
Y227E- Y228A 
TCGAAGCACTCTGAAGAAGGAGAAGCCGGAACCAAGGACAAT +658 → +699 
NSW954 ptkA Y225E- 
Y227E- Y228A 
ATTGTCCTTGGTTC CGGCTTCTCCTTCTTCAGAGTGCTTCGA +699 → +658 
NSW955 ptkA Y225E- 
Y227E- Y228E 
TCGAAGCACTCTGAAGAAGGAGAAGAAGGAACCAAGGACAAT +658 → +699 
NSW956 ptkA Y225E- 
Y227E- Y228E 
ATTGTCCTTGGTTCCTTCTTCTCCTTCTTCAGAGTGCTTCGA +699 → +658 
NSW957 ptkA Y225A- 
Y227A- Y228E 
TCGAAGCACTCTGAAGCCGGAGCCGAAGGAACCAAGGACAAT +658 → +699 
NSW958 ptkA Y225A- 
Y227A- Y228E 
ATTGTCCTTGGTTCCTTCGGCTCCGGCTTCAGAGTGCTTCGA +699 → +658 
NSW959 ptkA Y225F- 
Y227F- Y228F 
TCGAAGCACTCTGAATTTGGATTTTTTGGAACCAAGGACAAT +658 → +699 
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NSW960 ptkA Y225F- 
Y227F- Y228F 
ATTGTCCTTGGTTCCAAAAAATCCAAATTCAGAGTGCTTCGA +699 → +658 
Antibiotic resistance markers 
NSW107 cmlR GTTTTCCCAGTCACGACG 
NSW108 cmlR GAATTGTGAGCGGATAAC 
NSW152 kanR CAGCGAACCATTTGAGGTGATAGG 
NSW153 kanR CGATACAAATTCCTCGTAGGCGCTCGG 
 
Antibiotic resistance genes are indicated as follows: cml, Chloramphenicol resistance; kan, Kanamycin 
resistance. 
a Underlined sequences indicate endonuclease restriction cut sites.  
b Position of primer is indicated in relation to the translational start site (noted as +1) of the named gene. 
 
 
2.3 Plasmids used in this study 
 
Table 2-3: Plasmids used in this study 
 
Plasmid Description Reference 
pBL132 cmlR cassette in pUC19  (Stanley, Britton et al. 2003) 
pBL193 yvyE in pBL132 (Stanley and Lazazzera 2005) 
pDR111 amyE integration plasmid (Britton, Eichenberger et al. 2002) 
pETdegS degS-His6 in pET28b (Kobayashi 2007) 
pMAD In-frame markerless mutation plasmid (Arnaud, Chastanet et al. 2004) 
pNW33 ywfB in pBL132 (Kiley and Stanley-Wall 2010) 
pNW43 degU-His6 in pQE60 (Verhamme, Kiley et al. 2007) 
pNW90 sinR-His6  in pET28a (+) (Verhamme, Murray et al. 2009) 
pNW300 yueH in pBL132 (Kiley and Stanley-Wall 2010) 
pNW301 ptpZ in pBL132 (Kiley and Stanley-Wall 2010) 
pNW302 ybfP in pBL132 (Kiley and Stanley-Wall 2010) 
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pNW303 yomI in pBL132 (Kiley and Stanley-Wall 2010) 
pNW304 yvfO in pBL132 (Kiley and Stanley-Wall 2010) 
pNW305 ywbC in pBL132 (Kiley and Stanley-Wall 2010) 
pNW312 amyE ::Pspank-hy - ptpZ - lacI in pDR111 (Kiley and Stanley-Wall 2010) 
pNW316 amyE ::Pspank-hy - ptpZ H196A - lacI in pDR111 (Kiley and Stanley-Wall 2010) 
pNW330 ptpZ in pMAD (Kiley and Stanley-Wall 2010) 
pNW331 ugd in pMAD (Kiley and Stanley-Wall 2010) 
pNW341 ptkA in pMAD (Kiley and Stanley-Wall 2010) 
pNW348 ptkA D81A - D83A in pMAD (Kiley and Stanley-Wall 2010) 
pNW349 ptkA Y225A - Y227A - Y228A in pMAD (Kiley and Stanley-Wall 2010) 
pNW351 amyE ::Pspank-hy - ptkA - lacI in pDR111 (Kiley and Stanley-Wall 2010) 
pNW361 ahpF in pBL132 (Kiley and Stanley-Wall 2010) 
pNW365 icd in pBL132 (Kiley and Stanley-Wall 2010) 
pNW370 lctE in pBL132 (Kiley and Stanley-Wall 2010) 
pNW371 rocA in pBL132 (Kiley and Stanley-Wall 2010) 
pNW372 yjoA in pBL132 (Kiley and Stanley-Wall 2010) 
pNW373 yvyG in pBL132 (Kiley and Stanley-Wall 2010) 
pNW377 tuaD in pBL132 (Kiley and Stanley-Wall 2010) 
pNW380 amyE ::Pspank-hy -yvyG - lacI in pDR111 This study 
pNW382 amyE ::Pspank-hy - tkmA - lacI in pDR111 (Kiley and Stanley-Wall 2010) 
pNW387 tkmA ptkA in pMAD (Kiley and Stanley-Wall 2010) 
pNW388 amyE ::Pspank-hy -tkmA ptkA - lacI in pDR111 (Kiley and Stanley-Wall 2010) 
pNW390 ptkA Y225E - Y227E - Y228A in pMAD This study 
pNW391 ptkA Y225E - Y227E - Y228E in pMAD This study 
pNW393 ptkA Y225F - Y227F - Y228F in pMAD This study 
pNW396 ptkA Y225A - Y227A - Y228E in pMAD This study 
pNW395 tkmA in pMAD (Kiley and Stanley-Wall 2010) 
pNW399 yvyG in pMAD This study 
pNW546 Phag-yfp in pSac-Kan Constructed by N. Stanley-Wall 
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pNW558 oppA in pBL132 (Kiley and Stanley-Wall 2010) 
pNW559 yorK in pBL132 (Kiley and Stanley-Wall 2010) 
pNW560 ynfE in pBL132 (Kiley and Stanley-Wall 2010) 
pNW801 yvyG Y49A in pMAD This study 
pNW803 ptkA Y225E - Y227A - Y228A in pMAD This study 
pQE60 C-terminal His6- tag expression vector Qiagen ™ 
 
Antibiotic resistance genes are indicated as follows: cml, Chloramphenicol resistance 
 
 
 
2.4 Media and antibiotics 
2.4.1 Growth Media 
 
E. coli and B. subtilis strains were routinely grown in Luria-Bertani (LB) medium (10 g 
NaCl, 5 g yeast extract, and 10 g tryptone per litre) at 37°C unless otherwise stated. E. 
coli strain MC1061 (F'lacIQ lacZM15 Tn10 (tet)) was used for the routine construction 
and maintenance of plasmids. For analysis of biofilm formation MSgg medium was 
used (5 mM potassium phosphate and 100 mM MOPS at pH 7.0 supplemented with 2 
mM MgCl2, 700 μM CaCl2, 50 μM MnCl2, 50 μM FeCl3, 1 μM ZnCl2, 2 μM thiamine, 
0.5% (v/v) glycerol, 0.5% (w/v) glutamate) (Branda, Gonzalez-Pastor et al. 2001). For 
phage transduction, TY media was used (10 g NaCl, 5 g yeast extract, and 10 g tryptone 
per litre supplemented with 10mM MgSO4 and 1μM MnSO4) (Kearns and Losick 
2003).  Transduced cells were plated on selective TY media supplemented with 10mM 
sodium citrate. Media was solidified with up to 1.5% (w/v) agar as required.  
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2.4.2 B. subtilis competence media 
 
In order to generate genetically competent B. subtilis cells, an overnight lawn of 
exponentially growing cells was collected using wash buffer (see Appendix A: Buffers 
and Solutions) and the OD600 measured.  The cells were used to inoculate 12.5 ml of 
SpC media (1 x T-base (see Appendix A: Buffers and Solutions) supplemented with 1 
mM MgSO4, 0.5% (w/v) glucose, 0.2% (w/v) yeast extract, 0.025% (w/v) caseamino 
acids and 40 μg ml-1 tryptophan) to a final OD600 of 0.01. When generating JH642 
competent cells the media was also supplemented with 40 μg ml-1 phenylalanine.  Cells 
were shaken at 37˚C until 2 hours after the onset of stationary phase. The cells were 
diluted 10-fold into prewarmed SPII media (1 x T-base, 3.5 mM MgSO4, 0.5% (w/v) 
glucose, 0.1% (w/v) yeast extract, 0.01% (w/v) caseamino acids and 40 μg ml-1 
tryptophan and phenylalanine as required) and shaken for 90 minutes at 37˚C. Finally 
the cells were concentrated 10-fold in the SPII media and glycerol was added to a final 
concentration of 10% (v/v) (for cells to be stored at -80˚C for future use).  
 
2.4.3 Selection media supplements 
 
The antibiotics used in this work are detailed in Table 2-4. 
Table 2-4 : Antibiotics used in this work 
   B. subtilis E. coli 
Antibiotics Stock concentration (mg ml-1) Dissolved in Final concentration (μg ml-1 ) 
Ampicillin 100  H20 - 100  
Chloramphenicol 5  100% ethanol 5  - 
Erythromycin 1  95% ethanol 1 - 
Lincomycin 25  50% ethanol 25 - 
Kanamycin 50  H20 25 50  
Spectinomycin 100  H20 100  - 
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As required, IPTG was added to the media up to a final concentration of 100 μM for B. 
subtilis or 500 μM for E.coli. 
 
2.5 General molecular biology methods 
2.5.1 DNA methods 
 
2.5.1.1 Agarose gel electrophoresis 
 
Separation of DNA fragments ranging from 100bp - 12kb in size was achieved by 
running through 1-1.5% (w/v) horizontal agarose gels.  1X TAE buffer (see Appendix 
A: Buffers and Solutions) was used to dissolve the agarose powder, and was also used 
as running buffer.  DNA samples were mixed with 0.16 volumes of a 6X loading buffer 
(see Appendix A: Buffers and Solutions) prior to being loaded into the wells.  The gels 
were run at 120V for approximately 25 minutes.  Gels were stained in an ethidium 
bromide solution (0.004% v/v) for approximately 20 minutes before exposure to UV 
light in order to visualise the DNA and photography. 
 
2.5.1.2 Plasmid purification 
 
To purify plasmids from MC1061 cells, we used the QIAprep Miniprep Kit® (Qiagen) 
according to the manufacturer’s instructions.  This method is based on the original 
alkaline lysis method detailed by Birnboim and Doly (Birnboim and Doly 1979). 
Typically, 3 ml of cells from an overnight culture were collected by centrifugation and 
resuspended in a lysis buffer containing RNaseA. After lysis, the cell debris was 
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removed by centrifugation at 16,000 g for 10 minutes.  DNA was selectively captured 
by application to a silica membrane under high salt conditions.  As MC1061 is endA+ 
an additional wash step was used to remove this endonuclease. RNA and cellular 
proteins were removed by washing the column with additional high salt buffer.  The 
purified plasmid DNA was then eluted by applying 30-50 μl of a low-salt buffer to the 
column. 
 
2.5.1.3 Purification of B. subtilis genomic DNA 
 
Extraction of purified genomic DNA for PCR purposes was conducted essentially as 
described by Harwood et al. (Harwood and Cutting 1990).  The method utilises the 
classic phenol/chloroform method for extraction of nucleic acids. Essentially, cells are 
incubated with 1.2 mg ml-1 lysozyme for 30 minutes at 37°C in order to lyse the cells. 
This is followed by the addition of the detergent sarkosyl at a final concentration of 
0.9% (w/v) which assists with cell disruption.  Tris buffered phenol is added to the lysed 
cell mixture and vortexed well in order to dissolve cellular proteins.  The mixture is 
then centrifuged in order to separate the aqueous DNA-containing phase from phenol 
containing organic phase. The aqueous phase is removed and chloroform: isoamyl 
alcohol (24:1 v/v) is added to the mixture, vortexed and centrifuged as before.  The 
aqueous phase containing the DNA is removed from the organic lipid-containing 
chloroform phase.  The DNA is then precipitated by the addition of sodium acetate to a 
final concentration of 850 mM and ethanol. The precipitated DNA is pelleted and 
washed with 70% (v/v) ethanol, prior to resuspension in H20. 
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2.5.1.4 Extraction of DNA from agarose gels 
 
Purification of DNA from agarose gels after electrophoresis was conducted using the 
QIAquick Gel Extraction Kit® (Qiagen), in accordance with manufacturer’s 
instructions.  Essentially, DNA embedded within an agarose gel was removed and the 
gel was dissolved in QG buffer (Qiagen) at 50˚C for approximately 10 minutes, with 
shaking. As for the purification of plasmid DNA detailed above, this method involves 
the capturing of DNA by application of the gel-DNA mixture to a silica membrane 
under high-salt conditions.  Contaminants, such as the agarose, were removed from the 
column by washes with a high-salt buffer. Elution of the DNA was achieved by 
applying a low-salt buffer to the column. 
 
2.5.1.5 Polymerase chain reaction 
 
Polymerase chain reaction (PCR) is a method by which regions of DNA are amplified 
by a thermostable DNA polymerase in the presence of free deoxynucleotides.  
Essentially, the process begins by denaturing the DNA template by exposing it to high 
temperatures (typically 95˚C). Then, the temperature is reduced to allow 
oligonucleotides homologous to the region of interest to bind to the DNA template. 
Finally the temperature is increased to 72˚C or 68˚C (depending on the variety of Taq 
used), the optimum temperature for enabling the extension of the homologous strand by 
the DNA polymerase. The procedure is repeated for approximately 30 cycles.  Qiagen 
Taq DNA polymerase (Qiagen), Phusion DNA polymerase (Finnzymes) and Pfu Turbo 
Polymerase (Stratagene) were used in this work. Qiagen Taq DNA polymerase was 
predominantly used for screening of potential clones and for use in sQRT-PCR analysis, 
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whereas PCR fragments required for the construction of new strains and plasmids were 
amplified using Phusion.  Pfu Turbo polymerase was used for the introduction of site-
directed mutations according to the QuikChange protocol (Stratagene).  Reactions 
contained 1X reaction buffer, up to 200 μM of each dNTP, 0.5 μM each primer and 
0.02 U/μl enzyme. Genomic DNA or 1/50 dilution of plasmid DNA served as a 
template for amplification. 
 
2.5.1.6 Restriction endonuclease digests 
 
All restriction enzymes were supplied by New England Biolabs®. Digests were 
performed using the supplied endonuclease buffer. Digests typically contained 20 U of 
each enzyme in a 50 μl reaction. Reactions were carried out at the recommended 
temperature for the enzymes used and incubated for up to 7 hours for PCR products or 
up to 4 hours for vectors.  Restriction enzymes were removed from products destined 
for cloning using the QIAquick Gel Extraction Kit® (Qiagen) (see section 2.5.1.4). 
 
2.5.1.7 Phosphatase treatment of digested vectors 
 
As required digested DNA vectors were dephosphorylated using calf intestinal alkaline 
phosphatase (CIP) (NEB). CIP acts by removing the 5’ phosphate group from DNA, 
thus preventing self-ligation.  Reactions were performed according to manufacturer’s 
instructions, with the exception that the reactions were incubated for only 30 minutes at 
37°C and the enzyme was removed using the QIAquick Gel Extraction Kit® (Qiagen) 
(see section 2.5.1.4). 
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2.5.1.8 Ligation 
 
The generation of plasmids was achieved using T4 ligase (NEB). T4 ligase acts by 
reconstructing the phosphodiester bond between 5' phosphate and 3' hydroxyl termini of 
compatible restriction digested DNA ends. Reactions totalling 20 μl contained 1X T4 
ligase buffer and 400 U of T4 ligase. The reactions were incubated at 22˚C for at least 1 
hour prior to transformation into competent E. coli cells. 
 
2.5.1.9 Long flanking homology for the construction of double crossover deletions 
 
Long flanking homology was used for the construction of double crossover mutations in 
the genes sinR (NRS1858), yulD (NRS1822), yfmH (NRS1821), yvfG (NRS1825) and 
ytcA (NRS2059). The method was conducted as described by Mascher et al. (Mascher, 
Margulis et al. 2003).  Essentially, primer pairs are designed to amplify approximately 
1000 bp at the 5’ and 3’ ends of the gene. Additionally a PCR product corresponding to 
an antibiotic resistance cassette is also amplified.  A key feature of the method is the 
extended 5’ ends of the primers designed to amplify the flanking regions of the gene to 
be deleted. These extensions are homologous to the antibiotic resistance sequence, thus 
allowing for annealing of the primer extensions to the antibiotic resistance gene and 
enabling joining of the three PCR products.  The resulting PCR product was used in a 
transformation reaction with competent B. subtilis cells and colonies were selected 
based on the antibiotic resistance cassette. 
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2.5.1.10 Construction of plasmids for the insertion of genes at the amyE locus under the 
control of an inducible promoter 
 
Plasmid pNW312 used to introduce the ptpZ gene under the control of the IPTG 
inducible promoter, Pspank-hy at the non-essential amyE locus is a derivative of plasmid 
pDR111 (Britton, Eichenberger et al. 2002).  The ptpZ coding region, including 
ribosome binding site, was amplified from genomic DNA isolated for NCIB3610 using 
primers NSW172 (5’- GGATGTCGACCATCGTGCCCGTTATTTATTT-3’) and 
NSW173 (5’- GGATGCATGCGAATCGGCTGTTAAAAAAAACC -3’). The PCR 
product was cloned into the SalI and SphI sites of pDR111 using the restriction sites 
engineered into the primers (underlined in the primer sequence).  The insert was 
sequenced to ensure that PCR generated errors were not introduced into ptpZ. 
Additional plasmids were constructed in an identical manner using the primers and 
plasmids detailed in Table 2-2 and Table 2-3. 
 
2.5.1.11 Construction of complementation plasmids containing point mutations  
 
Plasmid pNW316 was used to introduce the ptpZ gene containing a point mutation 
encoding for a substitution of histidine at position 196 to an alanine, under the control 
of the IPTG inducible promoter, Pspank-hy at the non-essential amyE locus. It is a 
derivative of plasmid pNW312. The point mutation was introduced using primers 
NSW205 (5’- GTAGCCTCAGATGCCGCTAATGTGAAAACGAGA -3’) and 
NSW206 (5’- TCTCGTTTTCACATTAGCGGCATCTGAGGCTAC -3’) using the 
QuikChange™ mutagenesis kit (Stratagene).  QuikChange™ involves the incorporation 
of point mutations by amplification of a PCR product using primers which contain the 
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mutated bases in their DNA sequence.  Following PCR of methylated template DNA 
the reaction was digested using DpnI (NEB). Using this method, template plasmid DNA 
is removed by digestion, whereas the PCR product containing the desired point 
mutation(s) remains intact. The remaining DNA was transformed into E. coli MC1061 
cells. Plasmids containing the insert were sequenced. Additional point mutations were 
inserted in an identical manner for ptkA and yvyG, using the primers and plasmids 
detailed in Table 2-2 and Table 2-3. 
 
2.5.1.12 Construction of mutants using an adapted pMAD method. 
 
The construction of in-frame antibiotic-minus mutations was conducted using a method 
based on the original detailed by Arnaud et al. (Arnaud, Chastanet et al. 2004). 
Essentially, pMAD derived plasmids were transformed into competent domesticated B. 
subtilis cells at 30°C for 1 hour. At 30°C the temperature sensitive origin of replication 
present on the pMAD plasmid will initiate replication, thus the plasmid will be 
maintained outwith the chromosome.  Colonies were selected for resistance to 
erythromycin and lincomycin, antibiotics which belong to the macrolide-lincosaminde-
streptogramin (MLS) group. A pool of MLS resistant colonies was collected and used to 
inoculate 5 ml TY media plus antibiotic. The culture was grown with agitation at 30°C 
for 16 hours. This culture was then used to harvest phage containing the pMAD derived 
plasmid (see section 2.5.2.1). Undomesticated NCIB3610 was then transduced using the 
harvested phage, ensuring the temperature was kept to 30°C. After growth for 2 days at 
30°C, colonies were selected for on TY media supplemented with sodium citrate and 
MLS.  Next, a pool of NCIB3610 transduced colonies were collected and used to 
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inoculate LB media supplemented with MLS.  The culture was grown at 37°C for 16 
hours with agitation. Growth of the cells at 37°C prevents initiation from the 
temperature sensitive origin of replication, thus in the presence of antibiotics, 
maintenance of the resistance cassette requires integration of the plasmid into the 
chromosome.  Post-integration colonies were selected for on LB supplemented with 
MLS.  Next, a pool of colonies were collected and used to inoculate a culture of LB 
media. The culture was grown without agitation for 16 hours at 30°C, after which the 
culture was shaken for a further 4 hours at 30°C.  Growth at 30°C in the absence of 
antibiotics encourages removal of the plasmid from the chromosome.  The loci which 
the plasmid was first integrated into is left either as wildtype or will contain the plasmid 
engineered mutation, thus selection for mutations is necessary. 
 
2.5.1.13 Construction of plasmids for in-frame and markerless deletions  
 
Plasmid pNW330 used for the construction of an in-frame, antibiotic-minus deletion of 
ptpZ was constructed as follows.  Primers NSW225 (5’- 
GCATGGATCCGGAGTGGACATTTTGGCGCT-3’) and NSW218 (5’- 
GCATGTCGACATCGATCATGTCCTAGCCCCC-3’) were used to amplify the region 
located upstream from the coding sequence of ptpZ. The PCR product was cloned into 
pMAD (Arnaud, Chastanet et al. 2004) using the restriction sites engineered into the 
primers (underlined in the primer sequence) resulting in pNW328. Primers NSW219 
(5’- GCATGTCGACGGTTTTTTTTAACAGCCGATTCTC -3’) and NSW220 (5’- 
GCATCCCGGGCACTGTGCTTTTCGTTACCAC -3’) were used to amplify the 
region located downstream from the coding sequence of ptpZ which was cloned into 
pNW328 using the restriction sites engineered into the primers (underlined in the primer 
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sequence) resulting in pNW330. To introduce the mutation into NCIB3610, pNW330 
was first transformed into 168. SPP1 phage was harvested and was used to transduce 
NCIB3610. NRS2222 was constructed by integration and curing of pNW330 in 
NCIB3610, according to the method detailed in section 2.5.1.12. Further plasmids were 
constructed for in-frame mutations in an identical manner for tkmA, ptkA, ugd, yvyG and 
for tkmA and ptkA using the primers and plasmids detailed in Table 2-2 and Table 2-3. 
 
2.5.1.14 Generation of competent B. subtilis cells and transformation  
 
Transformation of competent B. subtilis cells with genetic material was performed 
based on the method described by Harwood et al. (Harwood and Cutting 1990).  
Essentially 100 μl of competent cells were placed in a sterile test tube with 100 μl of 
sterile transformation buffer (seeAppendix A: Buffers and Solutions).  Up to 10 μl of 
purified gDNA or 30 μl plasmid DNA was added to the test tube prior to incubation on 
a roller drum. All transformations were incubated for 30 minutes at 37˚C, with the 
exception of temperature sensitive plasmids (pMAD derived constructs) which were 
incubated at 30˚C for 1 hour.  Transformed cells were then plated onto selective media 
and incubated at the appropriate temperature. 
 
2.5.2 Generation of competent E. coli cells and transformation 
 
Chemically competent E. coli cells were generated using the classic CaCl2 method. 
Essentially, an overnight culture of E. coli cells was diluted 10-fold into LB liquid 
media.  The cells were then shaken at 37˚C until an OD600 of approximately 0.3 was 
Chapter 2 – Materials and Methods 
 65
reached. The cells were chilled on ice for 30 minutes prior to centrifugation at 3000g for 
15 minutes.  The cell pellets were then resuspended in 0.1 volume ice cold 0.1 M CaCl2. 
The cells were pelleted as before, then resuspended in 0.04 volumes ice cold 0.1 M 
CaCl2 and then incubated overnight on ice. Glycerol was added to a final concentration 
of 10 % before the cells were stored at -80˚C. Prior to transformation, E. coli cells were 
thawed on ice.  Genetic material was added to the cells and allowed to incubate on ice 
for 30 minutes. The cells were then heat shocked for 2 minutes at 37˚C.  The cells were 
chilled on ice for 15 minutes and then plates on selective media. Alternatively, plasmids 
carrying a kanamycin resistance cassette were incubated with 1 ml of LB for 1 hour at 
37˚C prior to plating on selective media. 
 
2.5.2.1 Phage transduction of undomesticated B. subtilis 
 
SPP1 phage (Yasbin and Young 1974) was used for the transfer of genetic information 
from donor to recipient B. subtilis cells.  The harvest of SPP1 phage containing 
B.subtilis DNA fragments and subsequent phage transductions into undomesticated 
B.subtilis was conducted following the method established by Kearns et al. (Kearns and 
Losick 2003). Harvesting phage was conducted as follows: essentially, 200 μl of an 
overnight donor-culture grown in TY media was incubated with TY media and a range 
of concentrations of SPP1 phage.  The mixture was incubated at either 37˚C or, in the 
case of temperature sensitive strains, 30˚C for up to 15 minutes. The phage-cell culture 
mix was then added to molten TY media supplemented with 0.7% (w/v) agar. The 
mixtures were then plated onto thick, fresh TY plates and monitored for plaque 
formation.  The 0.7% (w/v) agar containing the lysed cell and phage mixture was 
removed from the plate, vortexed with additional TY media and passed through a 0.22-
Chapter 2 – Materials and Methods 
 66
µm syringe filter.  In order to conduct the phage transduction recipient cells were grown 
until late stationary phase.  900 μl of recipient cells was added to 9 ml of TY media with 
or without the addition of up to 100 μl of SPP1 phage containing DNA from the donor 
strain. The mixture was incubated for either 30 minutes at 37˚C or 1 hour at 30˚C.  The 
cells were collected by centrifugation at 3000g for 10 minutes. 100 μl of supernatant 
was retained and used to resuspend the cell pellet prior to plating onto selective TY 
media supplemented with 10 mM sodium citrate.  Colonies were then streak purified on 
LB agar plates supplemented with the appropriate antibiotic.  
 
2.5.2.2 DNA sequencing 
 
DNA sequencing was utilised to ensure that all new constructs were free from unwanted 
mutations.  Additionally, the identification of the transcriptional start site of the tkmA 
operon was conducted using DNA sequencing.  All sequencing was performed by the 
DNA sequencing department at the University of Dundee (http://www.dnaseq.co.uk/). 
 
2.5.3 RNA methods 
2.5.3.1 Purification of total RNA from B. subtilis 
 
Cells for RNA isolation were inoculated into 25 ml of LB at an OD600 of 0.01 from an 
overnight lawn plate and grown at 37oC with shaking at 200 rpm in 250 ml flasks.  
When an OD600 of 1 was reached, 3 ml of cells were harvested by centrifugation at 
13,000g for 1 minute and immediately processed for RNA extraction using the 
RiboPure ™-Bacteria RNA extraction kit (Ambion®) according to the manufacturer’s 
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instructions.  RNA was checked for quality by running on an agarose gel and quantified 
using a Nanodrop ™.   
 
2.5.3.2 DNA Microarray Analysis 
 
B. subtilis microarrays consisting of 4105 gene specific oligonucleotides (Compugen) 
were printed at the Research Technology Support Facility at Michigan State University.  
Five oligonucleotides that have no significant similarity to the B. subtilis genome were 
used as negative controls.  To identify the genes that were up-regulated in the absence 
of both SinR and DegU, RNA was extracted from a degSU (NRS1499) and a degSU 
sinR (NRS1686) mutant strain.  For the DNA array analysis two independent RNA 
samples were used for each strain and two technical DNA array replicates were 
conducted. cDNA was synthesised using either 3 or 6 μg of total RNA by reverse 
transcribed with Superscript III (Invitrogen) for 2 hours at 50oC in the presence of 
amino-allyl-dUTP (Sigma).  RNA was degraded by hydrolysis using 15 μl of 0.1 M 
NaOH and incubation at 70oC for 10 minutes.  The sample was neutralised by the 
addition of 15 μl of 0.1M HCl and the cDNA purified using a MinElute PCR 
purification kit (Qiagen) and eluted in 10 μl H20.  To fluorescently label the cDNA, 0.5 
μl of fresh 1M NaHCO3 was added to the cDNA and was used to hydrate an aliquot of 
either GE Healthcare Fluorolink Cy3 dye (degSU cDNA) or GE Healthcare Fluorolink 
Cy5 dye (degSU sinR cDNA).  After 1-hour incubation at room temperature 
unincorporated dye was removed using the MinElute PCR purification kit. Both 
labelled cDNA populations were applied onto a microarray and hybridized overnight at 
42˚C for 16-18 hours. After washing, hybridized microarray slides were analysed using 
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a GenePix™ 4100A array scanner (Axon Instruments).  Images were processed using 
the GenePix Pro 5.0 software which generates red-green fluorescent intensity values for 
each spot.  The fluorescent signal intensities were imported into Microsoft Excel 
(available from http://www.dundee.ac.uk/lifesciences/Stanley-Wall/Home.html). The 
microarray datasets were filtered to remove those genes that were expressed at levels 
less than two standard deviations above the average background values in both 
channels. The intensity values were normalised relative to the ratio generated by 
dividing the total value of Cy3 fluorescence with that of the total value of Cy5 
fluorescence measure per array. The average value from the four spots per gene was 
calculated and those genes with an expression level of greater than 2.0 after 
normalization were selected.  At this point the genes that had previously been identified 
as directly repressed by SinR were eliminated (Chu, Kearns et al. 2006), e.g. genes in 
the epsA-O operon and the yqxM-sipW-tasA operon (Table 3-1).  This resulted in a 
group of 11 genes that had an average expression value of >2.0 and that had previously 
not been demonstrated to be SinR repressed. This work was conducted by Dr. Nicola 
Stanley-Wall. 
 
2.5.3.3 Semi-quantitative RT-PCR 
 
RNA was isolated from cultures of NCIB3610, degSU (NRS1499), sinR (NRS1859) 
and degSU sinR (NRS1860) as described above. The harvested RNA was DNAse 
treated and cDNA was synthesised as previously published (Stanley and Lazazzera 
2005). Essentially, cDNA synthesis was achieved by incubation of purified, DNase-
treated RNA with the reverse transcriptase enzyme, Superscript III (Invitrogen). The 
RNA is first incubated at 70°C in order to remove secondary structures which would 
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disrupt progression of the Superscript III. The temperature is then lowered to allow 
binding of random hexamers. These short primers are designed to possess very low 
specificity and coupled with their random sequences, they bind at various positions 
along the length of the purified RNA.  This increases the chance of the Superscript III 
converting a high proportion of the harvested RNA to cDNA. Elongation was 
performed once for 50 minutes to ensure maximal cDNA synthesis.  To ensure that the 
original RNA samples were free from contaminant DNA, samples of RNA lacking 
Superscript III (Invitrogen) were treated in parallel with samples intended for cDNA 
synthesis.  After cDNA synthesis, RNA-cDNA hybrid nucleic acid is present. To 
remove the contaminating RNA, the mixture is incubated with RNAse H (Invitrogen) 
for 20 minutes at 37°C.  To assess the level of transcription of target genes, cDNA was 
amplified as follows. 1 μl of synthesised cDNA was used in a standard 20 μl PCR 
reaction using Qiagen Taq DNA polymerase with the addition of 3.5 mM MgCl2 and 
8.3 nl ml-1 SyberGreen (Sigma).  PCR samples were held at 95˚C for 10 minutes prior 
to a 25-cycle PCR reaction involving a melting step at 95˚C, followed by an annealing 
step at 50˚C and then an elongation step at 72˚C.  Each PCR step was held for the 
duration of 25 seconds. The genes tkmA, ugd, ptpZ, yomI, ywbC and yvfO were 
amplified using gene-specific primers detailed in Table 2-2. To determine the melting 
temperatures of the PCR products the set point temperature was increased in 40 cycles 
(10 s each) by 1°C per cycle, starting from 50°C.  Expression of tkmA, ugd, ptpZ, yomI, 
ywbC, and yvfO, was calculated as fold changes relative to the wild type strain using the 
formula: Fold change = 2–ΔΔCt; with -ΔΔCt = (Ct(gene x) - Ct(constitutive gene))condition I - (Ct(gene 
x) - Ct(constitutive gene))condition II (Talaat et al., 2002).  The level of transcription of each gene 
was measured using Corbett qPCR reader, run using Rotorgene 8 software (Corbett) 
with expression of veg monitored as a reference gene (Hamon, Stanley et al. 2004). 
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2.5.3.4 RT-PCR as a tool for validating operon structure 
 
RNA was isolated from NCIB3610 grown in LB to an OD600 of 0.01, as described 
above.  cDNA was synthesised using an adapted method to the procedure detailed in 
section 2.5.3.3.  Instead of random hexamers, a reverse primer specific to ugd 
(NSW220) was used. If a single transcript was produced by the tkmA operon, elongation 
of cDNA synthesis initiated from within the ugd gene would produce a cDNA strand 
containing all four genes downstream of the tkmA promoter.  The following primer pairs 
were used for amplification of an internal region of ptkA (NSW225 and NSW254), ptpZ 
(NSW195 and NSW249), or ugd (NSW165 and NSW220) (See Table 2-2 for primer 
sequences). The resulting PCR products were analysed by gel electrophoresis and 
visualised by ethidium bromide staining and exposure to UV light. 
 
2.5.3.5 5’Rapid amplification of complementary DNA ends (RACE) 
 
The transcription start site of tkmA was determined using 5’RACE conducted using 
DNAse treated RNA harvested from NCIB3610 as described in section 2.5.3.3.  To 
synthesise cDNA corresponding to the promoter region of the tkmA gene, 5 μg of 
DNAse treated RNA was incubated with 2.5 pmol NSW227 (5’ – 
GGGCTCTTAATGATGACA – 3’) at 70°C for 10 minutes. The reaction mixture was 
made up to a total volume of 25 μl with the addition of 1x first strand buffer, 11.2 μM 
dithiothreitol  (DTT) and 0.4 mM dNTPs. The mixture was incubated at 42°C for 1 
minute prior to the addition of 200 U of Superscript II (Invitrogen ™) and then 
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incubated for a further 50 minutes. The reverse transcriptase was heat inactivated by 
incubation at 70°C for 15 minutes. To remove any remaining RNA template, RNAse H 
(Invitrogen). 500 ng of synthesised cDNA was 5’ dC-tailed using 20 units of terminal 
transferase (Tdt) (New England Biolabs ™), supplemented with 1X Terminal 
Transferase Reaction Buffer (20 mM Tris-acetate, 50 mM potassium acetate and 10 mM 
Magnesium Acetate), 0.25 mM CoCl2 and 200 μM dCTP.  The reaction was incubated 
at 37°C for 10 minutes and then 10 minutes at 65°C for to heat inactivate the Tdt. 
Touchdown PCR was used to amplify the tkmA promoter region using primers NSW367 
(5’ – GGCCACGCGTCGACTAGTACGGGUUGGGUUGGGUUG – 3’) and NSW228 
(5’ – GGGTGTAAGTGCGAAGAAA - 3).  The standard PCR reaction mixture 
included 1.5 mM MgCl2 , 5 μl of dC-tailed cDNA, 0.4 mM each primer, 1 HotStart Taq 
bead and 1X PCR buffer (Promega). Annealing temperature was gradually reduced 
from 58°C to 48°C in 0.5 increments, with a final 20 cycles at 48°C. The resulting PCR 
product was visualised by gel electrophoresis and staining prior to recombination into 
the TOPO-TA vector pCR2.1 (Invitrogen ™). The inserts cloned were sequenced and 
the transcription start site identified. 
 
2.5.4 Protein methods 
2.5.4.1 SDS-polyacrylamide gel electrophoresis 
 
The Bio-Rad protein gel electrophoresis mini-gel system was used for the running of 
SDS-PAGE gels. The resolving gels for SDS-PAGE contained the following: 375 mM 
Tris-HCl (pH 8.8), 0.1 % (w/v) SDS, 0.1% (w/v) APS, 0.1% (v/v) TEMED. 
Polyacrylamide was added to reach a final concentration of either 12 or 15% (v/v).  The 
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resolving gel was poured to approximately 2 cm from the top between two glass plates. 
Ethanol was applied to the top of the resolving gel to ensure a level gel. The ethanol 
was removed after polymerisation was achieved. The stacking gels for SDS-PAGE 
contained the following: 125 mM Tris-HCl (pH 6.8), 0.1 % (w/v) SDS, 0.1% (w/v) 
APS, 0.1% (v/v) TEMED and 6% (v/v) polyacrylamide.  The gels were run in 1X SDS 
running buffer (seeAppendix A: Buffers and Solutions) for approximately 1 hour at 
200V (constant voltage). Samples were run against 5 μl of SeeBlue®Plus2 protein 
marker (Invitrogen). 
 
2.5.4.2 Coomassie staining of polyacrylamide gels 
 
 Detection of proteins separated by electrophoresis through polyacrylamide gels was 
achieved by staining with coomassie stain (see Appendix A: Buffers and Solutions).  
The gels were incubated for approximately 20 minutes in the stain at room temperature 
with gentle shaking. To remove non-specifically bound stain, the gels were then 
transferred to destain solution (seeAppendix A: Buffers and Solutions).  Saturated 
destain was changed for fresh destain periodically until non-specific staining was 
sufficiently removed.  Gels were then photographed.  
 
2.5.4.3 Protein detection by Western blotting 
 
A western blot was conducted in order to detect the histidine tag of the DegS construct.  
Cells sampled prior to and 3 hours after induction of DegS-His6 expression were 
collected by centrifugation. The cell pellets were resuspended in SDS loading dye 
(seeAppendix A: Buffers and Solutions), normalised according to the OD600 
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measurement at the time of sampling. The samples were boiled for 10 minutes, and then 
cell debris was removed by centrifugation.  10 μl of the prepared samples was loaded 
into a 12% (v/v) SDS-PAGE gel. The gels were run for approximately 1 hour at 200V. 
The proteins were subsequently transferred onto a nitrocellulose membrane which was 
then incubated for >1 hour at room temperature in 1X TBS supplemented with 5% 
(w/v) skimmed milk powder. To detect the histidine tag, the membrane was incubated 
for 1 hour at room temperature with the primary antibody, α-His antibody raised in 
rabbit used at a dilution of 1:1000 (AbCam).  The membrane was thoroughly washed 
with TBST (seeAppendix A: Buffers and Solutions), then incubated with ImmunoPure 
Goat α Rabbit IgG antibody conjugated to horseradish peroxidase used at a dilution of 
1:5000 (Pierce). The membrane was washed again, prior to development with ECL 
reagents and exposure to X-ray film. 
 
 
2.5.4.4 Protein quantification by Bradford method 
 
To quantify the amount of purified protein, the Coomassie (Bradford) Protein Assay Kit 
was used (Pierce).  The kit contains modified ready-to-use components of the classic 
Bradford coomassie-protein binding colourimetric method.  Following the 
manufacturer’s instructions, a number of samples containing increasing concentrations 
of bovine serum albumin (BSA) or the test protein were prepared.  The coomassie 
reagent was added to the samples, the samples were read at 595 nm and a standard 
curve was plotted.  In parallel, the concentration of test protein was measured using a 
spectrophotometer ND-1000 (Nanodrop) with the ability to in put the specific molar 
extinction co-efficient (m-1 cm-1) (details the degree to which a substance absorbs light 
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at a given wavelength) and molecular weight of the test protein, which allows for the 
calculation of the concentration of protein from the absorbance at 280 nm. As the results 
from the Bradford and Nanodrop were in agreement with one another, future protein 
quantification was routinely carried out using the Nanodrop.  
 
2.5.4.5 Protein purification  
2.5.4.5.1 DegS 
 
For the overproduction of DegS-His6, plasmid pET28b-degS-His6 (Kobayashi 2007), was 
induced by the addition of 500 μM IPTG at OD600 0.4.  Growth was continued for 3 
hours prior to collection by centrifugation at 4˚C.  Cells were washed with ice cold 10 
mM Tris-HCl (pH 7.6).  DegS-His6 was purified from inclusion bodies according to the 
BugBuster protocol (Novagen). BugBuster is a gentle detergent which has been 
designed to disrupt E. coli cell walls for the purification of proteins. In addition to 
purification of soluble proteins, BugBuster can be used to wash cell debris from 
inclusion body pellets. After purification by BugBuster, the DegS-His6 inclusion body 
pellet was resuspended in denaturing buffer (50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 
8 M urea and 10 mM imidazole) and incubated on ice for 2 hours before the protein 
solution was applied to a HisTrap FF column (GE healthcare). DegS-His6 was slowly 
renatured by gradual removal of the urea over the course of 90 minutes at room 
temperature with the use of an AKTA purifier FPLC machine (GE Healthcare). DegS-
His6 was eluted from the column by the addition of 500 mM imidazole and was dialysed 
in 50 mM Tris-HCl (pH 7.6), 200 mM KCl, 10 mM MgCl2, 0.1 mM EDTA, 1 mM DTT 
and 50% (v/v) glycerol. 
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2.5.4.5.2 DegU 
 
DegU-His6 was purified as described previously (Verhamme, Kiley et al. 2007). 
Essentially, BL21 (λDE3) carrying pNW43 were grown to an OD600 of 0.5 at which 
point the expression of DegU–His6 production was induced by the addition of 50 mM 
IPTG. The induced cells were allowed to grow for 16 hours at 26°C. The cells were 
harvested and washed twice in ice cold 500 ml of 20 mM Tris-HCl pH 8.0 and 200 mM 
NaCl. The washed cells were suspended in 3.5 ml lysis buffer per 1 g wet weight cells 
(20 mM Tris-HCl pH 8.0, 10 mM imidazole, 2 mM benzamidine, 1.0% (v/v) Triton X-
100, 200 mM NaCl, and one Roche EDTA minus protease inhibitor cocktail tablet per 7 
ml). The suspended cells were incubated in the presence of 1 mg ml-1 lysozyme on ice 
for 30 minutes prior to lysis by French press. Following immobilised metal ion affinity 
chromatography (IMAC) purification DegU-His6 was purified from contaminating DNA 
by application to a DEAE-FF column (GE Healthcare ™). Purified DegU-His6 was 
dialysed before use (20 mM Tris-HCl (pH 8.0) 50 mM NaCl).   
 
2.5.4.5.3 SinR 
 
SinR-His6 was purified based on the original method established by Kearns et al (Kearns, 
Chu et al. 2005). The following alterations were made to the method: BL21 cells 
containing plasmid pNW90 were grown in 500 ml LB + 25 μg ml-1 kanamycin to an 
OD600 of 0.5.  The expression of SinR-His6 was initiated by the addition of 100 μM 
IPTG.  The cells were then grown for 16 hours at 26˚C. The cells were lysed using the 
Novagen BugBuster Master Mix (Novagen) in accordance with manufacturer’s 
instructions. SinR-His6 was purified by application through a HisTrap HP (GE 
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Healthcare) using an AKTA purifier FPLC machine (GE Healthcare). The histidine tag 
used for purification was removed using a thrombin cleavage capture kit in accordance 
with manufacturer’s instructions (Novagen).   
 
2.6 Analytical methods 
2.6.1 Complex colony analysis 
 
Analysis of biofilm formation was performed as described (Branda et al., 2001, 
Verhamme et al., 2007). B. subtilis strains were inoculated from a fresh LB plate and 
grown to mid-late exponential phase in LB.  10 μl of the undiluted culture was spotted 
onto an MSgg plate containing 1.5% (w/v) agar (containing IPTG as required) and 
incubated at 37oC for the time period indicated. Images of the bacterial colonies were 
captured using a Leica MZ16 FA stereoscope using LAS software version 2.7.1.  Due to 
slight changes in the appearance of colonies between different rounds of experiments, 
figures have been made by taking representative colonies from a single experiment.  In 
all cases, colonies were spotted with the wild type B. subtilis strain NCIB3610 on the 
same plate.  Subtle changes in the overall complexity of the wild type B.subtilis 
colonies which may be observed between different figures are within the accepted levels 
of natural variability.  
 
2.6.2 Pellicle formation 
 
 Analysis of pellicle formation was performed as described (Branda et al., 2001). B. 
subtilis strains were inoculated from a fresh LB plate and grown to mid-late exponential 
phase in LB.  For pellicle formation the culture was diluted 1000-fold into 1.5 ml MSgg 
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media in a 24-well plate and was incubated for 16 hours at 37oC. Images of the pellicles 
were captured using a Leica MZ16 FA stereoscope using LAS software version 2.7.1.   
 
2.6.3 Sporulation Analysis 
 
Sporulation analysis was conducted as described previously (Vlamakis, Aguilar et al. 
2008).  Essentially, colonies were grown on solid MSgg media for 24 or 72 hours at 
37°C prior to cell collection.  Liquid cultures were prepared by growing cells in 10 ml 
MSgg media inoculated with cells from an OD600 of 0.01. Cultures were grown for 24 
or 72 hours with shaking at 37°C.  Colonies were collected in 500 μl 1X PBS, whereas 
1ml of cells grown in liquid media was collected by centrifugation and resuspended in 
500 μl 1X PBS. Cells were gently sonicated in order to remove the matrix material from 
the cells without lysing the cells. The cells were then serial diluted in 1X PBS and 100 
μl of diluted cells were plated on LB agar plates. The dilution was then heated to 95°C 
to kill all non-sporulated cells and 100 μl of the heat treated diluted cells were plated on 
LB agar plates. The plates were incubated for 16 hours at 37°C and sporulation 
efficiencies were calculated. 
 
2.6.4 Electrophoretic mobility shift analysis (EMSA) 
 
For the assessment of DegU~P binding to the tkmA promoter, a PCR product 
corresponding to the promoter region of tkmA (PtkmA) was amplified using primers 
NSW146 and NSW147 and purified by gel extraction. Additionally, a PCR product 
corresponding to the promoter region of aprE (PaprE) was amplified using primers 
NSW61 and NSW654 and purified as above (see Table 2-2 for sequences). The 
Chapter 2 – Materials and Methods 
 78
promoter DNA was labelled using 50 μCi [γ-32P] ATP (Perkin-Elmer) and T4 
polynucleotide kinase (New England Biolabs). Unincorporated ATP was removed from 
the labelled DNA using an Illustra Microspin G-25 column (GE Healthcare). 
Phosphorylated purified DegU was produced essentially as described previously 
(Gueriri, Bay et al. 2008), with the exception that a final concentration of 10 μM 
purified DegU~P and 0.78 μM purified DegS were added to the phosphorylation 
reaction. The reaction was incubated for 30 minutes at 25˚C.  EMSA binding mixtures 
were prepared containing 15 mM Tris-HCl (pH 7.6), 0.2% (v/v) Tween-20, 1 mM 
MgCl2, 60 mM NaCl, 4% (v/v) glycerol, 15 mM DTT, 0.5 mg ml-1 bovine serum 
albumin, 1 μg poly (dI-dC), and a range of concentrations of DegU~P, made up to a 
total volume of 30 μl.  The reactions were initiated by the addition of 2 ng of 32P-
labelled DNA probe. 15 μl of the reaction mixtures were loaded onto a prewarmed  5% 
(v/v) Polyacrylamide (AccuFLOWGel; Acrylamide:Bis-Acrylamide solution 29:1) Tris 
Glycine gel (50 mM Tris-HCl, 400 mM glycine, 1.75 mM EDTA) which was run at 
100V for ~1-2 hours.  Dried gels were exposed to X-ray film overnight at -70° C prior 
to development.  
For the assessment of SinR binding to the tkmA promoter, labelled tkmA PCR product 
was produced as described above. Additionally, a PCR product corresponding to the 
promoter region of yqxM (PyqxM) was amplified using primers NSW50 and NSW51 and 
purified as described above (see Table 2-2 for sequences).  The SinR EMSA reaction 
mixture contained 1X SinR EMSA buffer (10mM Tris-HCL (pH 7.6), 1 mM MgCl2, 50 
mM NaCl, 5% (v/v) glycerol, 1mM EDTA, 1mM DTT, 50 ng ml-1 BSA and 50 ng ml-1 
Poly (dI-dC)) and a range of concentrations of SinR, made up to a total volume of 30 μl. 
The reactions were initiated by the addition of 2 ng of 32P-labelled DNA probe.  15 μl of 
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the reaction mixtures were loaded onto a prewarmed 5% (v/v) Polyacrylamide 
(AccuFLOWGel; Acrylamide:Bis-Acrylamide solution 29:1) 0.5X TBE gel (45 mM 
Tris-borate and 1 mM EDTA) which was run at 140V for ~1-2 hours.  Dried gels were 
exposed to X-ray film overnight at -70° C prior to development.  
 
2.6.5 Protease analysis 
 
Secreted proteases were monitored using LB agar plates supplemented with 1.5% (w/v) 
skimmed milk. B. subtilis cultures to be tested were grown to mid-late exponential 
phase in LB from a freshly streaked LB plate and subsequently diluted to an OD600 of 
0.01 in fresh LB medium. In total, 10 μl of the diluted culture was spotted onto a 1.5% 
(w/v) milk plate and incubated at 37°C for 16 hours. The diameter of the halo 
surrounding protease-positive strains was measured, and the diameter of the colony was 
subtracted. The experiment was conducted on at least three independent occasions and 
plotted as the mean ± SEM. 
 
2.6.6 Motility analysis 
 
Swimming and swarming analysis was conducted using low-salt LB medium (5 g NaCl, 
5 g yeast extract, and 10 g tryptone per litre) supplemented with 0.3% (w/v) and 0.7% 
(w/v) agar, respectively (Kearns and Losick 2003). For swarming assays, cultures were 
grown in 3ml LB media at 37°C, with shaking, until OD600 ~1.0 was reached.  The 
cultures were then concentrated to an OD600 10, and 10 μl of culture was spotted onto 
the swarming media. The swarming media plates were prepared directly prior to 
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inoculation.  Plates were poured in a laminar flow, and allowed to dry for 20 minutes 
prior to spotting.  The inoculated plates were then dried for a further 10 minutes before 
the plates were incubated at 37°C.  For swimming assays, media was prepared prior to 
use and the swimming plates were not dried.  Cell material was picked using a sterile 
pipette tip, and this was used to stab the centre of the swimming plate. The plates were 
incubated at 37°C.  The extent of swimming and swarming was noted for each plate at 
defined intervals. 
 
2.6.7 Microscopy 
 
Strains for nucleoid number analysis or for fluorescent reporter fusion visualisation 
were grown in LB at 37oC with shaking to an OD600 of 0.3.  Cells were collected by 
centrifugation and were concentrated 5-fold by resuspension in wash buffer (Appendix 
A: Buffers and Solutions). Cells to be analysed for nucleoid number were by stained 
using Hoechst 33342 (10 ng ml-1) (Invitrogen ™) for 5 minutes and were washed twice 
in wash buffer.  2 μl of cell suspension was spotted onto thin 1.5% (w/v) agarose slides 
and viewed using an Axio Imager M1 microscope (Zeiss). Hoechst 33342 excitation is 
at wavelength 361 nm and emission is at wavelength 486 nm. The peak excitation and 
emission wavelengths of YFP are 514 nm and 527 nm, respectively. Images were 
analysed using AxioVision Rel. version 4.6 image capture software (Zeiss). 
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3 Characterisation of the tkmA operon 
3.1 Introduction 
 
As discussed in Chapter 1, DegU and SinR regulate a number of multicellular 
behaviours displayed by B. subtilis including biofilm formation [for DegU see (Stanley 
and Lazazzera 2005; Kobayashi 2007; Verhamme, Kiley et al. 2007) and for SinR see 
(Kearns, Chu et al. 2005; Branda, Chu et al. 2006)]. To further understand the molecular 
basis of the co-regulation of biofilm formation by DegU and SinR, experiments were 
designed to determine whether they functioned via parallel pathways or if they were 
members of the same regulation cascade. Epistasis analysis presented in this chapter 
supports the conclusion that DegU and SinR operate using separate pathways to control 
biofilm formation.  Later in this chapter, I went on to identify a novel DegU and SinR 
regulated operon that is required for biofilm formation and I characterised the structure 
of this operon at the genetic level. 
 
3.2 DegU and SinR regulate biofilm formation via separate pathways 
 
I aimed to test whether DegU and SinR were part of the same or parallel pathways that 
regulates biofilm formation by B. subtilis. Mutations in sinR and degSU were 
introduced separately, and in combination, into the B. subtilis isolate NCIB3610. 
Colony architecture and pellicle formation were used as two independent measures of 
the capability to form a biofilm (Branda, Gonzalez-Pastor et al. 2001). The phenotype 
exhibited by the following strains was assessed with respect to the wild type parental 
strain (NCIB3610); degSU (NRS1499), sinR (NRS1859), and degSU sinR (NRS1860). 
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The degSU sinR (NRS1860) double mutant, exhibited a colony morphology that was 
distinct from the wild type strain and was dissimilar from either of the previously 
characterised single mutant strains, degSU (NRS1499) and sinR (NRS1859) (Figure 
3-1A). Consistent with previous findings, the degSU mutant strain was unable to form a 
robust stable pellicle (Stanley and Lazazzera 2005; Kobayashi 2007; Verhamme, Kiley 
et al. 2007) and the sinR mutant formed a very robust rugose pellicle (Figure 3-1B) 
(Kearns, Chu et al. 2005). The degSU sinR double mutant formed a pellicle that was 
distinct from either single mutant strain or wild-type strain (Figure 3-1B).  
 
 
Figure 3-1: Epistasis analysis of DegSU and SinR. 
Complex colony architecture assay of B. subtilis.  (A) Strains NCIB3610, degSU (NRS1499), sinR 
(NRS1859), and degSU sinR (NRS1860) were grown on MSgg agar plates for 40 hours at 37˚C prior to 
photographing.  Scale bar represents 5 mm.  (B) Pellicles were allowed to grow in MSgg media overnight 
at 37˚C prior to photography. (C) Strains as detailed above were patched onto an LB agar plate and grown 
for 16 hours at 37˚C prior to scraping and photography.  
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3.3 Identification of novel targets of DegU and SinR 
 
It was noted that by comparison with both the wild type and single mutant strains, the 
double degSU sinR mutant (NRS1860) tightly adhered to the surface of an agar plate 
(Figure 3-1C). This led to the hypothesis that a novel set of DegU and SinR co-
regulated genes existed and that one (or more) was responsible for the enhanced 
adhesion phenotype. It also provided a possible mechanism to identify novel loci 
involved in the control of biofilm formation. To identify these potential gene(s), DNA 
microarray analysis was used. As the number of genes controlled by DegU is 
significantly greater than those controlled by SinR, the expression profile of the degSU 
strain was compared to that of the degSU sinR strain (Dartois, Debarbouille et al. 1998; 
Ogura, Yamaguchi et al. 2001; Tsukahara and Ogura 2008) (Kearns, Chu et al. 2005; 
Chu, Kearns et al. 2006; Kodgire, Dixit et al. 2006). By identifying loci that were up-
regulated >2-fold in the degSU sinR strain compared to the degSU strain, a combination 
of putative DegU and SinR co-regulated genes, and known SinR-regulated genes, was 
generated (Table 3-1). A finalised list of eleven DegU & SinR co-regulated genes was 
compiled by removing known SinR-repressed genes (highlighted in red) (Table 3-1).  
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Gene Putative Operon Structure  Ratio a Putative/Known Function  
yvfO yvfO 5.48 ± 1.77 similar to arabinogalactan endo-1,4-beta-galactosidase 
yfmH yfmH 4.79 ± 0.55 unknown function – no known homologues 
yvfG yvfG 4.23 ± 0.55 inverse direction to epsA-O operon 
ptpZ tkmA-ptkA-ptpZ-ugd 3.66 ± 0.26 protein tyrosine phosphatase 
ywfD ywfBCDEFG 3.53 ± 0.22 similar to glucose 1-dehydrogenase 
ywbC ywbC 3.24 ± 0.29 glyoxylase family protein 
yomI yomI 3.01 ± 0.27 potential lytic transglycosylase 
yvyE yvyE-yvhJ 2.80 ± 0.3 unknown function - potential peptidase 
ybfP ybfP 2.56 ± 0.31  similar to transcriptional regulator (AraC/XylS family) 
yueH yueH-yueI 2.54 ± 0.08 unknown function – no known homologues 
leuD * ilvBHC-leuABCD 2.30 ± 0.24 leucine biosynthesis 
yulD yuxG-yulBCDE 2.17 ± 0.12 potential L-rhamnose 1-epimerase 
epsA epsABCDEFGHIJKLMNO 3.45 ± 0.54 Required for polysaccharide biosynthesis 
epsC epsABCDEFGHIJKLMNO 2.81 ± 0.18 Required for polysaccharide biosynthesis 
epsH epsABCDEFGHIJKLMNO 3.68 ± 0.28 Required for polysaccharide biosynthesis 
epsI epsABCDEFGHIJKLMNO 2.32 ± 0.51 Required for polysaccharide biosynthesis 
epsJ epsABCDEFGHIJKLMNO 4.68 ± 0.96 Required for polysaccharide biosynthesis 
epsK epsABCDEFGHIJKLMNO 3.19 ± 0.66 Required for polysaccharide biosynthesis 
epsL epsABCDEFGHIJKLMNO 8.27 ± 0.59 Required for polysaccharide biosynthesis 
epsO epsABCDEFGHIJKLMNO 2.89 ± 0.68 Required for polysaccharide biosynthesis 
tasA yqxM-sipW-tasA 5.08 ± 0.89 Protein component of spore coat and biofilm matrix 
 
Table 3-1: Genes identified as up-regulated in the absence of sinR and degSU. 
a. The value represents the average ratio of expression identified via DNA array analysis for the 
degSUsinR strain versus degSU strain.  A value greater than 1 represents a higher level of expression in 
the degSUsinR strain.  The errors represent the standard error of the mean from 3 independent 
experiments.  Genes highlighted in red indicate confirmed SinR regulated genes.  *leuD was not included 
in the study as deletion would result in a growth defect. 
 
 
For a subset of the genes (ptpZ, yomI, ywbC, and yvfO) semi-quantitative RT-PCR was 
used to verify the DNA microarray results. An increase in transcription that was at least 
3-fold higher in the degSU sinR mutant versus the wild type strain (p<0.05) was 
observed confirming that transcription was elevated in the absence of DegU and SinR 
(Figure 3-2). 
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Figure 3-2 : RT-PCR analysis of targets of DegU and SinR 
RT-PCR analysis in degSU (NRS1499) (light-grey bars), sinR (NRS1684) (mid-grey bars) and 
degSUsinR (NRS1686) (black bars).  Dashed line represents the transcriptional level of 1 in the wild type 
strain, NCIB3610.  Asterisks indicate where transcription was significantly different from wild type (p-
value < 0.05 for n ≥ 3).  Error bars represent standard error of the mean. 
 
 
 
3.4 Screening novel SinR DegU co-regulated genes for a role in biofilm formation 
 
 
Genes identified through the DNA microarray analysis were tested to see if they were 
responsible for the enhanced surface adhesion exhibited by the degSU sinR strain. To do 
this, a mutation in each gene was constructed and introduced into the wild-type and 
degSU sinR mutant strains (Table 2-1). None of the mutations screened were successful 
in relieving the enhanced cell-surface adhesion phenotype (data not shown). It is likely 
that a combination of mutations would be required to relieve this phenotype but this was 
not tested.  In parallel, taking into account the role that DegU and SinR have in 
controlling biofilm formation (Kearns, Chu et al. 2005; Kobayashi 2007; Verhamme, 
Kiley et al. 2007) the impact of deleting each gene on biofilm formation was assessed.  
Biofilm morphology was monitored after 40 hours incubation.  Mutation of ten of the 
eleven genes identified by DNA microarray analysis did not affect biofilm formation 
but deletion of ptpZ (NRS1827) altered the architecture of the biofilm by comparison 
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with the wild-type strain (Figure 3-3). For the remainder of this study, focus was 
devoted to the characterisation of the tkmA operon and its members to which ptpZ was 
shown to belong.  
 
 
 
Figure 3-3 : Assessing the impact on biofilm formation of mutations in the novel DegU and SinR co-
repressed genes. 
NCIB3610 (wild type) and strains mutant for yvfO (NRS1830), yfmH (NRS1832), yvfG (NRS1842), ybfP 
(NRS1828), ywfB (NRS1389), ywbC (NRS1831), yvyE (NRS1808), yulD (NRS1833), ptpZ (NRS1827), 
yomI (NRS1829) and yueH (NRS1826) were grown on MSgg agar for 40 hours at 37°C.  Scale bar 
represents 5 mm.  
 
 
3.5 Transcriptional analysis of the tkmA operon. 
 
The gene encoding PtpZ is found within a region of the chromosome including tkmA, 
ptkA, and ugd. The initial aim was to establish if these four genes formed an operon. 
This was necessary as i) the DNA microarray analysis only identified ptpZ as 
differentially expressed, ii) ugd is not co-located in the same region of the genome in 
other Gram-positive bacteria (data not shown), iii) and there is a 198-bp gap between 
the stop codon of ptpZ and the start codon of ugd that could conceivably contain a 
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promoter element (see Figure 3-5 for schematic drawing of the tkmA operon). We tested 
whether, as seen for ptpZ (Figure 3-2), transcription of tkmA and ugd was up-regulated 
in the absence of DegU and SinR. We used RT-PCR analysis with cDNA synthesised 
from RNA isolated from the wild type (NCIB3610) and the degSUsinR mutant strain. 
For tkmA, ptpZ and ugd respectively a 10-fold, 7-fold and 3-fold increase in 
transcription was observed in the absence of SinR and DegU by comparison to the wild-
type strain (Figure 3-4). These findings are consistent with the genes being co-regulated 
and suggest that the DNA microarray analysis was the limiting factor in the 
identification of tkmA, ptkA and ugd as differentially expressed in the absence of degU 
and sinR.  
 
 
 
Figure 3-4: sQRT-PCR analysis of the tkmA operon. 
Semi quantitative RT-PCR analysis of the tkmA operon. cDNA synthesised from degSUsinR (NRS1860) 
RNA was compared to cDNA synthesised from NCIB3610.  The level of transcription shown was 
obtained by comparison with wild type levels of transcription and normalised to the transcription of the 
control gene veg.  The dashed line represents the transcriptional level of 1 in the wild type strain, 
NCIB3610.  The asterisks indicate genes whose transcription is significantly different from wild type 
transcription levels (p-value < 0.05) where n ≥ 3.  The error bars represent standard error of the mean. 
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3.5.1 Identification of the transcriptional start site of the tkmA operon. 
 
To determine the transcription start site of the tkmA operon 5’-RACE was used. The 
start site was localised to either -33 bp or -32bp upstream of the tkmA coding sequence 
initiation codon (Figure 3-5). It was not possible to distinguish this more specifically as 
the anchor primer that is needed for the 5’RACE (NSW367) contains a series of 
guanine residues which cannot be distinguished from guanine residues in the amplified 
promoter region (Figure 3-5).  However, the favoured nucleotide is the guanine located 
at -33bp upstream from the initiation codon of tkmA for the transcriptional start site. The 
reasoning being that there is a perfect -10 binding site (TATAAT) for the housekeeping 
RNA polymerase sigma factor A centred 10bp upstream from this nucleotide (Figure 
3-5). Additionally, a sequence with a four out of six base pair match (TGGAGA) to the 
canonical -35 binding site (TTGACA) for the housekeeping RNA polymerase Sigma-A 
is centred at 35-bp upstream from the nucleotide (Figure 3-5) (Moran, Johnson et al. 
1982). When 5’RACE was applied to the region upstream from the ugd translation start 
site, no transcription initiation site could be identified (data not shown). Taken together 
the simplest explanation is that the tkmA-ptkA-ptpZ-ugd operon is a single transcript that 
is up-regulated in the absence of DegU and SinR and driven from a single 
transcriptional start site at 33-bp upstream from the translation initiation codon of tkmA 
(Figure 3-5). 
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Figure 3-5: Identifying the transcriptional start of the tkmA operon 
5’RACE analysis was used to identify the transcriptional start site of the tkmA operon. Genes are 
represented by hollow arrows containing the gene name in italics. A black, stalked arrow schematically 
indicates the start position of transcription. A stalked, hollow circle indicates the translational stop site. A 
section of the tkmA promoter sequence can be found directly below the operon structure schematic. 
Positive and negative numbers refer to the position of the nucleotide with reference to the translational 
start site, designated as +1.  The translational start codon ATG is highlighted by a grey box.  Conserved 
sequences, including the ribosome binding site (RBS), -10 TATAA box and -35 box, are outlined in 
black.  The proposed transcriptional start site (-33bp downstream of the translational start site) is 
highlighted by an asterisk.  The capital letters M, G, E indicate the translated sequence of TkmA.  A DNA 
sequencing readout showing the predicted transcriptional start site preceded by an engineered poly-G tail 
can be seen directly below the DNA sequence of tkmA.   
 
 
 
 
 
 
3.5.2 The tkmA operon is transcribed as a single transcript. 
 
To determine if tkmA, ptkA, ptpZ, and ugd were encoded on a single transcript, mRNA 
was isolated from wild-type B. subtilis and cDNA was synthesised using a reverse ugd 
gene specific primer (Figure 3-6). The cDNA generated corresponded to the ugd 
transcript and was used as a template for PCR with three primer pairs that were specific 
to the internal coding regions of tkmA, ptpZ and ugd. As a negative control, a sample 
that had been subjected to the same treatment but which lacked the reverse transcriptase 
was used to ensure that the PCR products were not the result of any contaminating 
genomic DNA (data not shown). As a positive control, genomic DNA was used to 
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ensure the product amplified was the correct size (Figure 3-6). All three gene-specific 
PCR products were amplified from the cDNA indicating that tkmA, ptkA, ptpZ and ugd 
are co-transcribed (Figure 3-6).  
 
 
 
 
Figure 3-6: tkmA, ptkA, ptpZ and ugd are co-transcribed. 
Regions of DNA internal to tkmA, ptpZ and ugd were amplified from cDNA generated using an ugd-
specific reverse primer. Lane 1 contains 100bp ladder (NEB Biolabs™). Lanes 2 and 3 contain tkmA; 
lanes 4 and 5 contain ptpZ; and lanes 6 and 7 contain ugd PCR product. Lanes 2, 4 and 6 show PCR 
products amplified from cDNA template, while lanes 3, 5 and 7 show PCR products amplified from 
gDNA template. Primer combinations used for amplification of tkmA, ptpZ and ugd can be found in Table 
2-2. 
 
 
 
3.6 Electrophoretic mobility shift analysis of the tkmA promoter. 
 
3.6.1 Purification of DegS 
 
We wanted to establish whether DegU and/or SinR directly regulated transcription from 
the tkmA promoter. To test this we conducted electrophoretic mobility shift assays with 
purified and phosphorylated DegU-His6 and purified SinR-His6.  It has been shown 
previously that the phosphorylated form of DegU (hereafter referred to as DegU~P) is 
required for biofilm formation (Verhamme, Kiley et al. 2007). Therefore DegS was also 
purified as it is the cognate sensor kinase responsible for the phosphorylation of DegU.  
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Initial attempts to purify DegS in its native and active conformation were based on a 
method established by the Msadek research group (Dubrac and Msadek 2004). The 
expression vector pETdegS, carried by BL21 λDE3 pRep4 GroESL, designed for the 
over-expression of DegS-His6 was kindly provided by Prof. Msadek (NRS2219).  
Unfortunately, purification of soluble DegS could not be achieved using this approach.  
In an attempt to overcome this, NRS2219 was grown at a range of different 
temperatures in the hope that lowering the temperature of the cells during growth would 
allow DegS-His6 to fold more slowly, and thus increase the chance that DegS-His6 would 
be produced in its active form.  However despite extensive attempts to purify soluble 
DegS, this could not be achieved (Figure 3-7).   
 
 
Figure 3-7: Solubility testing of DegS-His6 at a range of growth temperatures. 
Cells were grown at the temperatures stated in the figure overnight.  Cells were lysed by sonication and 
centrifuged to separate soluble and insoluble proteins. Samples were normalised according to the OD600 
measurement of the culture.  10 μl of pellet (Pellet) or supernatant (Sup) boiled in SDS loading buffer 
was run on a 12% SDS polyacrylamide gel. ‘Marker’ refers to 5 μl SeeBlue Plus2 protein marker. A 
‘plus’ symbol denotes samples in which the expression of DegS-His6 was induced by the addition of 500 
μM IPTG, whereas a ‘minus’ symbol identified samples which were not induced.  Black boxes indicate 
presence of DegS-His6.  See materials and methods for details. 
 
 
 
As we were unable to purify DegS-His6 in its native conformation directly from the cells, 
a different method was used. The alternative method,  which is based on a method from 
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Dr. K. Kobayashi (Kobayashi 2007), involves the denaturation of insoluble inclusion 
bodies containing over-expressed DegS-His6.  Essentially, the inclusion bodies are 
purified from contaminating proteins, and then the purified protein is renatured slowly 
alowing the protein to re-fold into its active conformation.  A new plasmid, pETdegS, 
constructed for the purpose of over-expressing DegS-His6 was kindly provided by Dr. K. 
Kobayashi (Kobayashi 2007).  Cells containing the pETdegS construct were grown 
until an OD600 of 0.38 was reached.  At this point DegS-His6 expression was induced by 
the addition of 500 μM IPTG. Samples of cells were taken prior to induction of DegS-
His6 expression and at 3 hours after induction.  The samples were then assessed using 
SDS-PAGE in order to confirm that DegS-His6 was expressed.  Additionally, a western 
blot was conducted in order to detect the histidine tag of the DegS construct.  This was 
done to ensure that the histidine tag had not been degraded and could therefore still be 
used for the purification of DegS–His6 (Figure 3-8).   
 
 
 
 
 
Figure 3-8: SDS-PAGE and western blot analysis of DegS-His6 expression.  
(A) Cell samples before (-) and after (+) induction were resuspended in SDS loading buffer. 10 μl of each 
sample was run on a 12% SDS polyacrylamide gel. 5μl of SeeBlue Plus2 (Invitrogen) protein marker was 
also run on gel (M).  (B) Western blot analysis for the detection of DegS-His6.  Arrows on both (A) and 
(B) indicate the size that DegS-His6 is expected to run to (45.73 kDa). 
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Expression of DegS-His6 was confirmed (Figure 3-8A) and the histidine tag was found to 
be intact (Figure 3-8B). The cells containing DegS-His6 were pelleted and lysed using 
BugBuster (Novagene) (see Material and Methods section 2.5.4.5.1). DegS-His6 
inclusion bodies were then purified and finally resuspended in denaturation buffer 
(Figure 3-9).    
 
 
 
Figure 3-9: Purification of DegS-His6 inclusion bodies. 
Samples were run on a 12% SDS polyacrylamide gel. Samples were boiled in SDS loading buffer. Lanes 
were loaded as follows: M, 5 μl SeeBlue Plus2 protein marker; 1, whole cell lysis; 2, supernatant from 
wash 1 ; 3, supernatant from wash 2  ; 4, supernatant from wash 3 ; 5, supernatant from wash 4  ; 6, 
purified inclusion bodies resuspended in the denaturation buffer (see Materials and Methods). Arrow 
indicates the presence of DegS-His6 in the denaturation buffer sample. Expected size of DegS-His6 is 45.73 
kDa. 
 
 
 
After denaturation, the protein was applied to a HisTrap column, in which the His6-
tagged-protein was captured by the Ni-NTA beads. Other contaminating proteins were 
washed from the column. Next, the protein was refolded while still attached to the 
HisTrap column.  In contrast to the Kobayashi method, this step was performed using a 
FPLC machine. This allowed for a more gradual removal of the denaturing urea from 
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the bound DegS-His6, and it was felt that this would improve the quality of the re-folded 
DegS protein. After refolding of the protein was complete, elution of DegS-His6 was 
achieved by adding increasing amounts of imidazole (Figure 3-10).  
 
 
 
 
 
Figure 3-10: Elution trace of renatured DegS-His6 from HisTrap column. 
Trace shows the elution profile of DegS-His6 protein after purification through a HisTrap column. Protein 
was detected by UV absorbance at 280 nm.  Fractions were collected in 1ml volumes and were labelled as 
A1-A12, B1-B12 and C1-C3. The X2 fraction indicates the flow through collection from the stringent 
wash step. 
 
 
Assessment of the elution trace showed a strong peak correlating with the A7 fraction 
collection, indicating the presence of protein in this sample. In order to verify that the 
peak observed in the trace was due to the presence of DegS-His6, samples of collection 
fractions A5 to A10 were tested for the presence of DegS-His6 by running the samples on 
a 12% SDS polyacrylamide gel and staining with coomassie blue stain (Figure 3-11).   
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Figure 3-11: SDS-PAGE analysis of eluted DegS-His6 fractions 
Samples were run on a 12% SDS polyacrylamide gel. Samples were added to SDS loading buffer. Lanes 
were loaded as follows: M, 5 μl SeeBlue Plus2 protein marker; A5 to A10, 10 μl of each eluted fraction 
mixed with SDS loading buffer. Arrow indicates the presence of DegS-His6 in sample A7. Expected size of 
DegS-His6 is 45.73 kDa. 
 
 
 
Assessment of the SDS polyacrylamide gel revealed a band correlating to the expected 
size of Degs-His6 in the A7 fraction collection.  From this we can assume with a level of 
certainty that the protein present is DegS-His6.  Protein from this fraction was dialysed 
against DegS dialysis buffer (Materials and Methods) and concentrated prior to use. 
 
3.6.2 Purification of DegU 
 
DegU-His6 was purified as described previously (Verhamme, Kiley et al. 2007).  Plasmid 
pNW43 (degU-His6 in pQE60) was transformed into M15 E. coli cells containing the 
pRep4 vector. pRep4 encodes a repressor of the IPTG inducible promoter located within 
pNW43, thus ensuring that induction of degU-His6 occurs only in the presence of IPTG . 
The cells were then grown at 37 ˚C until an OD600 of 1.0 was reached.  Cells were 
sampled and then induced by adding IPTG to a final concentration of 100 μM IPTG.  
Growth was continued at 26˚C for 16 hours prior to harvesting the cells.  Cells 
containing DegU-His6 were lysed using a French press and the cell debris removed by 
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centrifugation at 4˚C prior to application to a Ni-NTA HisTrap column for protein 
capture.  Protein purification and elution was achieved by gradually increasing the 
concentration of imidazole present in the elution buffer, controlled by an Akta Prime 
FPLC machine. 
 
 
 
 
Figure 3-12: Elution trace of DegU-His6 from HisTrap column 
Trace shows the elution profile of DegU-His6 protein after purification through a HisTrap column. Protein 
was detected by UV absorbance at 280 nm.  Fractions were collected in 1ml volumes and were labelled as 
A1-A12, B1-B12 and C1-C11.  
 
 
 
Assessment of the elution trace showed two peaks ranging from fractions A9 to B6, 
indicating the presence of protein in these samples. In order to identify if DegU-His6 was 
present in either of these groups of fractions, samples of the above mentioned collection 
fractions were tested for the presence of DegU-His6 by running the samples on a 12% 
(v/v) SDS polyacrylamide gel and staining with coomassie blue stain (Figure 3-13).   
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Figure 3-13: SDS-PAGE analysis of DegU-His6 fractions eluted from a HisTrap column 
Samples were run on a 12% (v/v) SDS polyacrylamide gel. Samples were added to SDS loading buffer 
prior to running. Lanes were loaded as follows: M, 5 μl SeeBlue Plus2 protein marker; A9 to B6, 10 μl of 
each eluted fraction mixed with SDS loading buffer. Arrow indicates the expected size of DegU-His6 
which is 26.64 kDa. 
 
 
By assessing the SDS polyacrylamide gel together with the FPLC elution tract, we 
could determine that the second, larger peak correlating with fraction collection B3 
most likely contained DegU-His6.  Following IMAC purification fraction collections B1-
B6 were pooled and DegU-His6 was purified from contaminating DNA by application to 
a DEAE-FF column (GE Healthcare ™). It is necessary to remove contaminating DNA 
from the purified DegU-His6 prior to EMSA application, as DNA binding cannot occur 
otherwise.  Elution fractions containing DegU-His6 were collected by FPLC machine 
(Figure 3-14). 
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Figure 3-14: Elution trace of DegU-His6 from DEAE column 
Trace shows the elution profile of DegU-His6 protein after purification through a DEAE column. Protein 
was detected by UV absorbance at 280 nm.  Fractions were collected in 1ml volumes and were labelled as 
A1-A12, B1-B12, C1-C12 and finally D1-D11.  
 
 
Assessment of the elution trace showed a single peak ranging from fractions B6 to C7, 
indicating the presence of protein in these samples. In order to assess the purity of 
DegU-His6 present in this group of fractions, samples of the above mentioned collection 
fractions were tested for the presence of DegU-His6 by running the samples on a 12% 
(v/v) SDS polyacrylamide gel and staining with coomassie blue stain (Figure 3-15). 
 
 
 
Figure 3-15: SDS-PAGE analysis of DegU-His6 fractions eluted from a DEAE column 
Samples were run on a 12% (v/v) SDS polyacrylamide gel. Samples were added to SDS loading buffer 
prior to running. Lanes were loaded as follows: M, 5 μl SeeBlue Plus2 protein marker; B6 to C7, 10 μl of 
each eluted fraction mixed with SDS loading buffer. Arrow indicates the expected size of DegU-His6 
which is 26.64 kDa. 
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A strong band correlating to the expected size of DegU-His6 could be seen on the SDS-
polyacrylamide gel. In addition, present in all lanes except B6 and C2 is a band which 
corresponds to a protein which has a slightly higher molecular weight than DegU-His6. 
The identity of the additional band is unknown, and may be a minor contaminant. 
However it is important to note that the presence of this additional band does not impact 
on the ability of DegU-His6 to bind to its DNA targets (Figure 3-17 and Figure 3-18).  
Additionally, bands of a higher molecular weight were observed in lanes C1 and C2.  
Based on the size of DegU-His6 and the approximate size of the observed band, it is 
possible that these bands correspond to DegU-His6 trimers. All samples (B6-C7) were 
pooled and dialysed before use (20 mM Tris-HCl (pH 8.0) 50 mM NaCl).   
 
3.6.2.1 DegS phosphorylates DegU in vitro. 
 
Prior to EMSA analysis we confirmed that purified DegS-His6 was capable of 
phosphorylating DegU-His6 in vitro using γ-32P-ATP (Figure 3-16).  Interestingly, an 
additional band was detected that ran to ~98 kDa.  We predict that this may be a DegS-
dimer complex as it runs at approximately twice the molecular weight of a single DegS-
His6 protein. This additional band does not impair the ability of DegS-His6 to 
phosphorylate DegU-His6.  As we were able to achieve successful phosphorylation of 
DegU by purified DegS in vitro, we decided to proceed with the electrophoretic 
mobility shift analysis of the tkmA promoter region.  
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Figure 3-16: Phosphorylation of DegU-His6 by purified DegS-His6. 
Purified DegU-His6 and DegS-His6 were incubated with 32P γ-ATP, separately and in combination.  1μg of 
each protein, as required, was added to each reaction mixture.  Proteins were mixed with SDS loading 
buffer before they were loaded onto a 12% SDS polyacrylamide gel.  Gel was dried and exposed to X-ray 
film for 20 hours at -70˚C. Arrows indicate the size that DegU (26.64 kDa) and DegS (45.73 kDa) are 
expected to run to. 
 
 
3.6.2.2 DegU directly regulates the transcription of the tkmA operon.  
 
The activity of purified and phosphorylated DegU-His6 protein was established by the 
presence of a positive interaction between the known DegU~P regulated promoter, PaprE 
and the freshly phosphorylated DegU-His6 (Figure 3-17).  The promoter region of aprE 
was amplified using primers NSW61 and NSW654 (see Table 2-2 for full sequences).  
Additional non-sifting bands were observed.  It is highly unlikely that these bands 
correspond to PCR products which are not PaprE.  This is because prior to radio-
labelling, the PCR product was run through an agarose gel and a band corresponding to 
the expected size of PaprE was cut from the gel.  During the optimisation of the DegU 
EMSA protocol, several different buffering systems were tested.  Interestingly, multiple 
radiolabelled bands were only detected when the PaprE product was run through a Tris-
Glycine polyacrylamide gel.  Thus the presence of the multiple bands may be simply 
due to the conditions in which the EMSA was run.  It is important to stress that under 
Chapter 3 – Characterisation of the tkmA operon 
 101
these conditions freshly phosphorylated DegU-His6 is able to shift PaprE.  Therefore we 
felt it was appropriate to continue using these conditions during our investigation into 
the interaction between PtkmA and phosphorylated DegU-His6. 
 
 
Figure 3-17: Electrophoretic mobility shift analysis of the aprE promoter using purified DegU~P 
DNA binding reactions were conducted with γ-32P labelled DNA corresponding to the region -620 to 
+24bp surrounding the start of aprE.  1 ng labelled DNA was loaded into each lane, with increasing 
amounts of purified DegU~P-His6. Arrows indicate labelled DNA corresponding to the promoter region of 
aprE.   
 
 
A 542-bp region of DNA upstream from the translation start site of tkmA was amplified 
by PCR using primers NSW146 and NSW147 (See Table 2-2 for full sequences). The 
results showed that the mobility of the promoter region of tkmA was impeded by the 
addition of 1 μM DegU~P during gel electrophoresis (Figure 3-18). Greater retention 
was seen with increasing amounts of DegU~P (3 μM). Unlabelled DNA corresponding 
to the tkmA promoter was able to out-compete radio-labelled DNA for access to the 
binding domain of DegU~P, indicating that the interaction was specific (Figure 3-18). 
Consistent with this a region of DNA corresponding to the internal coding region of 
tkmA was not able to compete for the binding domain of DegU~P (Figure 3-18).  
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Figure 3-18: Electrophoretic mobility shift analysis of the tkmA promoter using purified DegU~P. 
DNA binding reactions were conducted with γ-32P labelled DNA corresponding to the region -500 to +42 
bp.  1 ng labelled DNA was loaded into each lane, with or without purified DegU~P-His6. Further binding 
reactions include the addition of 100 ng of unlabelled tkmA promoter region PCR product (PtkmA) (-500 to 
+42 bp fragment) or unlabelled internal tkmA (i-tkmA) (+3 to +379 bp) to the EMSA reaction. 
 
3.6.3 Purification of SinR 
SinR-His6 was purified as previously described (Verhamme, Murray et al. 2009). The 
histidine tag used for purification was removed using Novagen’s thrombin cleavage 
capture kit.  The purification of SinR was monitored at various stages by running 
samples on a 15% SDS polyacrylamide (Figure 3-19).  
 
 
 
 
Figure 3-19: SDS-PAGE analysis of SinR purification 
(A) Samples collected during the purification of SinR were assessed by SDS PAGE in order to determine 
the purity of SinR. White arrow indicates expected position of SinR-His6.  Samples were normalised by 
volume and 10 μl of each sample was loaded onto the gel.  Lanes were loaded as follows: lane 1, lysed, 
cell debris; lane 2. ultra centrifuge supernatant; lane 3, flow through from Ni-NTA column; lanes 4-8, 
series of washes with 20 mM imidazole; lane 9, liquid phase of Ni- beads prior to His tag cleavage (SinR-
His should be attached to the beads). (B) Samples of purified SinR before (1) and after (2) removal of 
thrombin after cleavage. 
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The activity of purified SinR-His6 protein was established by the presence of a positive 
interaction between the known SinR regulated promoter, PyqxM and the purified SinR-His6 
(Chu, Kearns et al. 2006) (Figure 3-20).  Under the conditions used, SinR was able to 
inhibit the progression of the yqxM promoter region through the gel. This test confirmed 
that SinR was active and under these conditions SinR would bind to its targets in vitro. 
 
 
Figure 3-20: Electrophoretic mobility shift analysis of the yqxM promoter using purified SinR. 
DNA binding reactions were conducted with γ-32P labelled DNA corresponding to the region -312 to +16 
bp surrounding the start of yqxM.  1 ng labelled DNA was loaded into each lane, with increasing amounts 
of purified SinR.  Further binding reactions include the addition of 100 ng of unlabelled yqxM promoter 
region PCR product to the EMSA reaction. 
 
 
3.6.3.1 SinR indirectly regulates the transcription of the tkmA operon. 
 
In contrast to DegU-His6, SinR-His6 did not interact with the tkmA promoter DNA (Figure 
3-21). These results were as anticipated as in silico analysis of the tkmA promoter region 
did not identify any DNA sequences corresponding to the SinR consensus binding (Chu, 
Kearns et al. 2006). The inhibitory action exerted by SinR on transcription from the 
tkmA promoter is therefore unlikely to be directly mediated (Figure 3-2 and Figure 
3-21).  
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Figure 3-21: Electrophoretic mobility analysis of the tkmA promoter using purified SinR. 
DNA binding reactions were conducted with γ-32P labelled DNA corresponding to the region -500 to +42 
bp.  1 ng labelled DNA was loaded into each lane, with or without purified SinR-His6. Further binding 
reactions include the addition of 100 ng of unlabelled tkmA promoter region PCR product (PtkmA) (-500 to 
+42 bp fragment).  
 
 
3.7 Discussion 
 
In summary the results from this investigation confirmed that DegU and SinR regulate 
biofilm formation via parallel pathways. Furthermore, a novel group of 11 genes were 
found to be upregulated in the absence of DegU and SinR. Given the involvement of 
DegU and SinR during biofilm formation, mutations were made in these 11 genes and 
their impact on biofilm formation was investigated. The results demonstrated that only 
mutation of one target, ptpZ, resulted in an altered colony phenotype (Figure 3-3).  
While the remaining 10 genes did not alter biofilm formation, based on the known 
functions of the genes identified, it is possible that DegU and SinR may regulate an 
even wider range of behaviours and cellular functions.  It must be noted that false 
positives are common occurrences with large scale screens such as DNA microarrays, 
and as only a selection of genes were double checked as being upregulated in the 
absence of DegU and SinR by semi-quantitative RT-PCR (Figure 3-2), the overlapping 
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targets of DegU and SinR remain to be validated. However as the focus of this study 
was to investigate the impact of DegU and SinR during biofilm formation, this was not 
included in the scope of this investigation and as such our attention was devoted to 
investigating the role of ptpZ during biofilm formation. 
The results from our investigation of the tkmA operon have shown that the transcription 
of this operon is under the control of the transcriptional regulators DegU and SinR. 
Recently we hypothesised that DegU and SinR were part of two separate but converging 
pathways that are required for biofilm formation by B. subtilis (Verhamme, Murray et 
al. 2009) and the work shown here supports this original hypothesis.  Moreover, this 
study has demonstrated that DegU directly regulates the transcription of the tkmA 
operon as it binds directly to the tkmA promoter region.  In order to identify the exact 
binding site of DegU within the 500 bp region of DNA used during the EMSA analysis, 
future experiments would include DNA footprinting analysis.   
It must be noted that limitations of the EMSA analysis do exist. A major limitation is 
that the extent to which the pool of DegU was phosphorylated by DegS cannot be 
determined.  It must be stressed that under the conditions used, it is clear that DegS was 
able to phosphorylate DegU (Figure 3-16).  Yet to conclusively determine which form 
of DegU was able to bind to the promoter region of tkmA, future experiments would 
include EMSA analysis using a form of DegU which could not become phosphorylated 
(DegU D56N) (Dahl, Msadek et al. 1991).  Using the information that is available, it is 
highly likely that the phosphorylated form of DegU was able to bind the promoter 
region of tkmA. Under the conditions used, DegU that was phosphorylated by DegS was 
able to shift the promoter region of aprE (Figure 3-17), a known target of DegU~P 
(Ogura, Shimane et al. 2003).  Given that the phosphorylated form of DegU is required 
to regulate biofilm formation by B. subtilis (Kobayashi 2007; Verhamme, Kiley et al. 
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2007) and that mutating tkmA, ptkA and ptpZ affect biofilm formation, it is most likely 
that the phosphorylated form of DegU binds to the promoter region of the tkmA operon. 
Taking into consideration that transcription from the tkmA promoter is up-regulated in 
the absence of degU (Figure 3-2) this suggests that DegU~P therefore functions as an 
inhibitor, and not an activator, of transcription from the tkmA operon. It is important to 
note that while mid-levels of DegU~P activate biofilm formation (Stanley and 
Lazazzera 2005; Kobayashi 2007; Verhamme, Kiley et al. 2007), high levels of 
DegU~P in the cell inhibit biofilm formation (Verhamme, Kiley et al. 2007). 
Furthermore, these findings add to the loci regulated by DegU~P during the formation 
of a biofilm (Kobayashi 2007; Verhamme, Kiley et al. 2007; Verhamme, Murray et al. 
2009). 
In contrast to the results for DegU, it was determined that the transcriptional regulator 
SinR does not directly regulate the transcription of tkmA operon. However, we cannot 
exclude the possibility that the increase in transcription may be due to pleiotropic 
effects on gene expression that occur when sinR and degU are deleted in combination. 
In addition, we cannot rule out the possibility that SinR may require an additional 
transcriptional regulator in order to exert its regulatory effect on the transcription of the 
tkmA operon. Such a situation exists for the lytABC operon where SlrR and SinR are 
required for a protein-DNA interaction to be established (Chai, Norman et al. 2010). 
Finally, it is also interesting to note that transcription of the tkmA operon is also directly 
regulated by Spo0A~P (Fawcett, Eichenberger et al. 2000; Molle, Fujita et al. 2003). 
This provides the second example of a locus involved in biofilm formation where the 
Spo0A and DegU regulatory cascades converge; the first being the promoter element of 
yuaB (Verhamme, Murray et al. 2009). 
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4 Investigating the role of tyrosine phosphorylation during biofilm formation  
4.1 Introduction 
 
The tkmA operon identified and characterised in Chapter 3 encodes the proteins TkmA, 
PtkA and PtpZ which are involved in regulating the activity of target proteins through 
tyrosine phosphorylation (Mijakovic, Poncet et al. 2003; Mijakovic, Petranovic et al. 
2006; Jers, Pedersen et al. 2010).  The products of the tkmA operon were first identified 
as regulators of the conversion of UDP-glucose to UDP-glucuronate, which is used as a 
precursor of the cell wall associated polysaccharide, teichuronic acid (Figure 1-15) 
(Mijakovic, Poncet et al. 2003).  Specifically, PtkA is a BY-kinase that activates the 
UDP-glucose dehydrogenase Ugd (Mijakovic, Poncet et al. 2003) by phosphorylation of 
the tyrosine residue at position 70 (Petranovic, Grangeasse et al. 2009). Conversely, 
PtpZ is a tyrosine phosphatase which acts by dephosphorylating Ugd~P, thus 
inactivating it (Mijakovic, Poncet et al. 2003).   
In addition to the role of PtkA as an activator of Ugd, it has additional target proteins 
and thus is described as a promiscuous BY-kinase (Mijakovic, Poncet et al. 2003; Jers, 
Pedersen et al. 2010). To date PtkA has been shown to phosphorylate 13 proteins (Ugd 
and TuaD (Mijakovic, Poncet et al. 2003), SsbA and SsbB (YwpH) (Mijakovic, 
Petranovic et al. 2006), and YorK, Asd, Eno, YjoA, YnfE, YvyG, InfA, Ldh and OppA 
(Jers, Pedersen et al. 2010)), and thus is an important regulator of a wide range of 
cellular processes. 
In this chapter, I aimed to investigate, in detail, the role of tyrosine phosphorylation 
during biofilm formation. I began by using a more sophisticated approach to introduce 
marker-less and in-frame mutations on the chromosome.  I addressed whether the other 
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proteins encoded by the tkmA operon namely, TkmA, PtkA and Ugd, participated in the 
regulation of biofilm formation. Using this method, I also repeated the construction of 
the ptpZ mutant and confirmed the participation of PtpZ during the regulation of biofilm 
formation (Figure 3-3). 
 
4.2 Characteristic features of PtkA 
4.2.1 Assessing the impact of deleting ptkA  
 
Having defined the structure of the tkmA operon (Figure 3-5 and Figure 3-6) I wanted to 
establish the role of tyrosine phosphorylation during the formation of a biofilm. As 
tkmA-ptkA-ptpZ-ugd form an operon (Figure 3-4 and Figure 3-6), an in-frame deletion 
in ptkA was made to circumvent downstream effects on transcription and/or the 
stoichiometry of the remaining proteins (see Materials and Methods). It has been 
reported that PtkA and PtpZ play a role in controlling DNA replication (Petranovic, 
Michelsen et al. 2007) and that a ptpZ mutant exhibits a severe growth defect 
(Petranovic, Michelsen et al. 2007). A growth defect would render interpretation of 
biofilm formation ambiguous; therefore I first tested whether the ΔptkA strain had a 
reduced growth rate. In both MSgg liquid medium and LB (data not shown), the ΔptkA 
mutant had a doubling time equal to that of the parental strain (Figure 4-1).  
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Figure 4-1: ΔptkA does not have a reduced growth rate 
Growth NCIB3610 (white triangles) and ΔptkA (black squares) was monitored for several hours in MSgg 
liquid media.  At various time points, the absorbance of the culture was assessed by reading the sample at 
wavelength OD600.  The graph displayed is representative of 3 independent rounds. 
 
Absence of PtkA has been shown to have deleterious effects on cell length and nucleoid 
number (Petranovic, Michelsen et al. 2007). Therefore we analysed cell length and 
nucleoid distribution of our ΔptkA strain using microscopy. In contrast to the previously 
published data, our preliminary findings suggested that there was no significant 
difference between the cell length of a ptkA mutant compared with wild type. 
Furthermore, under the conditions used in this study, deletion of ptkA did not appear to 
significantly alter nucleoid number (Figure 4-2).  Several reasons may explain this 
discrepancy.  Firstly, it must be noted that the Hoechst stain was not uniformly taken up 
by both the wild type NCIB3610 strain and the ΔptkA mutant (Figure 4-2).  Secondly, 
we did not test the original ptkA mutant used in the Petranovic study to see the impact of 
the mutation under our conditions.  It is possible that differences in either the method of 
strain construction or the genetic background may explain why we were unable to 
observe the effects on cell length and nucleoid number that was observed by Pertranovic 
et al. However, in our hands these results tentatively suggest that in NCIB3610, deletion 
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of ptkA does not result in a gross growth defect and that our ptkA mutant is unlikely to 
possess a defect in DNA replication.  
 
 
Figure 4-2: Staining of nucleoids in ΔptkA cells compared to NCIB3610 using Hoechst 33342. 
Phase contrast and fluorescent images of NCIB3610 and ΔptkA collected using Zeiss Axio Imager M1.  
Scale bars represent 5 μm.  
 
Having established that ΔptkA (NRS2544) did not exhibit a growth defect, the impact of 
deleting ptkA on biofilm formation was tested. Three independent indicators of biofilm 
formation were assessed; namely complex colony architecture, pellicle formation and 
the ability to form environmentally resistant spores (Branda, Gonzalez-Pastor et al. 
2001; Vlamakis, Aguilar et al. 2008). All of these processes have been linked with the 
biosynthesis and assembly of the extracellular matrix. Starting with complex colony 
architecture; we determined that ΔptkA was unable to develop the complex radial 
structures typical of the mature B. subtilis biofilm on semi-solid agar (Figure 4-3).  To 
confirm that the biofilm morphology of the ΔptkA mutant was specific to the absence of 
PtkA, a wild-type copy of ptkA was introduced into the amyE locus under the control of 
a heterologous promoter; Pspank-hy-ptkA-lacI (NRS2804). The biofilm architecture was 
fully restored compared to that shown by the wild-type strain both in the absence of 
IPTG and in the presence of 10 μM IPTG (compare Figure 4-3B to Figure 4-3C). These 
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findings confirm that the altered biofilm phenotype was specific to the disruption of 
ptkA.  
 
Figure 4-3: Complex colony architecture of ΔptkA and ΔptkA complemented with wild type ptkA. 
Strains (A) NCIB3610 and (B) ΔptkA (NRS2544) were assessed as described in Figure 3-1.  (C) Mutant 
ΔptkA + amyE-Pspank-hy-ptkA-lacI (NRS2804) was grown on MSgg agar with and without the addition of 
10 μM IPTG. The scale bar represents 5 mm.   
 
Next, we tested the effect of mutating ptkA on the ability of the strain to form robust 
pellicles. In contrast to the reduction in colony architecture complexity (Figure 4-3B), 
the pellicle formed by the ΔptkA strain showed extensive three dimensional structural 
complexity but it entirely lacked the “fruiting body structures” that are present on the 
wild-type pellicle (compare Figure 4-4C to Figure 4-4D).  
 
 
 
Figure 4-4: Pellicle morphology of ΔptkA compared to NCIB3610. 
Strains (A) NCIB3610 and (B) ΔptkA (NRS2544) were assessed as described in Figure 3-1.  The scale bar 
represents 5 mm (A and B) and 1mm (C and D).   
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Taken together, the altered colony morphology and lack of “fruiting body” formation on 
the pellicle, we decided to investigate whether or not the ΔptkA strain was able to 
sporulate.  After 24 hours incubation under biofilm formation conditions 13±2.5% of 
the ΔptkA mutant population had sporulated by comparison to the wild-type that 
exhibited 25±4% sporulation (n=3; p<0.06 2-way students t-test). After 72 hours the 
difference in the sporulation efficiency widened such that only 37±10 % of the ΔptkA 
cells in the colony had sporulated by comparison with 103±9% of the wild-type strain 
(n=3; p<0.01 students 2-way t-test). In contrast after 72 hours planktonic growth there 
was no difference between the sporulation levels of the wild-type strain and that of  the 
ΔptkA mutant indicating that the decrease in sporulation did not reflect a reduction in 
the sporulation efficiency per se (data not shown) (Vlamakis, Aguilar et al. 2008).  
From the results of our investigation into colony architecture, pellicle formation and 
sporulation ability, it is clear that ptkA plays an important role in the development of 
structurally complex and robust biofilms. 
 
4.2.2 Characterisation of the PtkA terminal tyrosine cluster 
 
The conserved C-terminal tyrosine domain serves as the site of autophosphorylation on 
PtkA, a process that is dependent on the catalytic activity of PtkA (Mijakovic, Poncet et 
al. 2003). The results from an in vitro assay suggest that the C-terminal tyrosine 
residues are not needed for phosphorylation of substrate proteins (Mijakovic, Poncet et 
al. 2003) but structural analysis of a PtkA homologue demonstrates that the C-terminal 
tyrosine domain interacts with the neighbouring kinase active site (Olivares-Illana, 
Chapter 4 - Investigating the role of tyrosine phosphorylation during biofilm formation 
 113
Meyer et al. 2008). Taken together, these findings render the role of the conserved 
tyrosine residues ambiguous. The influence that PtkA has on colony morphology 
presents a robust and simple route to clarify if the terminal tyrosine residues play a role 
in vivo during biofilm formation. To investigate the role of the terminal tyrosine cluster 
of PtkA during biofilm formation we constructed a strain in which the three terminal 
tyrosine residues were mutated to alanine (PtkA Y225A; Y227A; Y228A; NRS2799). 
Substitution of the terminal tyrosine cluster however did not impact on biofilm 
formation (Figure 4-5).  From these results we can conclude that the terminal tyrosine 
cluster does not appear to be required for the activity of PtkA during biofilm formation.  
A more detailed analysis is provided in Chapter 5. 
 
 
Figure 4-5: Alanine substitution of the PtkA terminal tyrosine cluster does not impact on biofilm 
formation. 
Strains NCIB3610 and ptkA Y225A-Y227A-Y228A (NRS2799) were grown on MSgg agar plates for 40 
hours at 37˚C prior to photographing. Scale bar represents 5 mm. 
 
 
4.2.3 Assessing the requirement of the kinase activity of PtkA during biofilm 
formation  
 
Bacterial tyrosine kinases (BY-kinase) share a strong degree of sequence conservation 
(Figure 1-13).  Structural analysis of a PtkA homologue, Cap5B belonging to 
Staphylococcus aureus, showed that the Walker A, the ‘DxD’ motif and the Walker B 
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motifs are required to coordinate and stabilise four water molecules and an Mg2+ ion 
into the active site where hydrolysis of a bound nucleotide occurs (Figure 1-13) 
(Olivares-Illana, Meyer et al. 2008). Therefore the activity of PtkA is dependent on 
binding and hydrolysis of ATP coupled to the transfer of the released phosphate moiety 
onto a target substrate protein(s) (Mijakovic, Poncet et al. 2003).  
We aimed to confirm whether or not the catalytic kinase activity of PtkA was needed 
during biofilm formation. To achieve this, two strains were made that resulted in 
substitutions on the chromosome leading to alterations in the PtkA amino acid 
sequence: 1) an amino acid point mutation in the second of the aspartic acid residues in 
the conserved ‘DxD’ motif required for ATP hydrolysis catalysis; (PtkA D83A; 
NRS2795); and 2) a dual ‘DxD’ aspartic acid to alanine substitution; (PtkA D81A and 
D83A; NRS2796). The nucleotide substitutions were introduced into the chromosome 
using pMAD (Arnaud, Chastanet et al. 2004) and in each case an isolate that had been 
subjected to the mutagenesis but had retained the wild-type sequence was retained as a 
control (see Materials and Methods). Each of the negative control strains exhibited 
wild-type morphology (data not shown). Consistent with the ‘DxD’ motif being 
required for the activity of PtkA, mutation to ‘AxA’ resulted in a biofilm morphology 
that was indistinguishable from the complete in-frame ΔptkA strain (NRS2544) 
(compare Figure 4-3B to Figure 4-6C).   
To confirm that the biofilm morphologies of the ptkA point mutation strains were 
specific to the point mutations introduced at the native locus, a wild-type copy of ptkA 
was introduced the ptkA D81A-D83A mutant at the amyE locus in under the control of a 
heterologous promoter; Pspank-hy-ptkA-lacI (NRS2804). The biofilm architecture was 
fully restored compared to that shown by the wild-type strain both in the absence of 
IPTG and in the presence of 10 μM IPTG (compare Figure 4-6C to Figure 4-6D). These 
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findings confirm that the altered biofilm phenotype was specific to the disruption of 
ptkA. 
 
 
 
Figure 4-6: Complex colony architecture of ptkA ‘DxD’ motif point mutation strains. 
Strains were grown on MSgg agar plates with and without the addition of 10 μM IPTG as required for 40 
hours at 37˚C prior to photographing. Scale bar represents 5 mm. 
 
 
The data presented here enables us to conclude that the ‘DxD’ motif of PtkA is 
necessary for its role during biofilm formation.  The ‘DxD’ motif is essential for 
hydrolysis of nucleotides and is needed for autophosphorylation of the terminal tyrosine 
cluster of PtkA.  Establishing the requirement of the ‘DxD’ motif during biofilm 
formation is an important step in determining whether or not the kinase activity of PtkA 
is required during biofilm formation.  However these results alone cannot specifically 
confirm that the kinase activity of PtkA is necessary for its role during biofilm 
formation.  To achieve our goal of understanding if the kinase activity of PtkA is 
required for its role in biofilm formation, further experiments were conducted.  These 
experiments are detailed in section 4.3. 
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4.3 Characterisation of TkmA 
 
In addition to its role as a kinase, PtkA also exhibits ATPase activity (Mijakovic, Poncet 
et al. 2003).  To (indirectly) distinguish whether the ATPase or kinase activity of PtkA 
was responsible for its role in biofilm formation, an in-frame deletion of tkmA was 
constructed (NRS3541) (Figure 4-7B).  As the translational start site of PtkA is located 
within the coding sequence of TkmA, an artificial ptkA ribosomal binding site and PtkA 
translational start site were engineered into the chromosome (Figure 4-7B).  TkmA is 
the cognate BY-kinase modulator that interacts with PtkA allowing it to phosphorylate 
its target proteins (Mijakovic, Poncet et al. 2003; Jers, Pedersen et al. 2010).  Thus in 
the absence of TkmA, PtkA is unable to exhibit kinase activity and can no longer 
phosphorylate substrate proteins but its ATPase activity remains intact (Mijakovic, 
Poncet et al. 2003).  
 
 
 
Figure 4-7: Representation of tkmA and tkmAptkA mutations constructed on the chromosome. 
Schematic representation of ΔtkmA and ΔtkmAΔptkA deletion strains.  (A) Wild type tkmA and ptkA.  
Translational start and stop codons are highlighted in green and red, respectively.  (B) Deletion of tkmA. 
Translational start and stop codons are highlighted as mentioned in (A).  Primer engineered restriction site 
for hindIII is highlighted in yellow. Primer engineered replacement of the native ptkA ribosome binding 
site (RBS) is in bold text.  (C) Deletion of tkmA and ptkA. Translational start and stop codons are 
highlighted as mentioned in (A) and the restriction site is highlighted as mentioned in (B). 
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4.3.1 Assessing the impact of deleting tkmA on biofilm formation 
 
Upon deletion of tkmA we observed a reduction in colony complexity and a loss of 
complex aerial structures and fruiting bodies (Figure 4-8C), consistent with TkmA 
being required for biofilm formation. The heterologous expression of tkmA under the 
control of the Pspank-hy promoter was able to complement the tkmA mutation (in the 
absence of IPTG) (Figure 4-8D). Taken together this demonstrates that TkmA is 
required for biofilm formation and supports the hypothesis that the kinase activity of 
PtkA is essential for its role during biofilm formation. 
 
 
Figure 4-8: Complex colony architecture of ΔtkmA and ΔtkmA ΔptkA deletion strains 
Strains (A) NCIB3610, (B) ΔptkA  (NRS2544), (C) ΔtkmA  (NRS3541), (D) ΔtkmA+ Pspank-hy-tkmA  
(NRS3544), (E) ΔtkmAΔptkA  (NRS3528), (F) ΔtkmAΔptkA+ Pspank-hy-tkmA- ptkA  (NRS3536), (G) 
ΔtkmAΔptkA+ Pspank-hy-tkmA (NRS3535), and (H) ΔtkmAΔptkA+ Pspank-hy-ptkA (NRS3537) were grown on 
MSgg agar plates without the addition IPTG for 40 hours at 30˚C prior to photographing. Scale bar 
represents 5 mm.   
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4.3.2 TkmA remains active in the absence of PtkA 
 
Interestingly, deletion of tkmA did not phenocopy the ΔptkA strain (NRS2544) (compare 
Figure 4-8B to Figure 4-8C). Therefore we hypothesised that TkmA retained activity in 
the absence of PtkA and that TkmA was capable of interacting with other proteins. To 
test this we constructed a strain lacking both tkmA and ptkA (NRS3528) (Figure 4-7C).  
We predicted that if our hypothesis was correct restoration of tkmA expression in the 
strain mutant for both tkmA and ptkA would return the colony phenotype to that of a 
ptkA mutant. When grown on MSgg media ΔtkmAΔptkA (NRS3528) displayed a 
complex colony architecture that was indistinguishable to the ΔtkmA mutant (NRS3541) 
(compare Figure 4-8C with Figure 4-8E).  We confirmed that addition of both the tkmA 
and ptkA coding regions (NRS3536) under the control of an inducible promoter was 
necessary and sufficient to return the mutant phenotype back to that of wild type B. 
subtilis (Figure 4-8F).  From this we conclude that both TkmA and PtkA are required 
for biofilm formation and that TkmA is epistatic to PtkA.  
Next, only the tkmA coding region was introduced into the ΔtkmAΔptkA mutant strain 
(NRS3535).  The complex colony architecture of this strain was indistinguishable from 
the ΔptkA mutant (NRS2544) (compare Figure 4-8G with Figure 4-8B). As a change to 
colony architecture was observed upon expression of tkmA, this indicated that, as 
hypothesized above, TkmA can function (at least in part) in the absence of PtkA.  In 
contrast, expression of only the ptkA coding region in the ΔtkmAΔptkA mutant strain 
(NRS3537) had no impact on complex colony architecture (Figure 4-8H). This further 
supports the conclusion that substrate phosphorylation by PtkA during biofilm 
formation relies on activation of its kinase activity through interaction with TkmA. 
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When taken together we conclude that the kinase activity of PtkA is required for its role 
during biofilm formation, whereas the ATPase activity of PtkA is not. 
 
 
4.4 Characterisation of PtpZ 
 
As for the deletion of PtkA, we aimed to establish the role of tyrosine phosphorylation 
during the formation of a biofilm by deleting ptpZ, the gene encoding the tyrosine 
phosphatase PtpZ. The initial ptpZ mutant that was constructed as part of the screening 
process was generated using single-crossover disruption (Figure 3-3). As tkmA-ptkA-
ptpZ-ugd form an operon (Figure 3-5 and Figure 3-6), an in-frame deletion of ptpZ was 
made to circumvent downstream effects on transcription and/or the stoichiometry of the 
remaining proteins (see Materials and Methods). It was first necessary to establish if the 
in-frame ptpZ mutant exhibited a severe growth defect, as has been previously reported 
(Petranovic, Michelsen et al. 2007). A growth defect would render interpretation of 
biofilm formation ambiguous; therefore we tested whether the ΔptpZ strain had a 
reduced growth rate. In both LB (data not shown) and MSgg liquid medium the ΔptpZ 
mutant had a doubling time equal to that of the parental strain (Figure 4-9).  
 
Chapter 4 - Investigating the role of tyrosine phosphorylation during biofilm formation 
 120
 
Figure 4-9: Growth of ΔptpZ mutants compared to NCIB3610 
Growth of NCIB3610 (white diamonds) and ΔptpZ (NRS2222) (black triangles) in MSgg media. Results 
are representative of >3 independent rounds. 
 
 
Absence of PtkA has been shown to have deleterious effects on cell length and nucleoid 
number (Petranovic, Michelsen et al. 2007). Therefore we analysed cell length and 
nucleoid distribution at the single cell level using microscopy of the ptpZ mutant strain 
in comparison to the wild type NCIB3610 strain. Our preliminary findings suggested 
that there was no significant difference between the cell length of a ptpZ mutant 
compared with wild type. Furthermore, under the conditions used in this study, deletion 
of ptpZ did not appear to significantly alter nucleoid number (Figure 4-10).  However, 
as for ptkA, it must be noted that the Hoechst stain was not uniformly taken up by both 
the wild type NCIB3610 strain and the ΔptpZ mutant (Figure 4-10).  
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Figure 4-10: Nucleoid staining of ΔptpZ compared to NCIB3610 using Hoechst 33342 
Phase contrast and fluorescent images of NCIB3610 and ΔptpZ collected using Zeiss Axio Imager M1.  
Scale bars represent 5 μm.  
 
However when taken together, these results tentatively suggest that in NCIB3610, 
deletion of ptpZ does not result in a gross growth defect and that our ptpZ mutant is 
unlikely to possess a defect in DNA replication.   
 
4.4.1 Impact of deletion of ptpZ on biofilm formation 
 
An approach similar to that used for PtkA was taken to assess the impact of deleting 
ptpZ on biofilm formation. As determined for the ΔptkA mutant, the ΔptpZ mutant was 
unable to develop the complex radial structures typical of the maturing B. subtilis 
biofilm at 24 hours (Figure 4-11B).  To ensure that the ΔptpZ mutant phenotype was 
specific to the absence of PtpZ, a wild type copy of ptpZ was introduced to the amyE 
locus in the ΔptpZ mutant under the control of a heterologous promoter; Pspank-hy-ptpZ-
lacI (NRS2467). In the presence of 100 μM IPTG biofilm architecture was comparable 
to that of the wild-type strain (Figure 4-11B compared to Figure 4-11C). These findings 
confirm that the altered biofilm phenotype was specific to the disruption of ptpZ. 
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Figure 4-11: Complex colony architecture of ptpZ mutants 
(A) Strains NCIB3610, (B) ΔptpZ (NRS2222) and (C) ΔptpZ + Pspank-hy-ptpZ (NRS2467) were grown on 
MSgg media with or without the addition of 100μM IPTG for 24h at 37˚C. Scale bar represents 5 mm.   
 
 
Again, in contrast to the reduction in colony architecture complexity (Figure 4-11B) the 
pellicle formed by the ΔptpZ strain showed extensive three dimensional structural 
complexity but entirely lacked the “fruiting bodies” that are present on the wild-type 
pellicle (compare Figure 4-12A and C with Figure 4-12B and D).  
 
 
 
Figure 4-12: Pellicle morphology of ΔptpZ compared to NCIB3610 
Strains NCIB3610 (A + C) and ΔptpZ (B + D) (NRS2222) were assessed as described in Figure 3-1.  The 
scale bar represents 5 mm (A and B) and 1mm (C and D).   
 
 
These alterations in colony morphology and pellicle morphology were accompanied by 
a reduction in the level of sporulation from ~25 ±4% in the wild-type strain to ~8± 3.6 
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% in the ΔptpZ mutant (n=3; p<0.05 2-way students t-test). The decrease in sporulation 
was found to be specific to cells growing in the biofilm colony as after 24 hours growth 
in liquid medium the wild type strain and the ΔptpZ mutant had sporulated at a 
frequency of ~33±1.5% and ~40±9%, respectively. However in contrast to the ΔptkA 
mutant, the impact of deleting ΔptpZ became less apparent over time; such that by 48 
hours the lack of PtpZ had only a minor impact on the ability to form a biofilm (data not 
shown). The sporulation analysis confirmed this conclusion. After 72 hours of 
incubation ~65±3% of the ptpZ mutant population had sporulated, a value that was not 
significantly different from the wild-type strain (n=3; p=0.09 2-way students t-test). 
 
4.4.2 Assessing the requirement of the phosphatase activity of PtpZ during biofilm 
formation  
 
The phosphatase activity of PtpZ has been shown to be reduced by ~95% when the 
histidine residue at position 196 was mutated to alanine (Mijakovic, Musumeci et al. 
2005). Therefore to establish whether the phosphatase activity of PtpZ was required to 
control biofilm formation a mutant allele of ptpZ (PtpZ-H196A) was introduced into the 
amyE locus under the control of a heterologous promoter; Pspankhy-ptpZ-H196A-lacI 
(NRS2468). In contrast to the wild-type allele of PtpZ, the mutant PtpZ-H196A protein 
was not capable of restoring wild-type colony morphology (compare Figure 4-13C to 
Figure 4-11C). These findings support the conclusion that the phosphatase activity of 
PtpZ is required for its role during biofilm formation.  
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Figure 4-13: Complex colony architecture of a ptpZ point mutation strain. 
(A) Strains NCIB3610, (B) ΔptpZ (NRS2222) and (C) ΔptpZ + Pspank-hy-ptpZ H196A (NRS2468) were 
grown on MSgg media with or without the addition of 100μM IPTG for 40h at 37˚C.  Scale bar represents 
5 mm.   
 
4.5 Influence of known and predicted targets of PtkA and PtpZ on biofilm 
formation 
 
We wanted to identify the downstream target(s) of PtkA that is phosphorylated during 
biofilm formation. In vitro analysis currently indicates that PtkA has 13 confirmed 
substrates (Mijakovic, Poncet et al. 2003; Mijakovic, Petranovic et al. 2006; Jers, 
Pedersen et al. 2010). Additionally, using phosphoproteome analysis a further 8 proteins 
have been identified as tyrosine phosphorylated (Levine, Vannier et al. 2006; Eymann, 
Becher et al. 2007; Macek, Mijakovic et al. 2007) (Table 4-1).  When investigating 
potential targets of PtkA during biofilm formation we set two criteria: 1) the protein 
must be able to become phosphorylated on a tyrosine residue and 2) biofilm formation 
must be affected when the gene encoding the protein is mutated.  With these criteria in 
mind, we began by investigating the impact on biofilm formation of known PtkA 
targets.  
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4.5.1 Mutation of known targets of PtkA and PtpZ have no impact on biofilm 
formation 
 
One obvious potential target of PtkA during biofilm formation was Ugd. Ugd is 
regulated by both PtkA and PtpZ (Mijakovic, Poncet et al. 2003; Mijakovic, Musumeci 
et al. 2005) and is co-transcribed with ptkA and ptpZ (Figure 3-6). Ugd is a uridine-5’-
diphosphoglucose (UDP-glucose) dehydrogenase (Mijakovic, Poncet et al. 2003). When 
phosphorylated on tyrosine-70 by PtkA, Ugd is activated and can catalyse the oxidation 
of UDP-glucose to UDP-glucuronate (Petranovic, Grangeasse et al. 2009). UDP-
glucuronate is subsequently used as a precursor for the production of teichuronic acid 
which is a component of the cell wall (Soldo, Lazarevic et al. 1999). It has been 
postulated that Ugd may be required for biofilm formation (Mijakovic, Petranovic et al. 
2005; Hung, Chien et al. 2007). To test whether Ugd was required for biofilm formation 
we constructed an in-frame deletion in ugd (NRS2471). The Δugd mutant exhibited a 
colony morphology that was indistinguishable from the parental strain biofilm (Figure 
4-14), indicating that Ugd is not needed. However encoded on the B. subtilis 
chromosome is an additional proven and one putative UDP-glucose dehydrogenase 
called tuaD and ytcA, respectively (Mijakovic, Poncet et al. 2003; Mijakovic, 
Petranovic et al. 2005). Functional redundancy between these proteins is a possibility, 
therefore a series of single, double and triple mutant strains were constructed and the 
ability to form a robust biofilm was tested. None of the strains tested had an influence 
on colony architecture (Figure 4-14). Taken together these findings indicate that Ugd, 
YtcA and TuaD are not the downstream substrates of PtpZ and PtkA regulated during 
post-translational control of biofilm formation by B. subtilis. 
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Figure 4-14: Complex colony architecture of ugd, tuaD and ytcA mutants 
Strains Δugd (NRS2471), tuaD::pNW377 (NRS3232), ΔytcA (NRS2227), Δugd + tuaD::pNW377 
(NRS3229), Δugd + ΔytcA (NRS2821), ΔytcA + tuaD::pNW377 (NRS3230) and Δugd + ΔytcA + 
tuaD::pNW377 (NRS3231) were grown on MSgg agar for 40 hours at 30°C.  Scale bar represents 5 mm. 
 
4.5.2  The target of PtkA during biofilm formation remains unidentified 
 
Having eliminated Ugd, TuaD, and YtcA as targets of PtkA during biofilm formation, 
we widened our search. Global phosphoproteome analyses have broadened our 
understanding of the processes that are regulated by tyrosine phosphorylation in bacteria 
(Levine, Vannier et al. 2006; Eymann, Becher et al. 2007; Macek, Mijakovic et al. 
2007). We therefore chose to take a systematic mutagenesis approach to try and identify 
the target of PtkA during biofilm formation. After removing Ugd and TuaD (Figure 
4-14), 19 proteins have been identified as tyrosine phosphorylated and therefore 
represent potential targets of PtkA (Table 4-1). 7 genes are known to encode essential 
proteins (asd, aspS, yaaD, yurY, infA, ssbA and eno) and thus were excluded from our 
analysis. The gene ssbB was also excluded from the analysis as SsbB shares 63% 
identity and 81% similarity to SsbA, an essential protein. This left 11 proteins (AhpF, 
CitC, Ldh, OppA, RocA, YjoA, YvyG, YnfE, SdhA, YxxG, and YorK) of which 
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mutations could be constructed in 9 of the corresponding genes (ahpF, citC, ldh, oppA, 
rocA, yjoA, yvyG, ynfE and yorK). 
 
Gene Name Essential a Function b Position of Phosphorylated Tyrosine c Reference 
ahpF No Alkyl hydroperoxide reductase (large subunit)  Y393 (Macek, Mijakovic et al. 2007) 
asd Yes Aspartate-semialdehyde dehydrogenase Y146 (Macek, Mijakovic et al. 2007) 
aspS Yes Aspartyl-tRNA synthetase Y70 or Y194 (Levine, Vannier et al. 2006) 
sdhA (citF) Yes† Succinate dehydrogenase (flavoprotein subunit) Y146/ Y270 /Y276 /Y279 / Y310 / Y332 
(Levine, Vannier et 
al. 2006) 
icd (citC) No Isocitrate dehydrogenase Y207 (Levine, Vannier et al. 2006) 
pdxS (yaaD) Yes Pyridoxal-5'-phosphate synthase (synthase domain)  Y193 
(Levine, Vannier et 
al. 2006) 
sufC (yurY) Yes ABC transporter (ATP-binding protein) Y243 (Levine, Vannier et al. 2006) 
eno Yes Enolase Y281* (Macek, Mijakovic et al. 2007) 
ldh (lctE) No L-lactate dehydrogenase Y224 (Macek, Mijakovic et al. 2007) 
spo0KA (oppA) No Oligopeptide ABC transporter (binding protein) Y301 (Macek, Mijakovic et al. 2007) 
rocA (ipa-76d) No 3-hydroxy-1-pyrroline-5-carboxylate dehydrogenase Y5* 
(Macek, Mijakovic 
et al. 2007) 
yjoA No Unknown Y150 (Macek, Mijakovic et al. 2007) 
ynfE No Unknown Y12 (Macek, Mijakovic et al. 2007) 
yorK No Unknown Y473 (Macek, Mijakovic et al. 2007) 
yvyG (yviC) No Unknown Y49 (Macek, Mijakovic et al. 2007) 
yxxG Yes† Unknown Y102* (Macek, Mijakovic et al. 2007) 
ugd No UDP-glucose dehydrogenase Y70 
(Petranovic, 
Grangeasse et al. 
2009) 
tuaD No UDP-glucose dehydrogenase Unknown (Mijakovic, Poncet et al. 2003) 
ssbA Yes Single-strand DNA-binding protein Y82 
(Mijakovic, 
Petranovic et al. 
2006) 
ssbB No Single-strand DNA-binding protein Y82 
(Mijakovic, 
Petranovic et al. 
2006) 
infA Yes Initiation factor IF-1 Y60 (Macek, Mijakovic et al. 2007) 
 
Table 4-1: Tyrosine modulated proteins identified by literature review 
a Genes were designated as essential or non-essential based on previously published data (Kobayashi, 
Ehrlich et al. 2003) or our own findings †.  
b Protein functions were designated according to previously published data.   
c The proteins AspS and SdhA (CitF) contain several tyrosine residues. The techniques used to identify 
these proteins as modulated by phosphorylation were not capable of identifying the specific 
phosphorylated residue. * Indicates instances when the phosphorylated residue could not be specifically 
confirmed as a tyrosine.  
 
Mutation of two genes (sdhA and yxxG) resulted in a severe growth defect (Figure 
4-15).  As a consequence of this growth impairment, interpretation of the effect of the 
mutation on biofilm formation would be very difficult.  As a result sdhA and yxxG were 
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also removed from the screen. SdhA (previously known as CitF) is a succinate 
dehydrogenase and is involved in the TCA cycle (Hederstedt and Rutberg 1980), while 
yxxG encodes for a protein of unknown function.  Neither protein has previously been 
shown to be essential. 
 
Figure 4-15: Mutation of sdhA and yxxG results in a severe growth defect 
Growth of the mutant strains sdhA::pBL132 and yxxG::pBL132 were compared with wild type strain 
NCIB3610. Strains were streaked out for single colonies on LB media and incubated for 16 hours at 37˚C. 
 
After construction and verification of the mutant strains the impact on colony 
morphology was tested. Unfortunately, none were found to influence colony formation 
(Figure 4-16).  
 
 
Figure 4-16: Impact on biofilm formation of mutations in non-essential tyrosine modulated 
proteins. 
Strains mutant for ahpF (NRS3201), icd (citC) (NRS3205), ldh (lctE) (NRS3210), spo0KA (oppA) 
(NRS3211), rocA (ipa-76d) (NRS3212), yjoA (NRS3213), ynfE (NRS3216), yorK (NRS3214) and yvyG 
(yviC) (NRS3215) were grown on MSgg agar for 40 hours at 30°C.  Scale bar represents 5 mm.   
 
Chapter 4 - Investigating the role of tyrosine phosphorylation during biofilm formation 
 129
Therefore despite extensive efforts to identify the substrate phosphorylated by PtkA it 
remained elusive. It is of course possible that one, or more, of the essential proteins is 
(are) the target of PtkA. However it is important to remember that the B. subtilis strain 
NCIB3610 is the progenitor of the B. subtilis 168 strain that was used in the 
phosphoproteome analyses and they contain several single nucleotide polymorphisms 
(Srivatsan, Han et al. 2008) (Levine, Vannier et al. 2006; Eymann, Becher et al. 2007; 
Macek, Mijakovic et al. 2007). Some of these genome level differences alter the ability 
of the two strains to form a biofilm (Branda, Gonzalez-Pastor et al. 2001; Kobayashi 
2008). The NCIB3610 strain also contains a plasmid of ~85 kbp which could 
conceivably encode proteins that are tyrosine phosphorylated and required for biofilm 
formation (Earl, Losick et al. 2007). Therefore it will be necessary to conduct global 
proteome analyses using NCIB3610 to identify further possible targets of PtkA that are 
modulated during biofilm formation. 
 
4.6 Discussion 
 
As detailed in the previous chapter, the tkmA operon was found to be regulated by the 
transcriptional regulators DegU and SinR. As both DegU and SinR are involved in the 
regulation of biofilm formation, I aimed to investigate the impact on biofilm formation 
of deleting genes belonging to the tkmA operon. Before assessing the impact of these 
mutations on biofilm formation, the effect of mutating ptkA and ptpZ on growth rate, 
cell length and nucleoid number were checked.  This was done as it was previously 
demonstrated by Petranovic et al., that disruption of ptpZ displayed a severe growth 
defect when succinate was provided as the sole carbon source (Petranovic, Michelsen et 
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al. 2007).   In contrast, our construction of clean, in-frame ΔptkA and ΔptpZ mutants did 
not display any growth defect under the conditions tested.  Furthermore, the ΔptkA and 
ΔptpZ mutants were not affected for cell length or nucleoid number, as was also 
demonstrated for the ptkA mutant constructed by Petranovic et al. (Petranovic, 
Michelsen et al. 2007).  It is possible that the differences observed in regard to cell 
length, nucleoid number and growth between our mutant strains and those constructed 
by Petranovic et al. have arisen as a result of the different methods of strain 
construction or because our study utilised the NCIB3610 B. subtilis isolate whereas 
Petranovic et al. utilised the 168 B. subtilis isolate.  The main aim of these experiments 
was to ensure that under the conditions tested that no effect on cell growth would occur 
as this would impair our ability to interpret the effects of deleting the tkmA genes during 
biofilm formation, and this was achieved.  It is interesting that no effect on DNA 
metabolism was detected in our ΔptkA strain constructed in NCIB3610, as there are not 
thought to be any differences between the sequences of PtkA and the small single 
stranded DNA binding proteins of the B. subtilis isolates 168 and NCIB3610 (Zeigler, 
Pragai et al. 2008).  Perhaps this information suggests significant uncharacterised 
differences between isolates of B. subtilis.   
 
4.6.1 PtkA and PtpZ are essential for a structurally complex biofilm 
 
Next, it was demonstrated that deletion of ptkA and ptpZ resulted in a biofilm and 
pellicle formation defect (For ptkA mutants see Figure 4-3 and Figure 4-4  and for ptpZ 
mutants see Figure 4-11 and Figure 4-12). Additionally, it was determined that deletion 
of ptkA and ptpZ resulted in a decrease in spores harvested from complex colonies (For 
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ptkA mutant see section 4.2.1 and for ptpZ mutant see 4.4.1).  However, no impact on 
sporulation was observed in liquid media, thus it was concluded that the impact on 
sporulation in the ptkA and ptpZ mutants was a result of the altered complex colony 
architecture and not a direct effect on the developmental process of sporulation. These 
results demonstrate the importance of a structurally complex biofilm for the formation 
of spores by B. subtilis. Our results are in agreement with previous reports which 
demonstrated that disruption to the complex architecture results in a sporulation 
decrease (Vlamakis, Aguilar et al. 2008). While the target of PtkA and PtpZ was not 
identified in this study, it is possible that they may act by affecting the production of a 
component of the extracellular matrix, which is essential for the construction of an 
architecturally complex colony.  Although it is important to note that PtkA and PtpZ 
most likely will not act on the production of EPS, as the operon encoding the 
biosynthetic machinery for the production of EPS encodes the putative BY-kinase, 
EpsB.  
 
4.6.2 Kinase activity is essential for biofilm formation 
 
Further to identifying that PtkA is necessary for biofilm formation, we aimed to assess 
whether the kinase activity of PtkA was necessary for its role during biofilm formation.  
To do this, a strain containing alanine substitutions at the ‘DxD’ motif was made. The 
kinase activity of BY-kinases is associated with the Walker motifs, including the ‘DxD’ 
motif.  Disruption of the ‘DxD’ motif of PtkA has been shown in previous studies to 
inhibit PtkA from phosphorylating tyrosine residues on GST (when fused to TkmA) 
(Mijakovic, Poncet et al. 2003).  This both demonstrates the requirement of the ‘DxD’ 
motif for kinase activity and the loose substrate specificity of PtkA.  In our study, the 
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ptkA D81A-D83A mutant was unable to form robust complex colonies, which suggested 
a role for the kinase activity of PtkA during biofilm formation. As mutation of the 
‘DxD’ motif also disrupts ATPase activity of PtkA, we determined whether loss of 
kinase activity or ATPase activity caused the disruption to biofilm formation. To 
confirm this hypothesis, the tyrosine kinase modulator TkmA was deleted and biofilm 
formation was assessed.  
In Gram-positive organisms, activation of kinase activity relies on an interaction 
between the BY-kinase and the cognate bacterial tyrosine kinase modulator (Lee and Jia 
2009).  Deletion of tkmA in the presence of PtkA resulted in a defect to biofilm 
formation (Figure 4-8C). This demonstrated that, as expected, TkmA was involved in 
the activation of the kinase activity of PtkA and thus the kinase activity of PtkA was 
required for its role in biofilm formation.  Furthermore it was identified that TkmA 
possesses targets in addition to its cognate partner PtkA (Figure 4-8).  While it is rare to 
find examples of tyrosine kinase modulators with multiple targets, they do exist.  For 
example, the bacterial tyrosine kinase Cap5B2 belonging to S. aureus is co-located on 
the chromosome along side the gene encoding for the tyrosine kinase modulator 
Cap5A2 (Olivares-Illana, Meyer et al. 2008).  Cap5A2 activates the kinase activity of 
Cap5B2. However, S. aureus also encodes an additional bacterial tyrosine modulator 
and kinase pair called Cap5A1 and Cap5B1, respectively (Olivares-Illana, Meyer et al. 
2008). Studies have demonstrated that the kinase modulator Cap5A1 is able to activate 
the kinase activity of Cap5B2 more efficiently than Cap5A2 (Soulat, Jault et al. 2006). 
The ability of a BY-kinase to dissociate from its cognate kinase modulator is a feature 
which is specific to Gram positive BY-kinases. In B. subtilis previously published data 
collected using a fluorescent tagged construct of PtkA suggests that PtkA may become 
dissociated from its kinase modulator during stationary phase (Jers, Pedersen et al. 
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2010).  It should be noted however that this work was conducted using an artificial 
system where the transcription of PtkA-GFP was active in stationary phase.  This is in 
contrast to the work presented in this thesis which suggests that as levels of DegU~P 
rise in the cell upon entry into stationary phase, the transcription of the tkmA operon 
will be repressed.  Thus further research is required to confirm whether PtkA 
disssoicates from TkmA under native conditions.    
The knowledge that TkmA may be able to activate proteins in addition to PtkA, at least 
in the absence of PtkA, calls into question the specificity of the response to a specific 
stimulus.  It will be interesting to identify the additional targets of TkmA and to 
understand what impact they may have in the event that PtkA is not interacting with 
TkmA.  Furthermore, it would be interesting to discover how common this is among 
Gram-positive bacterial tyrosine kinase-modulator pairs.  
 
4.6.3 Deletion of ptkA and ptpZ result in similar phenotypes 
 
An interesting outcome of this study is that deletion of both the kinase PtkA and the 
phosphatase PtpZ result in a defect of biofilm and pellicle formation.  It may seem 
counter intuitive that deletion of the kinase and its partner phosphatase would have the 
same outcome.  This however is not an unusual case as deletion of the BY-kinase BceF 
and phosphatase BceD belonging to Burkholderia cepacian result in a decrease in the 
production of cepacian, the major exopolysaccharide component. Cepacian production 
is positively correlated with the formation of mature biofilms by B. cepacian, thus 
deletion of either kinase or phosphatase results in a defect to biofilm formation.  
Additionally, deletion of the BY-kinase Wzc and phosphatase Wzb belonging to the 
Gram-negative Acinetobacter lwoffii RAG-1 result in the formation of colonies which 
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are emulsan-negative (Nakar and Gutnick 2003); emulsan is an extracellular 
lipoheteropolysaccharide bioemulsifier. Apoemulsan, the protein-free polysaccharide, 
inhibits biofilm formation by reducing hydrophobicity (Dams-Kozlowska and Kaplan 
2007). Taken together, deletion of both the kinase and phosphatase result in increased 
biofilm formation.  Furthermore, deletion of the BY-kinase CpsB and the phosphatase 
CpsD belonging to Streptococcus pneumoniae D39 both result in the formation of rough 
colonies (Morona, Miller et al. 2004); the formation of smooth colonies is associated 
with the production of capsular polysaccharide (CPS), an essential exopolysaccharide 
required for virulence (Morona, Miller et al. 2004). Thus both kinase and phosphatase 
are required for polysaccharide production. At least in terms of the regulation of 
polysaccharides it has been proposed that cycling between a targets’ phosphorylated and 
unphosphorylated state maybe essential for polysaccharide synthesis (Olivares-Illana, 
Meyer et al. 2008).  However as we have demonstrated, the regulation of biofilm 
formation by PtkA and PtpZ is not mediated by regulating Ugd or TuaD (UDP-glucose 
dehydrogenases), therefore the production of teichuronic acid is not essential for biofilm 
formation.  The impact of deleting PtkA and PtpZ on total exopolysaccharide 
production remains to be investigated. In order to fully understand the mechanism by 
which PtkA and PtpZ regulate biofilm formation, the target of these regulators during 
biofilm formation must be identified. 
 
4.6.4 The target of PtkA and PtpZ remains elusive 
 
In this chapter we aimed to identify the target of PtkA and PtpZ during biofilm 
formation.  Initial investigations showed that the most likely targets, Ugd, TuaD and 
YtcA, did not affect biofilm formation (Figure 4-14).  A screen of known PtkA targets 
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and known tyrosine phosphorylated proteins was conducted, however no impact was 
observed on biofilm formation (Figure 4-16).  A significant drawback of using the 
phosphoproteome screens that were available was that the proteins used were isolated 
from cells that were not grown under biofilm inducing conditions (Levine, Vannier et 
al. 2006; Eymann, Becher et al. 2007; Macek, Mijakovic et al. 2007).  Future 
experiments would include a phosphotyrosine proteomic screen conducted under 
biofilm forming conditions, utilising the ptkA and ptpZ mutants in order to identify 
proteins which are phosphorylated in the absence of ptpZ and unphosphorylated in the 
absence of ptkA compared to wild type B. subtilis. 
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5 Terminal tyrosine cluster extended analysis and YvyG investigation 
 
5.1 Extended characterisation of the terminal tyrosine cluster of PtkA 
 
As discussed in Chapter 4, the bacterial tyrosine kinase PtkA is necessary for the 
development of architecturally complex biofilms by B. subtilis.  By constructing strains 
which contained alanine substitutions at the terminal tyrosine cluster, we aimed to 
assess whether or not PtkA required the terminal tyrosine cluster in order to regulate 
biofilm formation.  Our results suggested that the terminal tyrosine cluster was not 
required during biofilm formation (Figure 4-5).  As the terminal tyrosine cluster is a 
well conserved feature of BY-kinases (Figure 1-13), this result came as a surprise.  It is 
unusual to conserve features of a protein which serve no obvious function.  With this in 
mind, we aimed to extend our investigation of the terminal tyrosine cluster of PtkA by 
replacing the terminal tyrosine cluster with residues which would structurally mimic a 
tyrosine, but which were either unable to be phosphorylated or mimicked a 
phosphorylated tyrosine. 
To mimic the negative charge associated with a phosphorylated tyrosine residue, the 
tyrosine residue was replaced with glutamic acid (Figure 5-1).  In addition, the tyrosine 
residues were replaced by phenylalanine in order to simulate a non-phosphorylated 
tyrosine (Figure 5-1). Phenylalanine and tyrosine share significant structural similarity; 
however phenylalanine lacks the functional hydroxyl group attached to the end of the 6-
carbon aromatic ring, thus preventing phenylalanine from becoming phosphorylated 
(Figure 5-1).   
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Figure 5-1: Amino acid structure 
Structures of the amino acids tyrosine, alanine, glutamic acid and phenylalanine were obtained from 
http://www.chem.ucla.edu/harding/IGOC/A/amino_acid.html. 
 
 
 
A collection of strains were constructed in which either 1, 2 or 3 of the tyrosine residues 
were replaced by glutamic acid, or all 3 were replaced by phenylalanine. In addition one 
strain was constructed in which only tyrosine at position 228, previously shown to be 
the preferential site of autophosphorylation, was mutated to a glutamic acid residue 
(Mijakovic, Poncet et al. 2003).  For ease of interpretation, tyrosine residues not 
mutated to glutamic acid or phenylalanine were replaced by alanine.  This allowed us to 
rule out phosphorylation of the native tyrosine residues.  Interestingly, replacement of 
the native tyrosine residues with glutamic acid residues did not impact on biofilm 
formation (Figure 5-2D).  In sharp contrast, replacement of the tyrosine residues with 
phenylalanine resulted in a loss of complex colony architecture (Figure 5-2F).  
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Figure 5-2: Complex colony architecture of ptkA phosphomimic mutants 
Strains (A) NCIB3610, (B) ΔptkA Y225E-Y227A-Y228A (NRS3585), (C) ΔptkA Y225E-Y227E-Y228A 
(NRS3563), (D) ΔptkA Y225E-Y227E-Y228E (NRS3557), (E) ΔptkA Y225A-Y227A-Y228E (NRS3573) and 
(F) ΔptkA Y225F-Y227F-Y228F (NRS3566) were grown on MSgg agar plates for 40 hours at 30˚C prior to 
photography. Scale bar represents 5 mm.  
 
 
 It was noted that the colony morphology of ptkA Y225F-Y227F-Y228F was very similar to 
that of the ΔptkA and ptkA D81A-D83A mutants (Figure 4-3 and Figure 4-6).  In order to 
rule out the possibility that the ptkA Y225F-Y227F-Y228F phenotype was a result of an 
unintended point mutation at the D81A-D83A motif, the ptkA locus from ptkA Y225F-
Y227F-Y228F was sequenced.  The sequence results confirmed that the ‘DxD’ motif was 
wild type. The only mutations detected within the ptkA sequence were the phenylalanine 
substitutions at the terminal tyrosine cluster (data not shown). 
To confirm that the biofilm morphology of the ptkA Y225F-Y227F-Y228F  strain was 
specific to the point mutations introduced at the native locus, three alleles of ptkA were 
introduced independently into the amyE locus under the control of the IPTG inducible 
promoter Pspank-hy; 1) wild type ptkA, 2) ptkA D81A-D83A and 3) ptkA Y225A- Y227A- 
Y228A. Consistent with the phenotype being specific to the ptkA Y225F-Y227F-Y228F 
mutation, and not a mutation at a heterologous location, biofilm architecture was fully 
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restored upon induction of wild type ptkA (compare Figure 5-3B to Figure 5-3C).  
Additionally, considerable restoration was achieved by the induction of ptkA Y225A-
Y227A-Y228A in the ptkA Y225F-Y227F-Y228F mutant background (compare Figure 5-3B 
to Figure 5-3D).  In contrast ptkA D81A-D83A was unable to restore the complex colony 
morphology of ptkA Y225F-Y227F-Y228F mutant to that of the wild type colony (compare 
Figure 5-3B to Figure 5-3E).  Taken together, the results tentatively suggest a role for 
unphosphorylated tyrosine residues within the terminal tyrosine cluster. 
 
Figure 5-3: Complex colony architecture of ptkA Y225F-Y227F-Y228F complemented with ptkA 
Strains (A) NCIB3610, (B) ptkA Y225F-Y227F-Y228F (NRS3566), (C) ptkA Y225F-Y227F-Y228F + Pspank-hy-
ptkA (NRS3576), (D) ptkA Y225F-Y227F-Y228F + Pspank-hy-ptkA Y225A-Y227A-Y228A (NRS3577), and (E) 
ptkA Y225F-Y227F-Y228F + Pspank-hy-ptkA D81A-D83A (NRS3579) were grown on MSgg agar plates with 
and without the addition of 10μM IPTG as required for 40 hours at 30˚C prior to photographing. Scale 
bar represents 5 mm.  
 
5.2 Investigating the role of PtkA during other multicellular behaviours  
 
PtkA is a promiscuous BY-kinase (Mijakovic, Petranovic et al. 2005). The work 
presented here demonstrates that PtkA influences biofilm formation, pellicle formation 
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and sporulation (Kiley and Stanley-Wall 2010).  In addition, it has been shown that 
PtkA also controls DNA metabolism (Mijakovic, Petranovic et al. 2006; Petranovic, 
Michelsen et al. 2007) and teichuronic acid production (Mijakovic, Poncet et al. 2003).  
Furthermore, we have identified that the transcription of the tkmA operon, to which ptkA 
belongs, is under the direct control of the transcriptional regulator DegU (Figure 3-18).  
In addition to its role as an activator of biofilm formation, DegU~P is known to regulate 
a number of multicellular behaviours including swarming motility (Kobayashi 2007; 
Verhamme, Kiley et al. 2007) and protease activity (Ogura, Yamaguchi et al. 2001). As 
DegU~P is a regulator of ptkA transcription, we aimed to investigate whether 
multicellular behaviours known to be regulated by DegU~P are also regulated by PtkA.  
In particular we aimed to investigate if PtkA was also involved in regulating swarming 
motility and protease production.  
 
5.2.1 PtkA does not influence protease production  
 
In order to acquire nutrients from the environment many bacteria secrete extracellular 
proteases (hereafter referred to as exoproteases).  In B. subtilis, 7 exoproteases have 
been demonstrated to be secreted in response to high levels of DegU~P (Antelmann, 
Tjalsma et al. 2001).  These include AprE (alkaline serine protease), NprE (neutral 
protease B), Bpr (bacillopeptidase), Vpr (serine protease), Mpr (metalloproteases), Epr 
(minor serine protease) and WprA (cell wall-associated protein precursor).  The most 
abundant of the exoproteases are AprE and NprE, whereas Vpr, Bpr, Mpr, Epr and 
WprA are regarded as minor proteases.  DegU was first proposed by Steinmetz et al. to 
activate exoprotease production (Steinmetz, Kunst et al. 1976). Later it was determined 
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that the over-expression of DegU-HY (which dephosphorylates 7-fold slower) resulted in 
an increase in exoprotease production (Msadek, Kunst et al. 1990).  Moreover, it was 
shown that exoproteases expression is heterogeneous, in that only a sub-population of 
cells are switched on for exoprotease production and that in addition to requiring 
DegU~P, cells also require Spo0A~P, in order to down regulate the repression of aprE 
by AbrB and SinR (Veening, Igoshin et al. 2008).  As high levels of DegU~P are 
required to activate exoprotease production, but high levels of DegU~P also repress 
biofilm formation, it has been proposed that exoprotease production may also act as a 
means of releasing cells from a biofilm (Verhamme, Kiley et al. 2007). Thus protease 
production can be viewed as a multicellular event. 
 
To investigate if PtkA was involved in the regulation of protease production, strains 
containing mutations in either the ‘DxD’ motif or the terminal tyrosine cluster were 
spotted onto agar plates containing 1.5% milk alongside the wild type parental strain.  
Production of the exoproteases leaves a cleared halo surrounding the colony due to milk 
digestion.  We chose to use strains containing point mutations rather than the ΔptkA 
strain as it was assumed that the mutant strains would produce the mutant version of the 
PtkA protein and therefore would be the most comparable.  Any change to the level of 
protease activity of the strain could then be attributed to either the kinase activity of 
PtkA or may provide additional information about the role of the terminal tyrosine 
cluster.  The results from these experiments showed that upon mutation of the ‘DxD’ 
motif or the terminal tyrosine cluster, protease production was unaffected compared 
with wild type protease production (Figure 5-4).  Thus, we can conclude that PtkA is 
not involved in the production of exoproteases. 
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Figure 5-4: Protease activity is not dependent on PtkA activity 
(A) Bar graph showing average protease production from wild type NCIB3610 (light grey), ptkA D81A-
D83A (dark grey) (NRS2796) and ptkA Y225A-Y227A-Y228A (black) (NRS2799).  Error bars represent 
standard error of the mean. Data represents 3 independent rounds. (B) Photograph of digestion of milk 
protein by wild type NCIB3610, ptkA D81A-D83A and ptkA Y225A-Y227A-Y228A colonies. Colonies were 
incubated at 37˚C for 16 hours prior to photography. 
 
 
5.2.2 PtkA influences swarming motility 
 
Swarming motility is a multicellular behaviour displayed by many different species of 
bacteria, including B. subtilis (Kearns 2010).  Swarming motility is defined as the 
migration of a population of cells over a substrate, and relies on the cooperation of cells 
belonging to a dense population.  In B. subtilis, many factors are required to coordinate 
this complex multicellular behaviour.  A key feature of a swarming population is the 
formation of cell rafts; collections of ordered cells which sit side-by-side in order to 
achieve rapid and directed movement (Kearns and Losick 2003). Additionally, 
swarming cells require production of the antibiotic lipopeptide surfactin. The use of a 
surfactant to reduce surface tension is a common feature among swarming bacteria 
(Kearns 2010).  It is now well established that domesticated B. subtilis have lost the 
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ability to swarm (Kearns and Losick 2003; Patrick and Kearns 2009).  The genetic basis 
for this is a frameshift mutation in the swrA gene, which leads to a truncation after 
tyrosine 13 (Kearns, Chu et al. 2004). The swrA gene encodes for an activator of the 
fla/che operon which encodes proteins required for the biosynthesis of the bacterial 
flagella as well as the swrB gene. SwrB activates the transcription of the late flagella 
genes including hag, which codes for flagellin (Kearns and Losick 2005). Moreover, 
domesticated B. subtilis possesses a mutation in the sfp gene (Nakano, Corbell et al. 
1992) which results in the loss of surfactin production.  
The transcriptional regulators DegU and SinR regulate swarming motility (Amati, 
Bisicchia et al. 2004; Blair, Turner et al. 2008). Firstly, very low levels of DegU~P 
activate swarming motility in the undomesticated NCIB3610 isolate, whereas high 
levels inhibit swarming motility (Verhamme, Kiley et al. 2007). Secondly, SinR is able 
to indirectly regulate the activity of the flagella motor.  SinR represses the transcription 
of the epsA-O operon (Kearns, Chu et al. 2005), which encodes EpsE.  EpsE has been 
demonstrated to act as a clutch, thus uncoupling the flagellum from the motor (Blair, 
Turner et al. 2008).  
 
Integration of these multiple factors contributing to swarming motility must be achieved 
in order to activate swarming motility. In chapter 4.2, I demonstrated the requirement of 
PtkA during biofilm formation. With this in mind, I aimed to test whether PtkA also 
participated in the regulation of other multicellular behaviours, such as swarming 
motility.  To address this, wild type NCIB3610, ptkA D81A-D83A and ptkA Y225A-
Y227A-Y228A were assessed for their ability to swarm under laboratory conditions.  As 
with protease production assay, our intention was to keep the protein present and use the 
D81A-D83A and terminal tyrosine cluster mutations as these will allow us to see if 
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kinase activity is needed and if a role for the terminal tyrosine cluster could be 
identified.  
Assessment of the motility of the strains was carried out under standard swarming 
conditions (Kearns and Losick 2003). Cultures of NCIB3610, ptkA D81A-D83A and ptkA 
Y225A-Y227A-Y228A were grown to an OD600 of 1.0, concentrated to a final OD600 of 10 
and were spotted onto LB media plates solidified with 0.7% agar.  The distance of the 
swarm was measured at defined time points and photographs of the swarm plates were 
taken after 6 hours incubation at 37˚C.  The results showed that in comparison to wild 
type cells, the ptkA D81A-D83A and ptkA Y225A-Y227A-Y228A mutants were unable to 
swarm (Figure 5-5). These results suggested a role for PtkA during swarming motility 
and in particular, demonstrated that the kinase activity of PtkA was required during 
swarming. Additionally, the results indicated that the terminal tyrosine cluster was 
important for the regulation of this multicellular behaviour.   
 
Figure 5-5: Swarming of ptkA D81A-D83A and ptkA Y225A-Y227A-Y228A.  
(A) Strains NCIB3610 (black diamonds), ptkA D81A-D83A (NRS2796) (black squares) and ptkA Y225A-
Y227A-Y228A (NRS2799) (white triangles) were grown in LB until OD600 1.0 prior to being concentrated 
to OD600 10. LB media solidified with 0.7% agar was spotted with 10 μl of culture and incubated at 37 ˚C 
for 360 minutes. Dashed line represents time point at which photographs of the swarming plates were 
taken. (B) Photographs of the strains were taken after 6 hours swarming.  Scale bar represents 1 cm. 
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In light of the discovery that PtkA was important for swarming motility, we then 
decided to further investigate potential targets of PtkA during swarming.  
 
5.3 YvyG is a potential target of PtkA during swarming 
 
To identify the target of PtkA during swarming motility, we decided to first test the 
most obvious potential target, YvyG (Jers, Pedersen et al. 2010).  YvyG is encoded by 
the yvyG gene which is situated upstream of the genes encoding for the transcriptional 
regulator and cognate sensor kinase pair, DegU and DegS (Figure 5-6). 
 
 
    
 
 
Figure 5-6: Schematic representation of the chromosomal region surrounding yvyG. 
Arrows indicate open reading frames (ORF), the direction of the arrow indicating the direction of the 
ORF. The gene yvyG is highlighted in red. Black arrows indicate genes which encode proteins essential 
for swarming and swimming motility. Stalked circles indicate sites of transcriptional termination. 
Numbers flanking the chromosomal region indicate the position on the chromosome in relation to the 
origin of replication. 
 
The yvyG gene is located on the chromosome between flgM and flgK, which encode an 
anti-sigma factor required for inactivating σ-D (Mirel, Lauer et al. 1994) and a protein 
necessary for forming the hook-filament junction (Mirel, Lauer et al. 1994), 
respectively.  YvyG however encodes a protein of unknown function and specific 
involvement in motility had not been demonstrated.  YvyG has been shown to become 
phosphorylated in vivo (Macek, Mijakovic et al. 2007) and in vitro (Jers, Pedersen et al. 
2010).  The bacterial tyrosine kinase that is responsible for the phosphorylation of 
YvyG is PtkA (Jers, Pedersen et al. 2010).  Taken together, we hypothesised that YvyG 
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plays a role in motility and that the function of YvyG is controlled by phosphorylation 
mediated by PtkA.  To test our hypothesis, we first assessed the impact of mutating 
yvyG on swarming.  As a disruption mutant was already available (yvyG::pBL132, 
previously used to assess the impact on colony architecture see Figure 4-16), we used 
this mutant to get an initial insight into the effect on swarming.  The results showed that 
a disruption to yvyG completely inhibited swarming motility (Figure 5-7). As a negative 
control a strain lacking the gene required to synthesise the flagellin protein (hag) was 
used. 
 
 
Figure 5-7: Swarming of yvyG::pBL132 
Swarming motility of NCIB3610 (black diamonds), yvyG::pBL132 (NRS3216) (white squares), and Δhag 
(NRS2253) (black triangles). Data is representative of >3 independent rounds. 
 
 
This strain, however, was constructed by introducing a plasmid into the chromosome at 
the yvyG locus with the aim of disrupting the transcription of the gene. As yvyG is 
located within an operon that is essential for motility (Figure 5-6) this carries the risk 
that construction of a mutation of this sort will impose polar effects on genes 
neighbouring yvyG, thus indirectly affecting swarming motility.  In order to verify if the 
affect on swarming motility was a result of the disruption to yvyG or a disturbance to its 
neighbouring genes, an in-frame marker-less deletion was constructed at the yvyG locus 
(Figure 5-8). 
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YvyG is phosphorylated on a single tyrosine residue at position 49 (Macek, Mijakovic 
et al. 2007).  In light of the evidence suggesting a role for PtkA during swarming, the 
fact that YvyG is a known target of PtkA and the prediction that yvyG may also be 
important for swarming, we proposed that PtkA phosphorylates YvyG at residue Y49, 
thus regulating the activity of YvyG during swarming.  For these reasons, a mutant 
strain containing a tyrosine to alanine substitution at position 49 was also constructed in 
order to test if the inability to become phosphorylated affected the role of YvyG during 
swarming. 
 
 
 
 
Figure 5-8: Schematic representation of the ΔyvyG mutant construction 
(A) Wild type yvyG.  Translational start and stop codons are highlighted in green and red, respectively.  
(B) Deletion of yvyG. Translational start and stop codons are highlighted as noted in (A).  Primer 
engineered restriction site for XbaI is highlighted in yellow.  
 
 
After construction of the deletion strain and the yvyG Y49A point mutant, but prior to 
assessing the effects of the mutations on swarming motility, colony complexity was 
assessed to ensure that the morphology of ΔyvyG was the same as the original 
yvyG::pBL132 mutant (Compare Figure 4-16 and Figure 5-9 ).  The resulting colony of 
the newly constructed ΔyvyG mutant retained its original phenotype, as did the single 
point mutation of yvyG Y49A (Figure 5-9).  These results are in agreement with the 
previous experiments (Figure 4-16) 
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Figure 5-9: Complex colony morphology of ΔyvyG and yvyG Y49A. 
The strains NCIB3610, ΔyvyG (NRS3570) and yvyG Y49A (NRS3571) were grown on MSgg agar for 40 
hours at 30°C.  Scale bar represents 5 mm.  
 
Next, swarming and swimming analysis were conducted using the ΔyvyG mutant. The 
strain lacking yvyG was unable to swim or swarm (Figure 5-10).  Motility could be 
restored by adding back the wild type copy of yvyG at a heterologous location on the 
chromosome.  These results demonstrate for the first time in vivo that yvyG is required 
for both swimming and swarming motility.  Additionally, these results demonstrate the 
requirement of higher levels of yvyG for swarming motility rather than swimming, since 
a higher level of complementation could be linked with the higher demand of flagella 
for swarming than swimming (Fraser and Hughes 1999). 
 
 
Figure 5-10: Swimming and swarming motility of ΔyvyG 
(A) Swimming and (B) swarming motility of NCIB3610 (black diamonds), Δhag (NRS2253) (black 
squares), ΔyvyG (NRS3570) (white triangles), ΔyvyG + Pspank-hy yvyG (NRS3578) without the addition of 
IPTG (black circles) and with the addition of 10 μM IPTG (white circles). Data is representative of >3 
independent rounds. Error bars represent the standard error of the mean. 
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Next, the impact on motility of mutating the tyrosine at position 49 to an alanine was 
assessed.  In contrast to the results obtained for the deletion of yvyG, it was discovered 
that the Y49A mutation did not impact on swimming nor swarming motility (Figure 
5-11).  
 
 
Figure 5-11: Swimming and swarming motility of yvyG Y49A. 
(A) Swimming and (B) swarming motility of NCIB3610 (black diamonds), Δhag (NRS2253) (black 
squares), and yvyG Y49A (NRS3570) (crosses). Data is representative of >3 independent rounds. Error 
bars represent the standard error of the mean. 
 
 
Taken together, these results confirm that YvyG participates in swarming and 
swimming motility.  However, contrary to our hypothesis this function is independent 
of phosphorylation, as the yvyG Y49A mutant was unaffected for swarming and 
swimming motility.  The discovery that the role of YvyG during swarming motility is 
independent of the phosphorylation status of the protein called into question the validity 
of the results demonstrating that the kinase activity and terminal tyrosine cluster of 
PtkA are necessary for swarming motility.  In order to address this discrepancy, we 
decided to reassess the impact of the ptkA D81A-D83A and terminal tyrosine cluster 
mutations on swarming motility. 
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5.4 Reassessment of PtkA involvement during swarming and swimming motility 
 
To begin reassessing the impact of mutating ptkA on motility, we aimed to test whether 
the addition of wild type ptkA could restore swarming motility to the ptkA D81A-D83A 
mutant. 
 
 
 
Figure 5-12: Swarming motility of ptkA D81A-D83A + Pspank-hy ptkA 
Swarming was assayed using the strains NCIB3610 (black diamonds), ptkA D81A-D83A (NRS2796) 
(crosses), and ptkA D81A-D83A + Pspank-hy ptkA (NRS2807) in the absence of IPTG (white circles), in the 
presence of 1 μM IPTG (grey circles), and the presence of 10 μM IPTG (black circles). Graph is 
representative of > 3 independent rounds.  
 
The results showed that upon artificial induction of ptkA expression from a heterologous 
location on the chromosome, swarming motility did not return to the ptkA D81A-D83A 
mutant.  The inability of this mutation to be complemented raised the concern that the 
phenotype observed was not caused by the D81A-D83A mutation, despite biofilm 
formation being restored with this same construct (Figure 4-6). In order to ascertain 
what could have caused the lack of swarming motility in the D81A-D83A mutant, the 
level of transcription from the promoter of the hag gene was assessed. The hag gene 
encodes for the flagellin structural protein component of the B. subtilis flagella and is 
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transcribed by the alternative sigma factor, σD RNA polymerase (Mirel and Chamberlin 
1989). The expression of hag is essential for motility. A strain was constructed which 
contained the promoter region of hag fused to the gene coding for YFP.  The level of 
Phag-YFP observed in the ptkA D81A-D83A mutant was indistinguishable from the level 
observed in wild type cells (Figure 5-13).  
 
 
Figure 5-13: Transcription of Phag-YFP in ptkA D81A-D83A 
Phase contrast and fluorescent images of wild type (NRS3076) and ptkA D81A-D83A (NRS3243) collected 
using Zeiss Axio Imager M1. Both strains contain Phag reporter fusions with yfp.  Scale bars represent 20 
μm.  
 
 
Based on the results of the experiment above, we are unable to determine the cause of 
the lack of motility observed in the D81A-D83A mutant.  As ptkA D81A-D83A was 
constructed using the pMAD method, which uses transduction to transfer a large region 
of DNA into the cell for homologous recombination, it is possible that an undesired 
mutation(s) was carried over during the transduction of the ptkA D81A-D83A mutation 
into NCIB3610.  Complementation of the ptkA D81A-D83A mutation by addition of a 
wild type copy of ptkA at a heterologous location was unable to restore motility, 
however complex colony architecture was restored using this construct (Figure 4-6).  
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Taken together, we can conclude that the lack of swarming motility in the ptkA D81A-
D83A mutant is not the cause of the altered colony morphology.   
In parallel to investigating the validity of the non-swarming phenotype displayed by the 
ptkA D81A-D83A mutant, we also assessed the non-swarming phenotype of the terminal 
tyrosine cluster mutant.  As for the ptkA D81A-D83A mutant, we attempted to 
complement the terminal tyrosine cluster mutant by introducing a wild type copy of 
ptkA at a heterologous location on the chromosome under the control of an IPTG 
inducible promoter.  Again upon addition of IPTG, swarming motility could not be 
restored to the ptkA Y225A-Y227A-Y228A mutant (Figure 5-14). 
 
 
 
Figure 5-14: Swarming of ptkA Y225A-Y227A-Y228A + Pspank-hy ptkA 
(A) Swarming was assayed using the strains NCIB3610 (black diamonds), Δhag (black square), ptkA 
Y225A-Y227A-Y228A (white triangles), and ptkA Y225A-Y227A-Y228A in the absence of IPTG (white 
circles), in the presence of 1 μM IPTG (grey circles), and the presence of 10 μM IPTG (black circles). (B) 
Photographs of swarming plates taken at 8 hours incubation. Scale bar represents 2cm. 
 
 
As for the ptkA D81A-D83A mutant, we also decided to test if the lack of motility 
displayed by the terminal tyrosine cluster mutant was caused by an unanticipated 
Chapter 5 – Terminal tyrosine cluster extended analysis and YvyG investigation  
 153
mutation within the hag gene or (indirectly) a regulator of the fla/che operon.  To 
achieve this, we again utilised the hag reporter fusion construct.  The results showed 
that hag transcription was significantly lower in the terminal tyrosine cluster mutant 
than in the wild type cells (Figure 5-15).  Attempts were made to restore hag expression 
by adding back in a wild type copy of ptkA at a heterologous location; however this was 
not successful (Figure 5-15). This was anticipated since induction of expression did not 
restore swarming motility itself (Figure 5-14). 
 
 
 
Figure 5-15: Transcription of Phag in ptkA Y225A-Y227A-Y228A and ptkA Y225A-Y227A-Y228A + Pspank-hy 
ptkA 
Phase contrast and fluorescent images of wild type (NRS3076), ptkA Y225A-Y227A-Y228A (NRS3244) and 
ptkA Y225A-Y227A-Y228A + Pspank-hy ptkA (NRS3248) collected using Zeiss Axio Imager M1. Scale bar 
represents 20 μm. 
 
 
 
As the lack of swarming motility and hag transcription in the ptkA Y225A-Y227A-Y228A 
could not be complemented, we must conclude that this phenotype is not a result of the 
terminal tyrosine cluster mutation.  The cause of the unusual phenotype may be 
explained by the fact that the ptkA Y225A-Y227A-Y228A displays unusually long chains 
of cells compared to wild type cells, a phenotype which could also not be 
complemented. Hyper-chaining phenotypes have been associated with mutations in the 
swrA gene (formerly yvzD), responsible for the regulation of swarming-dependent 
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genes, including hag (Kearns and Losick 2005). The swrA gene of ptkA Y225A-Y227A-
Y228A was sequenced in order to determine if the phenotype of ptkA Y225A-Y227A-
Y228A could be accounted for by a mutation in the swrA gene.  The sequencing results 
showed that swrA was wild type in the ptkA Y225A-Y227A-Y228A mutant (data not 
shown).  In conclusion, the cause of the unusual hyper chained phenotype displayed by 
the ptkA Y225A-Y227A-Y228A mutant remains to be determined, and as such this remains 
a point of work which is on going. 
 
As verification of the non-swarming phenotypes of the ptkA Y225A-Y227A-Y228A and 
ptkA D81A-D83A mutants failed to confirm the role of ptkA during swarming, it was 
decided that the ptkA Y225A-Y227A-Y228A mutant would be remade.  The ptkA Y225A-
Y227A-Y228A strain was remade in an identical manner to the original mutant; using the 
standard pMAD protocol.  Prior to assessing the strains’ ability to swarm, the colony 
morphology phenotype was assessed in order to ensure that the phenotype of the new 
mutant was the same as the original ptkA Y225A-Y227A-Y228A mutation (NRS2799). The 
new replacement ptkA Y225A-Y227A-Y228A mutant (NRS3559) displayed a phenotype 
that was indistinguishable from wild type (Figure 5-16). This is in agreement with the 
colony architecture analysis results for the original ptkA Y225A-Y227A-Y228A mutant.  
 
 
Figure 5-16: Colony architecture analysis of remade ptkA Y225A-Y227A-Y228A mutant 
Strains NCIB3610 and replacement ptkA Y225A-Y227A-Y228A mutant (NRS3559) were grown on MSgg 
agar for 40 hours at 30°C.  Scale bar represents 5 mm.  
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Next, the replacement remade ptkA Y225A-Y227A-Y228A mutant was assessed for its 
ability to swarm.  Swarming motility of the remade ptkA Y225A-Y227A-Y228A mutant 
was indistinguishable from the wild type cells, thus we can conclude that the terminal 
tyrosine cluster in not involved in the regulation of swarming motility. 
 
 
Figure 5-17: Swarming motility analysis of remade ptkA Y225A-Y227A-Y228A 
Swarming was assayed using the strains NCIB3610 (black diamonds) and ptkA Y225A-Y227A-Y228A 
(NRS3559) (black triangles). Graph is representative of > 3 independent rounds. 
 
 
As the replacement ptkA Y225A-Y227A-Y228A mutant showed no impact on swarming 
motility, this raised the question as to whether or not ptkA was at all involved in 
swarming motility. To address this concern, the swarming ability of the ΔptkA mutant 
was tested. The results clearly showed that there was no impact of deleting ptkA on 
swarming motility (Figure 5-18). These results are now consistent with our findings that 
the phosphorylation of YvyG is not required for swarming and we can conclude that 
PtkA is not involved in swarming motility.  
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Figure 5-18: Swarming analysis of ΔptkA 
Swarming was assayed using the strains NCIB3610 (black diamonds), Δhag (NRS2253) (white squares) 
and ΔptkA (NRS2544) (white triangles). Graph is representative of > 3 independent rounds.  
 
 
 
5.5 Discussion 
5.5.1 Phenylalanine substitutions suggest a role for the PtkA terminal tyrosine 
cluster 
 
In this section I aimed to further investigate the role of the terminal tyrosine cluster of 
PtkA.  To do this, amino acids that are structurally similar to tyrosine and mimic either 
a phosphorylated or unphosphorylated state were substituted into the terminal tyrosine 
cluster of PtkA (see Figure 5-2).  Analysis of the data led to the conclusion that 
mutation of the terminal tyrosine cluster may affect biofilm formation. While it was 
noted that replacement of the tyrosine with glutamic acid (mimicking a phosphorylated 
state) did not cause a disruption to biofilm formation, replacement of the terminal 
tyrosine residues with phenylalanine did (Figure 5-2). Additionally, it was noted that 
complementation of a ptkA Y225F-Y227F-Y228F mutant was less successful with ptkA 
Y225A-Y227A-Y228A than a wild type copy of ptkA.  This outcome was unexpected as no 
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difference was first observed between the complex colony of the ptkA Y225A-Y227A-
Y228A mutant and wild type B. subtilis.  It is important to note that the effects observed 
upon substitution of the terminal tyrosine cluster for phenylalanines may be due to an 
impairment of protein stability rather than a loss of tyrosine residues. Future 
experiments will aim to address this issue. 
In summary, the results of the extended investigation of the terminal tyrosine cluster of 
PtkA have tentatively suggested a role for the terminal tyrosine cluster during biofilm 
formation. This is the first study which has suggested that replacement of the terminal 
tyrosine cluster of PtkA with phenylalanines may affect the function of the protein.  In 
fact, other studies have demonstrated that a mutant form of PtkA possessing 
substitutions to phenylalanines at the terminal tyrosine cluster remained active, in the 
sense that it was able to phosphorylate Ugd (Mijakovic, Poncet et al. 2003).  It is 
important to keep in mind that Ugd is not required for biofilm formation and the ability 
of PtkA Y225F-Y227F-Y228F to phosphorylate other target proteins is unknown.   A key 
difference between our study and that of Prof. Mijakovic is that the work presented here 
involves constructing in-frame mutations on the chromosome, the effects of which were 
subsequently assessed in vivo, whereas the Mijakovic study assayed the kinase activity 
of purified mutated PtkA in vitro.   These differences perhaps highlight the need to 
observe mutations in their native environments in addition to studying the impact of 
mutations in vitro.   
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5.5.2 The terminal tyrosine cluster of PtkA may act like a gate 
 
Presuming that all of the mutant alleles of PtkA are stable, it is interesting to note the 
differences between the impacts of substituting the terminal tyrosine cluster residues 
with a range of different amino acids.  X-ray crystal studies of the PtkA homologue 
Cap5B2, from the Gram-positive bacterium S. aureus, demonstrated that the terminal 
tyrosine cluster of a form of Cap5B2 that is unable to autophosphorylate is positioned in 
the active pocket of the kinase (Olivares-Illana, Meyer et al. 2008).  It is mentioned that 
substitution of the terminal tyrosine cluster to glutamic acids (mimicking a 
phosphorylated state) allows Cap5B2 to phosphorylate the cognate partner CapO.  
Furthermore, deletion of the terminal tyrosine cluster region did not inhibit 
phosphorylation of CapO (Olivares-Illana, Meyer et al. 2008).     
Taken together, it appears that the terminal tyrosine cluster of BY-kinases may act like a 
gate; when phosphorylated the gate is open, thus allowing substrates to enter the active 
pocket of the kinase and become phosphorylated.  In contrast when unphosphorylated, 
the gate is closed, and substrates are prevented from becoming phosphorylated. 
Therefore, as the R-group of the amino acid alanine is significantly smaller than that of 
a tyrosine, it is tempting to hypothesise that the reason why no impact on complex 
colony architecture was originally observed upon substitution with alanines was 
because the amino acid was unable to block entry to the active site, and thus the ‘gate’ 
remained open. 
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5.5.3 Investigating the role of YvyG regulated by PtkA 
 
The role of PtkA during swarming and protease production was also explored. In 
summary, the results showed that PtkA does not regulate protease production or 
swarming motility.  However, while investigating the role of PtkA during swarming 
motility, this study highlighted a protein called YvyG.  YvyG is required for swarming 
and swimming motility by B. subtilis (Figure 5-10). PtkA has been shown to 
phosphorylate YvyG in vitro (Jers, Pedersen et al. 2010).  Indeed the localisation of 
YvyG changes depending on the presence or absence of PtkA, thus the authors 
concluded that the location of YvyG is controlled by its phosphorylation state.  
Interestingly the function of YvyG during motility is not dependent on being 
phosphorylated (Figure 5-11).  To expand on these initial findings, I intended to test 
whether the localisation of YvyG was due to a protein-protein interaction with PtkA (as 
they shared identical localisation patterns), or, as the authors suggest, the localisation of 
YvyG was due to becoming phosphorylated by PtkA. Thus, I aimed to test the impact of 
the YvyG Y49A mutation, which cannot become phosphorylated, on the localisation of 
the protein. However, a translational fusion of YvyG-GFP was unable to complement a 
yvyG mutant and restore swarming motility (data not shown) and therefore I felt that 
any data interpreted would be unreliable.  As the translational fusion proteins 
constructed by Jers et al. were not tested to ensure they were functional, this perhaps 
casts doubt on the conclusions drawn by the authors. Overall, the effect of 
phosphorylation on YvyG by PtkA is very interesting, as this study has demonstrated 
that YvyG is able to fulfil an uncharacterised function in addition to motility.  
YvyG was predicted to act as a chaperone as it was suggested to be a homologue of 
FlgN (Pallen, Penn et al. 2005).  FlgN is an export chaperone encoded by E. coli that is 
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involved in flagellar synthesis (Pallen, Penn et al. 2005).  However, it must be noted 
that YvyG and FlgN share very little protein sequence similarity (2 protein BLAST 
alignment shows that only a 6 amino acid run is shared by both proteins; YvyG is 160 
amino acids long).  Indeed, the designation of YvyG as a homologue of FlgN was based 
on two points: 1) that yvyG is located on the chromosome upstream of flgM (which 
mirrors the chromosomal location of flgN and flgM in E. coli); and 2) that the protein 
sequences of YvyG and FlgN are roughly the same length (Pallen, Penn et al. 2005).    
Therefore the function of YvyG as a chaperone remains to be confirmed.  It will be 
interesting to further understand the role of YvyG at the molecular level during flagella 
synthesis and motility.  An interesting outcome of this work has been the discovery that 
PtkA may able to regulate a novel and as of yet undefined function mediated through 
the phosphorylation of YvyG.  Furthermore this work may suggest that, in addition to 
its role controlling motility, YvyG possesses a further function(s), which is subject to 
regulation via phosphorylation.  
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6 Concluding remarks 
6.1 Novel functions are assigned to PtkA and PtpZ 
 
Biofilm formation by B. subtilis has been investigated in detail and, as such, a great deal 
is known about the complex regulatory network controlling biofilm formation at the 
level of transcription.  The work presented here adds to our knowledge of this complex 
regulatory network. An initial aim of this project was to investigate the relationship 
between two key regulators of biofilm formation by B. subtilis; SinR and DegU.  The 
results of the epigenetic study demonstrated that SinR and DegU regulate biofilm 
formation via parallel pathways (see section 3.2).  However, a novel group of genes 
were identified as DegU and SinR co-regulated targets (see section 3.3) and from this 
initial investigation, the gene ptpZ, encoding a bacterial tyrosine phosphatase, was 
found to be required for robust biofilm formation (see Figure 3-3). Following on from 
this, the genes tkmA, encoding a tyrosine kinase modulator, and ptkA, encoding a 
bacterial tyrosine kinase, were also found to be required for biofilm formation by B. 
subtilis (see sections 4.2 and 4.3). These findings allowed novel functions to be 
assigned to the bacterial tyrosine kinase, PtkA, and phosphatase, PtpZ.  Furthermore, 
the work presented here demonstrates for the first time in B. subtilis that biofilm 
formation is subject to regulation at the post-translational level.   
An interesting outcome of this work was that the UDP-glucose dehydrogenase Ugd, 
which is encoded by the gene ugd located within the same operon as tkmA, ptkA and 
ptpZ, is not the physiological target of PtkA and PtpZ during biofilm formation (see 
section 4.5.1). Ugd had been predicted to have a role in biofilm formation due to its role 
in the biosynthesis of teichuronic acid (Pagni, Lazarevic et al. 1999; Mijakovic, 
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Petranovic et al. 2004). Despite extensive attempts to identify the target of PtkA and 
PtpZ during biofilm formation, a target was not identified.  To identify the target of 
PtkA, future work will include the identification of proteins phosphorylated in the 
absence of PtpZ and unphosphorylated in the absence of PtkA using gas 
chromatography-mass spectrometry (GC-MS) coupled with enrichment for tyrosine 
phosphorylated proteins.   Cells would be cultured under biofilm forming conditions, 
and if a target of PtkA and PtpZ is identified, then further experiments would be 
conducted in order to identify the mechanism by which PtkA and PtpZ regulate biofilm 
formation.  
 
6.2 Potential role for phosphorylation of the terminal tyrosine cluster of PtkA  
 
Using a site directed mutagenesis approach, work presented in this thesis has tentatively 
suggested a role for the C-terminal tyrosine cluster of PtkA.  It was determined that 
substitution of the terminal tyrosine residues with the structurally similar amino acid 
phenylalanine had a significant impact on the biofilm architecture (see Figure 5-2). 
Conversely, substitution of the terminal tyrosine cluster with either glutamic acid 
(mimicking a phosphorylated state) (see Figure 5-2) or alanine (see Figure 4-5) did not 
effect biofilm formation.  In toto, the results detailed in sections 5.5.2 and 4.2.2 support 
the hypothesis that the terminal tyrosine cluster acts like a gate, whereby targets of PtkA 
would be able to enter the active site and become phosphorylated when the terminal 
tyrosine cluster itself is phosphorylated, as this displaces the C-terminal domain from its 
position blocking the active site (Lee, Zheng et al. 2008; Olivares-Illana, Meyer et al. 
2008).   This model is supported by other studies that investigated the role of the 
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terminal tyrosine cluster of BY-kinases.  Firstly, it was demonstrated that a mutant 
variant of Cap5B2, from S. aureus, in which the terminal tyrosine cluster residues were 
substituted for glutamic acid, was still able to phosphorylate its target CapO (Olivares-
Illana, Meyer et al. 2008).  This is consistent with the finding that mutation of the C-
terminal tyrosine cluster in PtkA to glutamic acid did not affect biofilm formation 
(Figure 5-2). The authors were also able to demonstrate that a variant of Cap5B2, in 
which the terminal tyrosine cluster was completely removed, could still phosphorylate 
CapO (Olivares-Illana, Meyer et al. 2008), indicating that access to the active site of the 
kinase was still possible.  Secondly, it was demonstrated that a mutant variant of the 
BY-kinase Wzc, from E. coli, which lacked the terminal tyrosine cluster domain, was 
still able to phosphorylate its target Ugd (Grangeasse, Obadia et al. 2003). Once more 
indicating that the active site of the kinase was accessible.  Thus, the data presented 
here, and the results from other studies, support an ‘open/closed gate’ hypothesis.  This 
may represent a generalised regulatory mechanism by which endogenous targets of BY-
kinases are phosphorylated. This of course remains to be experimentally proven and the 
assessment of protein stability and X-ray crystal structures of PtkA and the PtkA mutant 
variants would be highly informative in establishing if this hypothesis is correct.   
 
6.3 Do BY-kinases represent a valid target for the development of antimicrobials? 
 
It has been suggested that BY-kinases may provide a novel target for antibacterial 
therapeutic compounds (Cozzone 2009; Grangeasse, Terreux et al. 2009). This is based 
on a number of reasons: 1) BY-kinases are structurally different from eukaryote-like 
kinases and include unique features such as the conserved terminal tyrosine cluster. This 
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would ensure drug specificity for a prokaryotic target; 2) BY-kinases regulate a wide 
range of cellular processes which include the regulation of polysaccharide production 
and thus are implicated in the regulation of virulence in pathogenic bacteria; 3) BY-
kinases are encoded in a wide range of bacteria including pathogenic isolates suggesting 
that compounds developed would be effective across different species. However, in my 
opinon it remains to be established whether BY-kinases actually do represent a valid 
target for anti-microbial compounds. The proposed mechanism for blocking BY-kinase 
function centres on disrupting the oligomeric structure which is predicted for BY-
kinases from both Gram-positive (Olivares-Illana, Meyer et al. 2008) and Gram-
negative species (Lee, Zheng et al. 2008) during the regulation of polysaccharide 
production. It is thought that fusing an artificial C-terminal tyrosine cluster domain to a 
compound will target the molecule to the BY-kinase (Cozzone 2009).  Once the 
artificial C-terminal tyrosine cluster is positioned in the active site of the targetted BY-
kinase this will inhibit oligomerisation of neighbouring kinases. This would 
subsequently inhibit their function. It is unclear how stable these compounds will be, 
since it is possible that the artificial terminal tyrosine clusters fused to the compounds 
could become phosphorylated. This could conceivably dissociate the artificial terminal 
tyrosine cluster from the active pocket and render the compound ineffective. 
Additionally, there is the chance of developing resistance to potential compounds via 
co-evolution, which would naturally render the antimicrobial compound ineffective.  It 
also needs to be recognised that blocking the active site of BY-kinases may have 
various impacts depending on the specific kinase.  Indeed, substitution of the terminal 
tyrosine cluster of PtkA with phenylalanines (thus mimicking an unphosphorylated state 
in which the cluster is thought to sit in the active site) had a significant impact of colony 
morphology (see Figure 5-2).  However, phenylalanine substitution of the terminal 
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tyrosine cluster of CpsD from S. pneumonia did not significantly affect capsular 
polysaccharide production or virulence (Morona, Miller et al. 2004). Examples like this 
raise the question of how useful compounds designed to target BY-kinases will be in 
controlling their function.  Therefore it can be concluded that a significant amount of 
research remains to be conducted before BY-kinases should be proposed as novel anti-
bacterial targets.  
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8 Appendices 
8.1 Appendix A: Buffers and Solutions  
 
General buffers Composition 
  
B. subtilis transformation buffer 1X T-Base  
 2 mM EGTA  
  
10x PBS 1.37 M NaCl 
 26.8 mM KCl 
 104.36 mM NaHPO4 
 17.64 mM KH2PO4 
  
SDS running buffer 25 mM Tris-HCl (pH 8.3) 
 192 mM Glycine 
 0.1 % (w/v) SDS 
  
10X T-Base 150 mM (NH4)2SO4 
 800 mM K2HPO4 
 440 mM KH2PO4 
 34 mM Sodium citrate 
  
50X TAE 2 M Tris-acetate 
 50 mM EDTA (pH 8.0) 
  
10X TBE 0.9 M Tris-borate 
 0.02 M EDTA (pH 8.0) 
  
20X TBS 400 mM Tris-HCl (pH 8.0) 
 3 M NaCl 
  
TBST (also Western wash buffer) 1X TBS 
 0.05 % (v/v) Tween 20  
  
5X Tris-glycine 250 mM Tris 
 2 M glycine 
 8.75 mM EDTA (pH 8.0) 
  
Wash buffer 1X T-Base 
 1 mM Mg2SO4 
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Western Blocking buffer 1X TBST 
 5 % (w/v) skimmed milk powder 
  
Western Transfer buffer 25 mM Tris-HCl  
 192 mM Glycine 
 0.2 % (v/v) Tween 20 
 20 %  (v/v) Methanol 
  
  
  
gDNA extraction  
Lysis buffer 0.1 M NaCl  
 0.05 M EDTA (pH 7.5) 
  
  
  
Protein purification  
DegS cell pellet wash buffer 10 mM Tris-HCl (pH 7.6) 
  
DegS Denaturing buffer 50 mM Tris-HCl (pH 7.6) 
 150 mM NaCl  
 8M Urea  
 10 mM Imidazole  
  
DegS Renaturing buffer 50 mM Tris-HCl (pH 7.6) 
 150 mM NaCl  
 10 mM Imidazole  
  
DegS Elution buffer 50 mM Tris-HCl (pH 7.6) 
 150 mM NaCl  
 500 mM Imidazole  
  
DegS Dialysis buffer 50 mM Tris-HCl (pH 7.6) 
 200 mM KCl  
 10 mM MgCl2  
 0.1 mM EDTA  
 1 mM DTT  
 50% (v/v) Glycerol 
  
DegU cell pellet wash buffer 20 mM Tris-HCl (pH 8.0) 
 200 mM NaCl  
  
DegU Cell lysis buffer 20 mM Tris-HCl (pH 8.0) 
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 200 mM NaCl  
 10 mM Imidazole 
 2 mM Benzamidine 
 1.0 % (v/v) Triton X-100 
 
1 Roche protease inhibitor EDTA-
free tablet / 7ml buffer 
  
DegU HisTrap column wash buffer 20 mM Tris-HCl (pH 8.0) 
 200 mM NaCl  
 30 mM Imidazole 
  
DegU Elution buffer 20 mM Tris-HCl (pH 8.0) 
 200 mM NaCl  
 500 mM Imidazole 
  
DegU DEAE binding buffer 20 mM Tris-HCl (pH 7.6) 
 1 mM EDTA 
 0.5 mM DTT 
  
DegU DEAE elution buffer 20 mM Tris-HCl (pH 7.6) 
 1 mM EDTA 
 0.5 mM DTT 
 1 M NaCl 
  
DegU Dialysis buffer 20 mM Tris-HCl (pH 8.0) 
 50 mM NaCl  
  
Novagen Thrombin Cleavage buffer 20 mM Tris (pH 8.4) 
 150 mM NaCl 
 2.5 mM CaCl2 
 5 % (v/v) Glycerol 
 2 μl ml-1 Biotinylated Thrombin 
  
SinR cell lysis buffer Novagen BugBuster Master Mix 
 10 mM Imidazole 
  
SinR cell pellet wash buffer 20 mM Tris-HCl (pH 8.0) 
 200 mM NaCl  
  
SinR Dialysis buffer 10 mM Tris-HCl (pH 8.0) 
 10 mM MgCl2 
 1 mM EDTA 
 0.3 mM DTT 
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 1 mM PMSF 
  
SinR Elution buffer 50 mM Tris-HCl (pH 8.0) 
 500 mM NaCl 
 250 mM Imidazole 
  
SinR HisTrap column wash buffer 50 mM Tris-HCl (pH 8.0) 
 500 mM NaCl 
 20 mM Imidazole 
  
  
  
EMSA  
5X DegU phosphorylation buffer 500 mM Tris-HCl (pH 7.6) 
 0.5 mM EDTA 
 20 mM MgCl2 
 2.5 mM DTT 
 17.5% (v/v) Glycerol 
  
10X DegU~P EMSA reaction buffer 150 mM Tris-HCl (pH 7.6) 
 2 % (v/v) Tween 20 
 10 mM MgCl2 
 600 mM NaCl 
 5 mM DTT 
  
5X SinR EMSA reaction buffer 50 mM Tris-HCl (pH 7.6) 
 5 mM MgCl2 
 250 mM NaCl 
 25 % (v/v) Glycerol 
 5 mM EDTA 
 5 mM DTT 
 250 ng μl-1 BSA 
 250 ng μl-1 Poly (dI-dC) 
  
  
  
Dyes  
6X DNA loading dye for EMSA 0.025 % (w/v) Xylene cyanol 
 0.025 % (w/v) Bromophenol Blue 
 30 % (v/v) Glycerol 
  
2X SDS loading dye 375 mM Tris-HCl (pH 8.8) 
 20% β-mercaptoethanol 
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 4 % (w/v) SDS 
 0.2 % (w/v) Bromophenol Blue 
 20 % (v/v) Glycerol 
  
  
  
Solutions   
Coomassie destain 50 % (v/v) Methanol 
 10 % (v/v) Acetic Acid 
  
Coomassie stain 50 % (v/v) Ethanol 
 7.5 % (v/v) Acetic Acid 
 
0.1 %  (w/v) Coomassie Brilliant 
Blue 
  
ECL solution 1  100 mM Tris-HCl (pH 8.5) 
 2.5 mM Luminol 
 0.4 mM p-Coumaric Acid 
  
ECL solution 2 100 mM Tris-HCl (pH 8.5) 
 0.0192 % (v/v) H2O2 
  
Luminol solution 250 mM made in DMSO 
  
p-Coumaric Acid 40 mM made in DMSO 
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8.2 Appendix B: Papers published from this work 
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